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Abstract
Contamination of water by waterborne viruses causes serious health issues world-
wide. The current virus detection methods are expensive and time-consuming and
require access to well-equipped laboratories. This thesis describes the development
of an impedimetric all-polymer aptasensor for detection of three types of waterborne
viruses: norovirus, rotavirus and hepatitis A virus. The development of the aptasen-
sor involved sample preparation for aptamer selection of rotavirus and hepatitis A
virus, an iterative design process of the aptasensor, investigation of the surface im-
mobilisation of aptamers and finally an impedimetric electrical characterisation of
the sensor.
The sample preparation of the rotavirus was based on purification and biotinylation
of the virus to meet the requirements of the aptamer selection process. The selection
process, performed by an external collaborator, was based on streptavidin coated
magnetic bead separation, hence the needed biotinylation. It was found that the
BPH linker gave the highest yield when the biotinylated rotavirus were immobilised
onto the beads.
The design of the viral aptasensor was determined by an iterative design process.
The final chip design was based on a SD card design with an injection moulded PC
substrate and lid. The electrodes were screen-printed PEDOT:PSS.
The surface immobilisation of aptamers through UV cross-linking onto di erent
polymer substrates was tested. As the success of this step is crucial for the aptasensor
specificity and performances, the surface immobilisation was throughly investigated.
The aptamer UV cross-linking onto PEDOT:PSS was promising. Furthermore, some
passive absorption of the aptamers onto the PEDOT:PSS was found.
The impedimetric electrical characterisation of the aptasensor chip was done with
di erent media salinity and di erent pH values. The impedimetric measurements of
the di erent media salinity showed the expected behaviour with the greatest change
present in the region representing the solution resistance. The pH measurements did
not show any significant change of the impedance, hence the chip was stable in the
measured pH range, which corresponds to the expected pH range of water samples..
The stability of the aptasensor chip was tested over a 2 week period in continuous
flow. It was found that the electrodes were not damaged or degraded during the
time period, as a constant impedance signal was measured.
A solid foundation for the further development of the aptasensor for viral detection
has been established and from this a new cheap and simple viral detection method
can emerge.
iii

Resumé
Forurening af vand ved vandbårne virus forårsager alvorlige sundhedsmæssige prob-
lemer på verdensplan. De nuværende virus detektions metoder er dyre og tid-
skrævende og kræver adgang til veludstyrede laboratorier. Denne afhandling beskriver
udviklingen af en impedans baseret polymer aptasensor til påvisning af tre typer af
vandbårne virus: norovirus, rotavirus og hepatitis A virus. Udviklingen af aptasen-
soren involverede prøveforberedelse til aptamer selektion af rotavirus og hepatitis A
virus, en iterativ design proces af aptasensoren, undersøgelse af overfladen immo-
bilisering af aptamerer og endelig en impedans baseret elektrisk karakterisering af
sensoren.
Prøveforberedelsen af rotavirus var baseret på oprensning og biotinylering af virusset
for at opfylde kravene til aptamer selektionsprocessen. Selektionsprocessen, udført
af en ekstern samarbejdspartner, var baseret på separation af streptavidin overflade-
behandlede magnetiske partikler, deraf nødvendigheden af biotinyleringen. Det blev
konkluderet, at BPH linkeren gav det højeste udbytte, når de biotinylerede rotavirus
blev immobiliseret på partiklerne.
Designet af den virale aptasensor blev bestemt ved en iterativ designproces. Det
endelige chip design var baseret på et SD kort design med et sprøjtestøbt PC sub-
strat og låg. Elektroderne var serigrafitrykt PEDOT:PSS.
Overflade immobilisering af aptamerer gennem UV krydsbinding på forskellige poly-
mersubstrater blev testet. Eftersom succesen af dette trin er afgørende for aptasen-
sorens specificitet og ydeevne, blev overflade immobilisering grundigt undersøgt. UV
krydsbindingen af aptamerer på PEDOT:PSS var lovende. Desuden blev der fundet
passive absorption af aptamerer på PEDOT:PSS.
Den impedans baserede elektriske karakterisering af aptasensor chippen blev ud-
ført med medier af forskellig saltindhold og forskellige pH-værdier. De impedans
baserede målinger af forskellige saltindhold viste det forventede signal med den
største ændring i regionen der repræsenterer den elektriske modstand af opløsningen.
pH-målingerne viste ingen signifikant ændring af impedansen, dermed var chippen
stabil i det målte pH-område, som svarer til det forventede pH-område på vand-
prøver. Stabiliteten af aptasensor chippen blev testet over en 2 ugers periode under
kontinuerlig væskestrøm. Det blev konstateret at elektroderne ikke blev beskadiget
eller nedbrudt i tidsperioden, da et konstant impedans signal blev målt.
Et solidt fundament for videre udviklingen af aptasensoren til viral detektion er
blevet etableret, og ud fra dette kan en ny billig og enkel viral påvisningsmetode
opstå.
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Thesis introduction and overview
Clean water resources are essential for public health and to ensure a well functioning
society. Contamination of water resources by pathogens from e.g. sewage overflow
caused by heavy rain or ine cient raw or wastewater treatment cause a serious
public health risk. Di erent waterborne pathogenic microorganisms can be found
in the water: viruses, bacteria, protozoa or parasites. Each type demands di erent
sample preparation and detection methods. In this thesis the focus will be on wa-
terborne viruses and development of a new virus detection method of three virus
types: norovirus (NoV), rotavirus (RV) and hepatitis A virus (HAV).
Most cases of viral gastroenteritis caused by waterborne viruses in the adult popu-
lation are caused by NoV [1, 2]. RV is the major cause of gastroenteritis in small
children [2, 3]. Especially, children in developing countries su er from gastroenteri-
tis caused by RV due to bad sanitation and hygiene [2]. Apart from gastroenteritis,
hepatitis is one of the major diseases caused by waterborne viruses, where HAV
causes 50 % of all cases of hepatitis worldwide [2, 4]. Infected people shed viruses
in extremely high numbers, up to 1010 and 1013 viral particles per gram of stool for
patients su ering from HAV infection and gastroenteritis, respectively [1–3, 5].
In the case of viral outbreaks, the concentration of viruses in the wastewater greatly
increases and e ective water treatment for virus inactivation or removal cannot
ensure complete virus removal [2]. This creates a serious health risk since small
amount of infectious virus (virions) can cause illness. It is thus important to retain
contaminated water from the distribution system before it reaches the consumer
i.e. as drinking water or from wastewater irrigated food. Ideally, all raw water
treatment plants should continuously monitor the water before distribution to avoid
pathogenic outbreaks, but unfortunately that is not the case due to the complexity
of virus detection.
Due to their small size, approximately 25-100 nm in diameter, the three viruses,
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NoV, RV and HAV, cannot be observed by conventional light microscopy or easily
filtered to concentrate the sample. This obstacle challenges the current detection
methods. Currently, the most used detection technique is polymerase chain reac-
tion (PCR) where specific genomic section of the virus genome is amplified and
detected [2, 6]. All of the conventional detection techniques have common disadvan-
tages: they are time consuming, labor intensive and expensive. Furthermore, they
all require a full scale laboratory setting to perform the analysis. New detection
techniques, e.g. based on biosensors, that overcomes these disadvantages are thus
required. In this thesis the conventional viral detection techniques and the basic
knowledge of the three viruses, NoV, RV and HAV, are described in chapter 2.1.
The aim of this PhD project was the development of an aptasensor for the de-
tection of waterborne viruses that can overcome the challenges of the conventional
detection methods. The iterative steps involved in the development of the aptasen-
sor is illustrated in figure 1.1. The term aptasensor is used when aptamers are
used as the biorecognition element in a biosensor. The iterative steps listed in the
figure: assay requirements, target selection, aptamer selection, aptasensor selection
and aptasensor development, will all be touched upon in this thesis.
The developed aptasensor is an all-polymer sensor with a polymer substrate and
conducting polymer electrodes for electrochemical detection. The biorecognition el-
ements of the sensor are aptamers which are single stranded oligonucleotides that
can be selected to specifically bind a target molecule, much like the principle of an-
tibodies. The aptamer selection is done through a cyclic process called systematic
evolution of ligands by exponential enrichment (SELEX). In this thesis the basic
concepts of aptamers, aptamer selection and biosensors are described in detail in
chapter 2.2 and 2.3. Furthermore, the present development and use of aptasensors
for viral detection will be described in chapter 2.3.
Aptamers specific for NoV have already been developed by Beier et al. and Escudero-
Abarca et al. [7, 8]. This PhD project aims to prepare samples for the development
of aptamers that specifically targets the surface proteins of RV and HAV. The SE-
LEX process for the aptamer selection is performed by an external collaborator at
Fraunhofer Institute for Cell Therapy and Immunology (IZI), Germany. The selec-
tion of the right viral genotypes and serotypes for the aptamer selection is important
since each viral subtype has di erent prevalence and virulence. The work related
to selection of the right viral genotype and serotype and the sample preparation for
aptamer selection of the RV and HAV are described in chapter 3.
The iterative design and fabrication process for the viral sensor chip is described
in chapter 4. Parts of the design and fabrication was done in collaboration with
Flusens ApS. The initial chip development was based on previous work done by
Kiilerich-Pedersen et al., 2011 and 2013, and Daprà et al., 2013 [9–11].
3The surface immobilisation of the biorecognition elements onto the electrodes
in the biosensor is of pivotal importance to ensure a successfully working biosen-
sor. Thus, surface immobilisation of the aptamers on the electrode material is
explored. The electrode material, poly(3,4-ethylenedioxythiophene) polystyrene sul-
fonate (PEDOT:PSS), is rather chemically inert, which limits the available methods
for aptamer immobilisation. The explored immobilisation method is based on UV
crosslinking of the aptamers with the polymer substrate through a specific oligonu-
cleotide tag on the aptamer. The concept behind the UV crosslinking with the
specific oligonucleotide tag was initially described in the work of Dufva et al., 2004
and 2006, and Sun et al., 2012 [12–14]. The experimental work related to the sur-
face immobilisation is described in chapter 5. The work related to the ELISA based
surface immobilisation was done in collaboration with PhD Solène Cherré.
The experimental work related to the characterisation of the developed aptasensor
and electrochemical measurements is described in chapter 6.
In summary, the overall aim of this PhD thesis is the development of an aptasen-
sor for viral detection of NoV, RV and HAV. The thesis also aims at locating the
relevant viral genotype and serotype for aptamer development and preparing the vi-
ral samples for aptamer development. Furthermore, the aim is to explore the surface
immobilisation of the aptamers onto the electrode material and to electrochemically
characterise the developed aptasensor.
Diagnostic need
Assay requirements
Sensitivity
Specificity
Multiplexing
Detection matrix
Target selection
Virus strain 
Aptamer selection
Sample preparation
SELEX
Aptasensor selection
Material selection
Transducer method
Functionalisation 
Aptasensor development
Characterisation
Environmental stability
Target testing
Aptasensor validation 
for field testing
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3
4
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Figure 1.1: Overview of the iterative steps involved in the aptasensor development
for the detection of waterborne virus in environmental samples.
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1.1 Thesis outline
In this section an outline of the thesis is presented. Each chapter is briefly described
to give the reader a fast and easy overview of the content and structure of the thesis.
Chapter 2 - Theoretical introduction
This chapter focuses on three main topics: enteric viruses and detection methods,
aptamers and biosensors. The theoretical background knowledge needed to under-
stand the practical work of this thesis is presented in the chapter. The chapter also
gives the reader an overview of the current status within the field of aptasensors for
viral detection.
Chapter 3 - Virus preparation for aptamer selection
The considerations of the relevant viral genotypes and serotypes of RV and HAV
for aptamer development are given in this chapter. Furthermore, the viral sample
preparation methods for the aptamer development are described.
Chapter 4 - All-polymer aptasensor design and fabrication
development
The development of the all-polymer aptasensor chip is described in this chapter. The
di erent iteration steps of the chip design and the chip fabrication are described.
Chapter 5 - Exploring the surface immobilisation of
aptamers
This chapter describes the experimental work related to the surface immobilisation of
the aptamers. UV crosslinking of the aptamers to the electrodes surface is explored
in great detail.
Chapter 6 - Aptasensor characterisation and EIS
measurements
The impedimetric characterisation and stability measurements of the aptasensor is
described in this chapter.
Chapter 7 - Conclusion and perspective
Concluding remarks of the thesis and future perspectives are given in this chapter.
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Appendix A - Step by step protocols and material lists
Appendix B - Aptamer sequences
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Theoretical introduction
This PhD thesis touches upon three major topics: enteric viruses, aptamers and
biosensors. This chapter gives a short theoretical background introduction to these
three topics and gives an overview of the current scientific status within these fields.
Enteric viruses are introduced with special emphasis on the three di erent virus
types: norovirus (NoV), rotavirus (RV) and hepatitis A virus (HAV). Furthermore,
the detection methods of these enteric viruses in environmental water samples will
be described.
This chapter also focuses on aptamers and the selection of these. The usage of
aptamers and the advantages and disadvantages compared with antibodies will be
discussed.
The last section of the chapter concerns bio- and aptasensors. The section focuses
on electrochemical biosensors, aptasensors and aptasensors for viral detection.
2.1 Enteric viruses and virus detection methods
Viruses are very small (20-400 nm) infectious agents [15]. They cannot replicate
without a host cell which means that they completely rely on other life forms to
replicate [15, 16]. Cells, or viruses, do not have a ribonucleic acid (RNA) genomic
proof-reading system which means that RNA viruses are highly prone to genomic
mutations and thereby able to generate new viral strains. Once inside the host
body, viruses target di erent cell types for replication depending on the virus type.
Viruses contain either deoxyribonucleic acid (DNA) or RNA that code for the pro-
teins needed for virus uptake into host cell and replication and maturation inside
the host cell. Furthermore, they are typically host specific i.e. they only infect
humans, birds, monkeys, plants or bacteria etc., although some viruses can infect
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both humans and animals [16].
Viruses that are shed through the human faeces may cause gastroenteritis or hepati-
tis through ingestion of water contaminated with viruses of faecal origin [17]. The
group of viruses that infect the human host through the faecal-oral route and pri-
marily target and multiply in the cells of the gastrointestinal tract are called enteric
viruses [16, 17]. Figure 2.1 shows a schematic overview of the faecal-oral route of
infection. NoV, RV and HAV are all part of the group of enteric viruses [16]. All of
these viruses are shed in the faeces and both NoV and RV replicate in the epithelial
cells of the gastrointestinal tract while HAV replicates in the hepatocytes of the
liver. Typically, waterborne viruses are very stable since they do not have a lipid
envelope - so called non-enveloped viruses [6].
The major causes of acute non-bacterial gastro-enteritis worldwide in adults and
infants are infections caused by NoV and RV, respectively [3, 18]. Outbreaks of
NoV are usually observed during the winter months [18]. Infection with HAV can
cause acute hepatitis. It is estimated that HAV is responsible for 50 % of acute viral
hepatitis cases in the world [2].
Ingestion of virus polluted water can thus lead to severe illness and potentially lead
to a lethal outcome. NoV, RV and HAV are shed through the faeces in very high
numbers from infected people. Virus levels as high as 1010 to 1013 viral particles per
gram of stool have been reported [1–3, 5]. It is thus important to detect these viruses
in the water before they enter the human body and cause new cases of infection [2].
Furthermore, the infectious dose of these virus are as low as 10-100 virus particles
[1, 4]. Due to the high prevalence of infections with these three viruses they were
chosen as the focus for this PhD thesis.
2.1.1 Enteric viruses: norovirus, rotavirus and hepatitis A
virus
As described above, the enteric viruses have similar route of transmission. Figure
2.1 illustrates the faecal-oral route of transmission of enteric viruses. Individuals
are infected via the faecal-oral route after ingestion of food or water contaminated
with faeces or vomit [1, 4]. Thus, individuals drinking contaminated water or eating
food cultivated with contaminated water have a risk of getting infected. Further-
more, infection can be either symptomatic or asymptomatic leading to challenges in
preventing the spread of viruses. Secondary cases of infection can also occur after
person-to-person contact [4, 18].
This section provides a description of the three enteric viruses.
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Figure 2.1: Routes of transmission of enteric viruses [1]. Primary cases of infec-
tion with enteric viruses can be either symptomatic or asymptomatic. Primary cases
can directly lead to new cases of infection through food contaminated from viruses
from a single individual. Secondary cases can also occur through person-to-person
contact, by contaminated surfaces or through aerosols. Water contaminated with
viruses can also lead to infection. Furthermore, consumption of shellfish that filter
virus contaminated water can cause infection.
NoV
NoV belongs to the Caliciviridae family. The virus is a non-enveloped icosahedral
positive sense single stranded RNA (ssRNA) virus [19]. The NoV particle has a
diameter of 30-38 nm [1]. NoV is divided into five major genogroups: GI through
GV where GI, GII, and GIV infect humans [19]. Furthermore, genogroups GI, GII,
and GIII are subdivided into 8, 19, and 3 genotypes [19]. It is thus evident that
NoV expresses a great genetic diversity. Genogroup GII was associated with 89 % of
NoV cases in outbreaks in Europe from 2000-2005 with the predominating genotype
GII.4 in 56 % of the cases [19].
The virus capsid consists of the major capsid protein VP1 (90 dimers per virion)
and the minor capsid protein VP2 (one or two copies per virion) [20]. Figure 2.2
shows the genomic representation and the capsid structure of the NoV virion. The
genomic sequence of the protruding region of VP1 that is present on the virion sur-
face shows the highest genomic variability [19]. It is thus suspected that this region
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is the dominating region for formation of antigenic sites and receptor binding sites
on the virion [19, 20]. However, the basic understanding of the virus replication
is limited since the human NoV cannot be cultured in vitro due to the inability
of identifying receptor-bearing cell lines [19, 20]. Currently, only a successful cell
culture system for murine NoV exists [21]. VP1 can self-assemble into virus-like
particles (VLP), without RNA and VP2, and can thus be used as a model virus for
NoV research [20].
Figure 2.2: Norovirus capsid structure. a) Structural representation of the NoV
genome with the three open reading frames (ORF). ORF1 encodes for the non struc-
tural proteins. ORF2 and ORF3 encode for the structural proteins VP1 and VP2,
respectively. The colour coding of VP1 represents the genomic sequence for the dif-
ferent protein domains illustrated in b and c. The shell domain is represented in
yellow while the red and blue domain represents protruding domain of VP1. The red
subdomain is present on the virion surface thus susceptible to the highest genomic
variability. b) Ribbon diagram of the VP1 structure with colour coded domains. c)
VP1 dimer. d) Illustration of the the NoV virus like particle formed by 90 VP1
dimers. Figure from [22].
On a global scale, NoV is the leading cause of nonbacterial gastroenteritis in
humans and it usually occurs in outbreaks [19, 20, 23]. NoV outbreaks can occur
with attack rates as high as 70 % [1]. It infects people of all ages and rarely causes
death [1]. The most common symptoms of infections are diarrhoea, vomiting, fever,
and abdominal pain. After an incubation time of approximately 12-72 hours the
illness often lasts 1-4 days but viral particles can be found in the patients and shed
for up to two weeks [1]. The number of virus particles in the faeces and/or vomit
is very large ( >109 particles/g) [1]. Furthermore, the infectious dose of NoV is
estimated to be in the order of 10-1000 virus particles and viruses can be infectious
years after secretion from the human body [1, 24]. All of these factors combined
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illustrates why NoV is the dominating cause of non-bacterial gastroenteritis world
wide and why it requires e cient monitoring.
RV
RV belongs to the family of Reoviridae. The genome of the virus comprises of 11
double stranded RNA (dsRNA) segments [25]. The RV has an icosahedral structure
with a non-enveloped triple-layered protein capsid surrounding the dsRNA. The RV
diameter is around 100 nm for the mature virus particle [25]. The capsid of the
virion is composed of six structural proteins (VP1-4, VP6-7). VP6 is the interme-
diate capsid protein which interacts with the core proteins while VP4 and VP7 are
the outer capsid proteins [3]. Figure 2.3 illustrates the structure of the virion with
the structural and non-structural proteins and the 11 genomic segments of the virus
coding for the proteins [3].
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Figure 2.3: Illustration showing the relationships between the structure of the RV
virion and the dsRNA genomic segments. The mature virus particle has a triple-
layered capsid structure that surrounds the 11 dsRNA segments. The three layers of
the capsid are composed of an outer layer (VP4 and VP7), an intermediate layer
(VP6) and an inner core layer (VP1-3) [25]. Figure from [3].
Seven di erent serogroups (A-G) of RV have currently been identified. The
structural proteins carry epitopes specifying these groups. Groups A, B, and C can
cause human infection [3]. Group A is known to cause the most cases of human RV
infections [3]. Group A RV is distinguished by two main subgroups, G types, and
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P types. G types consist of di erent VP7 specific serotypes while P types consist
of di erent VP4 specific genotypes [3]. G genotypes and G serotypes correlate to
each other and no distinction between the two are made. On the other hand, the
correlation between the P genotypes (denoted in square brackets) and serotypes
have not been shown completely and the two are thus distinguished [3]. At least 73
di erent strains of G/P genotype combinations have been shown to infect humans
[26]. Four strains are responsible for about 75 % of all human infections: G1P[8]
(52 %), G2P[4] (11 %), G4P[8] (8 %), and G3P[8] (3 %) [3].
Group A RV is the dominating cause of acute infantile gastro-enteritis in the
world but the virus can also, though rarely, infect adults [3, 25]. RV infection
can be lethal especially in developing countries due to poor sanitation and limited
medical help. It is estimated that each year 2 million children under the age of 5
years die from diarrhoeal diseases where 40 % is caused by RV [3, 25]. In developing
countries 40-50 % of hospitalisations of children is due to a diarrhoeal disease caused
by RV [3]. Infections usually occur during cooler months in the winter period [25].
The incubation time is approximately 48 h, or less, with onset of the most common
symptoms: fever, diarrhoea and dehydration that lasts for approximately 3 days [25].
Group A RV have been adapted to cell culture and can thus be cultured in vitro.
A cytopathic e ect (CPE) caused by the virus infection in the cells is visible. As
a positive consequence of the successful RV culture several live attenuated vaccines
produced from cell culture have been licensed [25].
HAV
HAV belongs to the Picornaviridae family. The virus is a non-enveloped virus with
an icosahedral symmetry of 27-32 nm in diameter [4, 27]. The virus genome is
a positive sense ssRNA [27]. The virion structure is composed of four structural
proteins VP1-4, where VP1-3 are expressed at the surface of the capsid. Only one
HAV serotype exists and within this serotype several strains are found that can be
distinguished by genomic sequencing [27]. Genotype I represents most of the human
infections and genotype III most of the remaining [27]. Both genotypes I and III are
divided into subgroup A and B. HAV IA is the dominating subgenotype since 80 %
of isolates from infected individuals were HAV IA [28]
HAV infects people of all ages but infection is more predominant in children and
young adults and rarely with a lethal outcome [27]. HAV enters the body via the
gastrointestinal tract, replicates in the liver hepatocytes and is excreted in the faeces
[27]. The primary symptoms of acute viral hepatitis caused by HAV infection are
jaundice, fever, vomiting and diarrhoea [27]. The incubation period is 10-50 days
but viruses are shed in faeces before the onset of clinical symptoms and can thereby
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lead to secondary cases [27].
HAV can be cultured in vitro, but only in primary cells, and the culture is not
suited for routine work since the culture and isolation can take up to weeks, suc-
cessful culture is di cult and CPE is normally not present [4, 27]. The development
of the culture system has led to the development of a successful HAV vaccine with
inactivated virus. It is possible to inactivate the HAV with formaldehyde without
modifying the surface structure of the virion thus preserving the antigenic epitopes
of the virion [29, 30].
HAV virions are very stable viral particles since infectivity is preserved when
heated up to 80 ¶C and pH values down to 2 [30]. Furthermore they can remain
infectious when dried and stored at 25 ¶C, humidity 45 %, for at least 1 month and
remain infectious for days to several months in wastewater [27]. This illustrates why
HAV monitoring is extremely important in relation to public health.
2.1.2 Conventional detection methods for environmental
water samples
Once faecal matter, with infectious viruses, are present in the water environment
there is a risk of new cases. Even though viruses are diluted in the water they
can still cause infection, especially considering the low infectious dose, but the low
concentration is impeding detection. A concentration of the water sample before
detection is thus necessary. The detection of viruses in environmental water sam-
ples is commonly done with molecular detection methods but other techniques exist
as well. Faecal indicators have also been used as an indirect way of virus detection.
In this section the di erent techniques will be described.
Concentration and recovery of virus from environmental water samples
Concentration and recovery of enteric viruses from water samples is critical and nec-
essary prior to water analysis due to the low concentration of viruses present in the
water. Water sample volumes ranging from 1-1000 L must be reduced to a few mL to
enable analysis. Concentration of viruses can be done by utilising the electrokinetic
properties of the virus by electropositive or electronegative filters or by size exclu-
sion by ultrafilters [18, 31]. Electronegative filters, e.g. nitrocellulose membranes
(Millipore), require acidification and addition of salts to the water sample which is
di cult for large water samples [31]. Electropositive filters do not require any pre-
treatment of the sample but filters are usually more expensive than electronegative
filters [31]. The electropositive glass wool filter is an exception to the high cost but
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unfortunately glass wool filters show great variance in virus adsorption and hence
large di erence in virus recovery [31]. Virus concentration can also be performed
on the basis of size exclusion by ultrafiltration. Ultrafiltration does not require any
pretreatment or adjustment of the water sample but pretreatment of the filter can
increase the recovery [31]. Ultrafiltration requires expensive equipment which is not
suited for field testing [31]. The virus concentration by the di erent filters is followed
by an elution step, or a backflushing step for ultrafilters, which recovers the viruses
from the filters [18, 31]. The elution is performed by an elution bu er which can
either be an organic solution containing beef extract and/or glycine or an inorganic
solution e.g. sodium polyphosphates or sodium hydroxide [31]. The filter eluate can
be further concentrated to reduce the sample volume to an even smaller volume. As
an alternative to the filter based concentration methods ultracentrifugation of the
virus samples can be performed. Ultracentrifugation is centrifugation with forces Ø
100,000 ◊g [31]. Due to the small size of the enteric virus (? 25 nm - 100 nm) the
high gravitational forces are necessary in order to exceed the forces needed to pellet
the viruses. The ultracentrifugation method is not suitable for large volumes ( > 0.5
L) and requires expensive and delicate equipment. The concentration and recovery
of virus from environmental samples will not be covered more extensively in this PhD
thesis. For a more elaborate description of the concentration and recovery of en-
teric viruses from water the reader is referred to the review by Ikner et al., 2012 [31].
Virus detection methods of environmental water samples
Virus analysis of environmental samples is a di cult task. The methods for virus
detection are numerous and the current techniques are costly, slow and requires
trained personnel and specialised laboratory facilities. The most commonly used
methods are: molecular detection methods, immunological methods and electron
microscopy [18]. Traditional cell culture infectivity assays can also be used to detect
the virus but they require a cell culture system where viruses cause a CPE. Further-
more, human faecal indicators have also been proposed as an indirect method for
enteric viral detection in the environment but the correlation between the presence
of faecal indicators and enteric viruses have been questioned by experts in the field
[6]. This section focuses on the three most common detection methods.
Transmission electron microscopy (TEM) is a microscopical method with a sub
nanometer resolution. During TEM a beam of accelerated electrons is shot against
the sample to make a high resolution image of the sample. Identification of viruses
with TEM can be performed rather fast but it requires a high concentration of virus
in the sample i.e. a high virus titer (virus/mL) and the sample preparation is time
consuming. TEM can be combined with immunological methods, e.g. to aggregate
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virus particles, thereby enabling analysis of samples with a lower virus titer. Al-
though lower titer values can be used, the immune TEM (IEM) still requires a virus
titer of 105 - 106 for NoV [18]. The IEM technique was used to discover NoV in 1972
from an outbreak in Norwalk, Ohio, in October 1968 [32]. RV expresses a character-
istic surface morphology making this virus type easily distinctive from other virus
types when analysing samples with TEM. On the other hand, NoV and HAV do
not show characteristic surface morphologies thereby making identification di cult
[18]. TEM images of RV, NoV and HAV can be seen in figure 2.4. Furthermore, the
(a) Rotavirus (b) Norovirus
(c) Hepatitis A virus
Figure 2.4: TEM images of rotavirus, norovirus and hepatitis A virus. The char-
acteristic morphological pattern of the RV can be observed on image 2.4a. The The
diameter of the RV in this image is around 80 nm. The images 2.4b and 2.4c show
no distinct morphology of the NoV and the HAV thus preventing virus distinction by
EM. The diameters of HAV and NoV are between 27 and 38 nm. The RV image was
made by Ramona Valentina Mateiu, DTU CEN, Center For Electron Nanoscopy,
from a TLP RV sample described in chapter 3.2. Images of NoV and HAV were
obtained from Centers for Disease Control and Prevention, Public Health Image
Library, http://phil.cdc.gov/ .
TEM equipment is very expensive and must be handled by a trained microscopist
[18]. TEM is usually not used for environmental samples, but rather for clinical
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samples, due to the disadvantages and requirements of high titer values [18].
The most commonly used immunological method for virus detection is the en-
zyme linked immunosorbent assay (ELISA). ELISA utilises the antigen-antibody
specific interactions and can thus detect viruses with high specificity [18]. Figure 2.5
illustrates the principle of a colorimetric sandwich ELISA. The assay is performed in
a microtiter well plate where target (antigen) specific capture antibodies are immo-
bilised in the wells by passive absorption. The antigen-capture antibodies capture
the target virus and secondary detection antibodies, conjugated with horseradish
peroxidase (HRP), bind to the target. When a 3,3’,5,5’-Tetramethylbenzidine (TMB)
substrate is added HRP reacts with the TMB substrate and a blue colour develops.
When colour development is su cient the reaction is stopped and the light ab-
sorbance (optical density (OD)) through the well is measured. The OD value can
be used to estimate the amount of target virus present in the sample. If the target
virus is not present the capture antibody does not bind anything and no colour
development occurs in the well. The detection method in the ELISA can also be
based on fluorescent detection.
The antigen-antibody specific reaction in ELISA limits the use and increases the
complexity of the assay since antibodies for each specific virus strain of interest
must be included in the assay. Like TEM, the immunological methods is commonly
not used for environmental water samples due to the low concentrations of virus in
the samples [18].
Positive sample
HRP
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Figure 2.5: Principle of a sandwich ELISA. The assay illustrated in the figure
is a colorimetric assay performed in a microtiter well plate. The assay utilises the
enzymatic reaction between the enzyme HRP and the TMB substrate to make a blue
colour development when the target virus is present. A capture antibody captures
the target virus and a HRP conjugated antibody binds to the target virus. TMB
substrate is added to the well and a colour development indicates the amount of
target present in the sample by measuring the light absorbance through the well. If
there is no target virus or another non-target specific virus is present the capture
antibody does not bind anything and no colour development is seen when the TMB
substrate is added.
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The most widely used method used for virus detection of environmental water
samples is the molecular detection method: real-time reverse transcription poly-
merase chain reaction (RT-PCR). Real-time RT-PCR is a very sensitive detection
technique [6]. During the real-time RT-PCR reaction the genomic material of the
virus is exponentially amplified and detected by fluorescent markers. Real-time
RT-PCR has a higher sensitivity and reproducibility than conventional PCR where
the genomic detection is performed by gel electrophoresis after 30-40 PCR cycles.
The PCR analysis is a temperature cyclic process with distinct reaction steps: an-
nealing/hybridisation of primers, enzymatic extension of the DNA with polymerase
and finally denaturation of the double DNA strand. The initial step in the RT-
PCR analysis is to transcribe the RNA into complementary DNA (cDNA) since the
PCR analysis relies on the amplification of DNA. RT-PCR is thus applied to RNA
viruses. Figure 2.6 illustrates the principle of the real-time RT-PCR reaction and
shows a typical result. After each PCR cycle the amount of genomic material is
doubled which means that after 40 cycles 240 cDNA copies are made. The amount
of genomic material is measured after each cycle through a fluorescent probe, a
TaqMan probe in the figure, and fluorescence is plotted against the cycle number.
A threshold value determines whether or not a sample is considered positive. The
cycle number at which the fluorescence value increases above the threshold is called
the cycle threshold (Ct) value. The Ct value is used as a measure of how much DNA
was present in the initial sample, thus a low Ct value means a high DNA concen-
tration in initial sample and vice versa. After PCR analysis the genomic product of
the analysis can be sequenced and the genotype of the analysed viral strain can be
determined which is an advantage for environmental monitoring.
Although real-time RT-PCR is a powerful tool for virus detection some limitations
of the technique do exist. It is important to emphasise that real-time RT-PCR can
only be applied to known genetic sequences since the PCR reaction relies on care-
fully selected primers and probes. This means that the genetic sequence of the virus
must be known in order to detect it with RT-PCR. The used primers must be care-
fully selected to cover a broad range of virus genotypes [18]. The primer selection
can thus be challenging especially related to NoV that has a great genetic diversity.
Furthermore, PCR only detects genomic material and cannot distinguish between
infectious and non-infectious virus particles as long as the genomic sequence of the
viral genome is intact. Environmental water samples may contain real-time RT-PCR
inhibitory substances e.g. humic acids or beef extract from the pre-concentration [2,
18, 31]. In order to remove or reduce the amount of these inhibitory substances the
RNA of the viruses is extracted from the samples before performing the RT-PCR.
RNA extraction can be done by e.g. commercial available silica membrane columns
but many other methods exist. Even though virus detection with real-time RT-PCR
is challenging and standardised common assays does not exist it is still the preferred
method for environmental viral analysis.
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Figure 2.6: (a) Principle of real-time RT-PCR. Viral RNA must be transcripted
into cDNA for PCR analysis since polymerase only extends DNA and not RNA.
Once transcripted into cDNA the cyclic process of PCR is performed accordingly:
1) denaturation of double stranded DNA (at 95 ¶C), 2) annealing of primers and
TaqMan probe (typically between 45-60 ¶C) and 3) extension of cDNA with Taq
polymerase and fluorescence measurement (typically at 72 ¶C). The TaqMan probe
has a fluorescent label and a quencher. The Taq polymerase cuts the TaqMan probe
and thereby separates the fluorescent label and the quencher. Other fluorescent tech-
niques can also be used in real-time PCR like SybrGreen that fluoresces when bound
to double stranded DNA. The SybrGreen method is not sequence specific like the
TaqMan probe and is thus not preferred. (b) A schematic illustration of a real-time
PCR result. The fluorescence is measured at the end of each PCR cycle and plotted
against cycle number. A fluorescent threshold value determines when a sample is
considered positive. The Ct value of a sample represents the cycle number where the
fluorescence is above the threshold value. The Ct value is a measure of relative DNA
concentration i.e. the lower the Ct value, the higher the initial DNA concentration.
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2.2 Aptamers
Aptamers are single stranded oligonucleotides folded into a three dimensional (3D)
structure that recognise a specific target with high a nity and specificity [33]. The
in vitro selection of aptamers was first published in 1990 by Tuerk & Gold and
Ellington & Szostak, independently [34, 35]. The initial selected aptamers were
RNA aptamers but DNA aptamers have since been selected. DNA aptamers are
more chemically stable than RNA aptamers but their specificity and a nity do not
di er [36]. Both RNA and DNA aptamers have been selected to bind many di er-
ent targets from cell populations, proteins to small molecules and ions [33, 37, 38].
Furthermore, aptamers have been selected to bind non-immunogenic molecules and
toxic targets which is not possible with antibodies [33, 38, 39]. Aptamers can be
used as a substitution or replacement of antibodies in biosensing applications or in
ELISA but they can also be used in other applications, e.g. as therapeutic agents or
in basic medical research [36, 40–42]. The dissociation constant, Kd, for aptamer-
protein complexes typically lies in the low nanomolar range, much like antibodies
(nM to pM) [38, 41, 43].
Aptamers have many advantages compared to antibodies, in the following these will
be described. Aptamers are selected in vitro, independent of laboratory animals or
cell lines [39]. Once selected and produced no, or little, batch to batch variation
is anticipated since aptamers are produced by chemical synthesis and purified [36,
39]. Aptamers are relatively small in size (10-15 kilo Daltons (kDa)), compared
to antibodies (around 150 kDa), which means that they can access epitopes oth-
erwise inaccessible to antibodies [37–39]. Their small size is also an advantage in
electrochemical biosensing applications where aptamers are immobilised on to the
electrode surface and target binding must take place close to the electrode surface to
ensure a good signal. Aptamers can enter and function inside the cell which allows
for labelling of intracellular molecules to study intracellular mechanisms [38, 39].
Since aptamers are oligonucleotides they are not sensitive to temperature changes
as they can be denatured and renatured [36, 37, 39]. Finally, aptamers can be eas-
ily modified in order to enhance their stability in fluids like body serum but also
to ease immobilisation or detection by e.g. fluorescence [36, 39, 42]. Although,
labelling or modifying aptamers with di erent functional groups cannot always be
done without consequences as reduction in aptamer a nity after modifications have
been shown [38, 41]. All of these advantages make aptamers highly interesting as
binding molecules but it is important to anticipate that very few aptamers have been
selected compared to antibodies. Antibodies are still considered the gold standard
for many applications with standardised protocols but aptamers are without doubt
getting more and more attention due to their obvious advantages over antibodies.
Aptamers are selected from large and complex libraries of random oligonu-
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cleotides sequences and the selection is typically done by a process entitled sys-
tematic evolution of ligands by exponential enrichment (SELEX) [34]. The SELEX
process is described in section 2.2.1.
As this thesis focuses on aptamers and viruses, especially enteric viruses, the current
scientific advancement within the field of aptamers selected against viral targets will
be described in section 2.2.2.
2.2.1 The selection of aptamers by SELEX
SELEX is a cyclic process of in vitro aptamer selection involving three major steps:
target-nucleic acid interaction, separation and amplification. The SELEX procedure
was discovered and published by Tuerk and Gold in 1990 [34]. In their work, Tuerk
and Gold selected a RNA aptamer against a protein target. The SELEX process
have since then revolutionised the development of aptamers over the past decades
since relatively simple aptamer selection has become possible after the discovery of
the SELEX process. It is important to emphasise that SELEX selection is still a
labour intensive process that requires much technical experience and it may take
several months to years to select an aptamer [38]. Though, it is now possible to
reduce the selection time with automated robotic selection systems.
Figure 2.7 shows the principle of DNA aptamer selection by SELEX. Before the
SELEX is initiated the target can be immobilised onto a solid support, in this case
magnetic beads. Magnetic beads are used for easy separation of the unbound ss-
DNA. The first step in the SELEX process is incubation of the target with a nucleic
acid library of randomised sequences. The starting library usually consists of around
1012 - 1015 random individual ssDNA sequences [38, 42]. Typically, the randomised
region of the ssDNA pool is 30-60 nucleotides and this region is flanked by two
constant regions of approximately 20-25 nucleotides [38, 43]. The constant regions
act as primers to enable PCR amplification. After the target-ssDNA interaction
the unbound ssDNA, or non-binders, are separated and discarded from the target-
ssDNA complexes. Separation of non-binders from the target bound ssDNA can be
done by di erent approaches. The separation method used in figure 2.7 is magnetic
separation but other techniques such as nitrocellulose membrane filtration, a nity
chromatography or capillary electrophoresis are used, among others [38]. The ss-
DNA is then eluted from the target and amplified by PCR. The PCR amplicons are
used as the ssDNA starting pool for the next selection cycle. The a nity is thus
increased after each selection cycle. After the amplification step a counter selec-
tion, or negative selection, of closely related targets or separation matrices e.g. solid
supports like magnetic beads can be done to increase specificity and eliminate non
specific binders [38, 44]. The counter selection is performed after several positive
selection cycles [44]. When the output of a selection cycle has reached the desired
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Figure 2.7: Principle of the cyclic SELEX procedure. The target is bound to
magnetic beads for easy separation of the unbound ssDNA. The target is incubated
with a random ssDNA library and the unbound ssDNA is separated and discarded
from the target bound ssDNA. The target bound ssDNA is eluted from the target and
amplified by PCR. A counter selection can be performed to increase specificity by
removing ssDNA that binds to a counter target. The counter target can be a target
similar to the specific target. The cyclic process is continued until the cycle output
is dominated by target specific aptamers. After the cyclic process the ssDNA product
is cloned and sequenced for further analysis.
target a nity the aptamer candidates are cloned and sequenced for further analysis
and refining [38]. The number of cycles necessary to get an aptamer candidate with
high a nity and specificity usually lies around an average of 12 selection cycles [38].
Several conditions should be considered during the aptamer selection to ensure op-
timal binding conditions for the aptamer-target complex. It is important that the
aptamer binds the target in the working conditions of the anticipated application.
As aptamers are nucleic acids the temperature, pH and salt concentration of the
medium a ects the 3D folding of the aptamer and thus the a nity. The selection
conditions and bu ers must thus be carefully considered to achieve a high a nity
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of the aptamer together with the application [38].
2.2.2 Aptamers selected against viral targets
Aptamer selection for viral targets have mainly been developed for clinical applica-
tions like diagnostic or therapeutic tools but aptamers have also been selected for
environmental and food borne pathogen analysis. Aptamers as therapeutic tools is
an interesting field due to their ability to interfere and inhibit viral penetration and
replication in the host cell [33, 44].
The selection process of aptamers against di erent viruses is commonly done with
isolated and purified recombinant structural proteins [7, 45] but selection with the
whole virus was also done [8, 46]. The choice of target protein configuration can
e ect the a nity of the aptamer since the isolated recombinant structural protein of
the virus may have distinctively di erent folding than that of the structural proteins
in the complex configuration of the virus capsid [37, 44]. Furthermore, an aptamer
selected against a recombinant surface protein may target a site of the protein that
does not face outwards from the virus surface which hinders detection of the virion.
Whole-virus SELEX is challenging as the sample preparation of the virus, i.e. virus
inactivation an purification, is a di cult task that requires dedicated laboratories
with high safety levels [47]. When selecting aptamers with whole-virus SELEX it
is very hard to determine the targeted surface protein and the specific epitope, or
aptatope, of the virus.
This thesis focuses on three enteric viruses: NoV, RV and HAV. Currently no
aptamers selected against RV and HAV have been published. Aptamer selection
against the whole RV virion may be a challenge, both because of the genetic diver-
sity of the RV but also related to the stability of the infectious TLP RV virions (see
section 2.1.1). The outer capsid protein layer of the TLP, VP4 and VP7, can be
easily removed by chelating agents (e.g. EDTA) and thereby reducing the virions
to the non-infectious double-layered particles (DLP), with VP6 as the outer capsid
protein. This reducing step is commonly done in RV diagnostic as the genetic di-
versity of the DLP is smaller compared to TLP which means that the epitopes of
DLP is more constant. Due to this, antibodies targeting the structural proteins of
human RV is selected against the VP6 protein.
It is di cult to say why aptamers targeting HAV have not been selected. The iso-
electric point of HAV is 2.8 which means that at neutral pH the net charge of the
virus is negative [48]. The net charge of DNA is also negative at neutral pH which
may make it di cult in the selection process to bind the ssDNA to the target. Gen-
erally, aptamer selection of targets with isoelectric points < 6 is not advantageous
for aptamer selection [Personal correspondence with Dr. Marcus Menger, Fraun-
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hofer Institute for Cell Therapy and Immunology (IZI)]
Currently, two studies on selection of aptamers targeting human NoV have been
published [7, 8] and one study on an aptamer targeting murine NoV [49]. Escudero-
Abarca et al., 2014, [8], selected aptamers against whole human NoV (GII.2) im-
mobilised onto magnetic beads by antibodies. In their aptamer selection they in-
corporated counter selection steps with human stool specimens (negative of Human
NoV) and the bead-antibody complex. They where able to use the selected ap-
tamers in ELISA and enzyme linked aptasorbent assay (ELASA) to show that the
aptamers were able to target several di erent human NoV strains primarily within
genogroup II with a Kd in the range of 1-200 nM [8]. Beier et al., 2014, [7], used
a selection approach with the purified recombinant structural proteins, VP1, of the
viral strain GII.4 as target. They used counter selection with fecal extract and
experimental background materials. Their experimental binding studies are based
on surface plasmon resonance where the binding of the recombinant VP1 protein
of GII.4 and a non-structural NoV protein are compared. The study does not in-
vestigate the binding of the aptamer to whole virus, nor determine the dissociation
constant. Giamberardino et al., 2013, [49], used the murine NoV type 1 as a target
for aptamer selection. The murine NoV present a great advantage over the human
NoV as it can be cultured in vitro. In their study they used whole murine NoV as
targets and performed counter selection with nitrocellulose filters, feline calicivirus
and culture medium. The Kd of the aptamer-target complex was proven to be in
the low picomolar range. In their study it was also shown that the aptamer was able
to bind human NoV, GII.3. The aptamers selected against NoV is listed in table 2.1.
Table 2.1: Aptamers selected against NoV
Virus Target Type DNA/RNA Kd Reference
Human NoV, GII.2 Whole virus DNA 100-200 nM [8]
Human NoV, GII.4 VP1 DNA Not available [7]
Murine NoV type 1 Whole virus DNA Low pM range [49]
Comprehensive lists of many of the currently published aptamers selected against
viral targets can be found in reviews by Wandtke et al., 2015, Torres-Chavolla et
al., 2009, and Kieboom et al., 2015, [33, 44, 47]. It is evident from the reviews that
the aptamer selection against viruses are limited to a few di erent viruses: human
immunodeficiency virus [50], hepatitis B [51] and C virus [52], influenza A virus [45,
46, 53], vaccinia virus [54, 55] and SARS coronavirus [56].
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2.3 Bio- and aptasensors for viral detection
A biosensor is an analytical device that provides the user with rapid, accurate and
valuable information about a specific target in a sample. The biosensor converts an
analog biological response into a measurable signal that is processed for interpre-
tation [57]. In 1956 Clark introduced his oxygen electrode which initially set the
stage for development of electrochemical biosensors and led to the development and
commercialisation of the glucose oxidase biosensor in 1962 and 1974, respectively
[57]. Today, biosensor applications have expanded and are now used in many dif-
ferent fields of our society e.g. in medicine, food and water safety, public safety,
environmental monitoring etc. [58].
Figure 2.8 illustrates a schematic representation of the principle of a biosensor. A
Target analyte Bioreceptor Transducer Signal processing system 
Aptamers
Antibodies
Enzymes
...
Electrochemical
Optical 
Piezoelectric
...
... ...
Signal amplifier
(optional)
Figure 2.8: Principle of a biosensor. A biosensor is an analytical device that
consists of several components: a bioreceptor, a transducer, an amplifier and a sig-
nal processing system for signal analysis. The amplifier may not be present in all
biosensors. The biorecognition elements of the detector identifies and binds target
molecules. This biorecognition event results in a stimuli that is converted by the
transducer into a processable output signal. The output signal is amplified and pro-
cessed by the signal processing system where the signal is displayed for interpretation.
The biorecognition elements of the detector can be di erent biological components
e.g. aptamers, antibodies, enzymes, etc. Likewise, the transducer can be based
on di erent principles e.g. electrochemical detection, optical methods, piezoelectric
sensing etc. [58]
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biosensor consists of several di erent components: a bioreceptor with biorecognition
elements to catch the target analyte, a transducer that converts the signal into a
processable signal and a signal processing system [57].
In the following sections the general principles of biosensors will be introduced with
a focus on electrochemical biosensors, especially impedance based impedimetric ap-
tasensors for viral diagnostics.
2.3.1 Introduction to biosensors
As described above, a biosensor can be described by three major components: a
bioreceptor, a transducer that converts biorecognition events into a processable sig-
nal and a signal processing system for analysis, as illustrated in figure 2.8. Biosen-
sors may also have a signal amplifier. Biosensors are classified according to the
biorecognition element or by the mechanism of the transduced signal [58] [59]. The
bioreceptor mechanism can be based on di erent biorecognition elements, e.g.: ap-
tamers, antibodies, enzymes etc. and the transducer principle can be based on e.g.:
electrochemical, piezoelectric, optical etc. [58].
In order for a biosensor to be ideal and successful several conditions must be ful-
filled. The biorecognition elements must be highly specific and selective [57]. The
biological response of the biorecognition reaction should be precise, accurate and
reproducible as well as linear in the desired concentration range [57]. Furthermore,
the reaction should be independent of pH changes, temperature changes and sample
flow [57]. For fast analysis the biosensor must be able to perform real-time anal-
ysis [57]. And last, an ideal biosensor must be cheap, small and easy to use by
non-trained personnel with a minimum of sample preparation [57]. It is important
to notice that the interaction between the bioreceptor and the transducer and the
performance of the two are of paramount importance to have a biosensor with high
sensitivity and specificity.
Impedimetric biosensors
A subtype of biosensors are impedimetric biosensors that utilise electrochemical
impedance spectroscopy (EIS) to measure the electric changes and perturbations of
a biosensor system caused by target binding. The unique ability of impedimetric
biosensors to directly convert a biological recognition event into an electrical signal
makes them highly interesting as biosensors [57]. The principle of impedimetric
biosensing can thus be label-free which means that no further chemical labelling,
e.g. fluorescent or enzymatic, is needed in order to detect the biological reaction.
Impedimetric biosensors have several fundamental advantages compared to other
types of biosensors. The complexity of the experimental setup of impedimetric
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biosensors is low as well as the fabrication cost of the sensors [57]. Furthermore, the
sensors are robust, can be miniaturised and have good detection limits [57].
When designing an impedimetric biosensor several important factors must be consid-
ered: the choice of biorecognition elements and the surface immobilisation of these,
the electrode material and the electrode dimensions [57]. The bioreaction must take
place close to the electrode surface in order for the electrodes to detect the reaction
[57]. This means that large biorecognition elements or long immobilisation spacer
arms must be avoided. Commonly, enzymes, antibodies or nucleic acids are used as
biorecognition elements in biosensors but recently aptamers have received increased
interest as replacement of antibodies [37, 44, 57]. When aptamers are used as the
biorecognition element in a biosensor the sensors is referred to as an aptasensor [44].
The electrode material is commonly gold, carbon or graphite [57], but also conduct-
ing polymers are of great interest. To reduce the fabrication cost of the sensor, gold
electrodes fabricated in clean-room facilities must be omitted and simpler methods
like screen-printing of conducting polymers or carbon can be applied. Furthermore,
screen-printing easily facilitates mass production. Depending on the electrode mate-
rial the right surface immobilisation of the biorecognition elements must be carefully
chosen. It is pivotal for the performance of the biosensor that the biorecognition
elements are present on the electrode surface in the right amount and in the right
configuration.
In general, the properties of the components of an electrical system is described
by the electric current, the applied potential and the electric resistance according to
Ohm’s law. The electrochemical properties of an impedimetric biosensor can thus be
measured by either measuring the current generated from an electron transfer, the
charge accumulation on the electrodes or the changes of the conductive properties of
the medium [57]. Di erent techniques can be applied to measure these parameters
e.g.: EIS, amperometry or potentiometry. EIS is a useful technique for biosensing
applications where the changes of the electric properties of the sensor are related
to target binding events on the electrode surface [57]. Thus, the experimental work
related to the characterisation of the developed aptasensor (described in chapter
6) is based on EIS. Hence, the following theoretical description will focus on the
principles of EIS.
2.3.2 Electrochemical Impedance Spectroscopy
This section focuses on the theory of EIS in order to understand the important char-
acteristics of the electrical components of an EIS based biosensor. The biorecogni-
tion elements, in this case aptamers, are immobilised on the electrode surface at the
electrode-electrolyte interface. The binding event of a target, in this case a virus,
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to the aptamers will result in a redistribution of charges at the electrode-electrolyte
interface and give rise to a change of the electric parameters of the components of
the electrochemical system. The following section will describe the basic theory of
the electronic components of a biosensor and an equivalent circuit model in order
to get a theoretical understanding of EIS.
Basic theory of EIS
In EIS a small alternating current (AC) excitation potential is applied to the electric
system, or cell, and the current response of the system is measured. The impedance
of the system can thus be calculated from the applied potential and the current
response. By varying the frequency of the excitation potential through a frequency
range of interest an impedance spectra of the electric system can be acquired and
analysed [57].
The excitation potential, Et, is a sinusoidal signal expressed by:
Et = E0sin(Êt) (2.1)
where Et is the potential, in volts (V), at time t, E0 is the amplitude of the signal
and Ê is the angular frequency [60]. In degrees, Ê is given by:
Ê = 2ﬁf (2.2)
where f is the frequency in hertz (Hz).
The current response is also a sinusoidal signal shifted by the phase, „, given by:
It = I0sin(Êt+ „) (2.3)
where It is the current response, in amperes (A), at time t and I0 is the amplitude
of the signal [60].
The total impedance of the system can thus be calculated from the excitation po-
tential and the current response with a relation equivalent to Ohm’s law:
Z = Et
It
= E0sin(Êt)
I0sin(Êt+ „)
= Z0
sin(Êt)
sin(Êt+ „) = Z0e
j„ (2.4)
where Z0 is the magnitude of the impedance and j2 = ≠1 [60]. By applying Euler’s
formula to the complex impedance it can be expressed as a function of sine and
cosine on a complex plane:
Z(Ê) = Z0ej„ = Z0(cos„+ jsin„) (2.5)
The total complex impedance of an electric circuit can thus be divided into a
real, ZRE, and an imaginary, ZIMG component:
Ztotal(Ê) = Z0(cos„+ jsin„) = ZRE + jZIMG (2.6)
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and be represented in the non-complex plane by calculating the magnitude, in ohms
( ), and the phase, in degrees, by:
Z0(Ê) = |Ztotal(Ê)| =
Ò
Z2RE + Z2IMG (2.7)
„(Ztotal(Ê)) = arctan
3
ZIMG
ZRE
4
180/ﬁ (2.8)
The total impedance of the electric system can thus be represented by the magni-
tude and the phase as a function of the log of the frequency by so called Bode plots
or on a complex plane by ZIMG as a function of ZRE in a Nyquist plot. The Nyquist
plot does not reveal the frequency dependence of the impedance directly on the plot
but the high frequency components of the data are always found in the left side of
the plot.
An electrical circuit is composed of three basic passive electronic elements: resis-
tors, capacitors and inductors. In this basic theoretical description of EIS the focus
will be on resistors and capacitors as these are the relevant elements in a biosensor.
More complex circuit elements, like the Warburg impedance or the constant phase
element (CPE), can also be present in a biosensor system.
A resistor is an electric element that is able to resist the flow of electric current
through the element. The electrical resistance, R, in ohms ( ), of a resistor is di-
rectly proportional to the applied potential over the current flow according to Ohm’s
law. The resistance of a resistor is not frequency dependent and there is no phase
shift of the impedance through the resistor. Thus the impedance, ZR, of a resistor
is equal to the resistance, R.
A capacitor is an electric element that is able to build up charges. The general
principle of a capacitor can be illustrated by a plate capacitor where two conducting
plates are spaced from each other by a very small distance with an electric insulating
layer. By applying a potential across the plates charges build up on one of the
plates until a steady state potential is reached. When a AC potential is applied to
the capacitor the charges build up on di erent sides of the capacitor according to
the AC frequency. At low frequencies the capacitor blocks the current and at high
frequencies the capacitor acts as a conductor. Thus, the impedance of a capacitor is
frequency dependent and a phase shift of the impedance of ≠90 degrees is observed
through an ideal capacitor. The complex impedance of a capacitor is given by:
ZC(Ê) =
1
jÊC
(2.9)
where C is the capacitance of the capacitor in farads (F).
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A CPE is a non-ideal capacitor and the impedance of a CPE, ZCPE, is given by
[60]:
ZCPE =
1
(jÊ)–C (2.10)
where – is a coe cient between 0 and 1 (typically 0.9 - 1 for a CPE). For an ideal
capacitor – equals 1.
The Warburg element is a special case of a CPE where – = 0.5 . The Warburg
element is a complex electrical component that represents the mass transport of
di usive species in the solution [61]. The impedance of a Warburg element, ZW , is
given by [60]:
ZW = ‡(Ê)≠1/2(1≠ j) (2.11)
where ‡ is the Warburg coe cient. The Warburg element will not be described in
further detail in this thesis. For a thorough theoretical description of the Warburg
element the reader is referred to the book Electrochemical Impedance Spectroscopy
and its Applications by Andrzej Lasia [62].
In an electric circuit the di erent circuit elements can be combined either in
parallel or in series. The total impedance of a parallel RC circuit is given by:
1
Ztotal
= 1
ZR
+ 1
ZC
= 1
R
+ jÊC (2.12)
and the total impedance of a serial RC circuit is given by:
Ztotal = ZR + ZC = R +
1
jÊC
(2.13)
Figures 2.9, 2.10 and 2.11 illustrates the electric circuit, the Nyquist plot and
the Bode plots for a parallel RC circuit, a serial RC circuit and a RC parallel circuit
in series with R, respectively. The total impedance of the circuits is calculated from
equations 2.12 and 2.13. And the magnitude and phase of the total impedance for
the Bode plots are calculated from equations 2.7 and 2.8.
In the parallel RC circuit the Nyquist plot, figure 2.9b, shows the characteristic
semi-circle of such circuit. The diameter of the semi-circle is equal to the resistance
of R1 = 10 k . In the Bode plots, figure 2.9c, it is evident that the resistor is dom-
inating in the low frequency range as the magnitude of the impedance is equal to
the resistance of R1 and the phase shift of the impedance is equal to 0. At high fre-
quencies the capacitor is dominating and the resistor is bypassed as the magnitude
of the impedance is 0 and the phase shift is -90 degrees.
The Nyquist plot of the serial RC circuit, figure 2.10b, does not show a semi-circle
but rather a constant value of the real part of the impedance equal to R1 = 10 k 
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Figure 2.9: Impedance spectra of a RC parallel circuit. Circuit elements: R1 =
10 k , C1 = 10µF .
and only the imaginary part of the impedance changes. The Bode plots, figure
2.10c, show that the capacitor is the dominating component at low frequencies as
the magnitude of the impedance goes towards infinity and a phase shift of -90 is
observed. At high frequencies the resistor is dominating and the magnitude equals
R1 and no phase shift is observed.
By combining the parallel and the serial circuits as illustrated in figure 2.11a the
semi circle observed in the Nyquist plot of the parallel RC circuit (figure 2.9b) is
preserved but in figure 2.11b it is shifted to the right of the spectra. The shift equals
the value of R2 = 1 k . The Bode plots, figure 2.11c, reveals that the low frequency
range is dominated by the serial connection of the resistors R1 and R2 equal to 11 k 
and a phase shift close to 0. At high frequencies the circuit is dominated by the
resistor R2. In a frequency range around 101 Hz the circuit is dominated by the
capacitor seen by the negative phase shift of around -55 degrees. The phase shift
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Figure 2.10: Impedance spectra of a RC serial circuit. Circuit elements: R1 =
10 k , C1 = 10µF .
does not reach -90 degrees due to the serial connection with R2.
By looking at both the Nyquist and Bode plots for the representation of measured
impedance data it is thus possible to simulate a model for an equivalent circuit of
e.g. a biosensor. The values of the di erent circuit elements are fitted to the simu-
lated circuit model and thereby enabling calculation of the changes of the electrical
properties of the biosensor when a target binds to the sensor.
Equivalent circuit model for an electrode pair in solution
Figure 2.12 illustrates an equivalent circuit model for an electrode pair in a solution.
This circuit model is an ideal simplified circuit model. In the case of the developed
all-polymer aptasensor the electrode material is an intrinsic conducting polymer,
PEDOT:PSS. This electrode material is not an ideal conductor which means that the
electrode has a internal resistance, Ri. At the electrode-electrolyte interface three
electrical components are found: the charge transfer resistance, Rct, the double layer
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Figure 2.11: Impedance spectra of a RC parallel circuit in series with R. Circuit
elements: R1 = 10 k , R2 = 1 k , C1 = 10µF .
capacitance, Cdl, and the Warburg impedance, ZW . The circuit at the electrode-
electrolyte interface is known as a Randles electrical equivalent circuit [61]. The
charge transfer resistance, Rct, models how charges are moving across the electrode-
electrolyte interface. The double layer capacitance, Cdl, represents the built-up of
charges on the electrode surface. The double layer capacitance never behaves as an
ideal capacitor and can be substituted by a CPE with the coe cient – between 0.9
and 1. As stated earlier, the Warburg element is a complex electrical component that
represents the mass transport of di usive species in the solution [61]. The Warburg
impedance represents the steady-state di usion of ionic species without advection of
the solution. In the case of the developed all-polymer aptasensor the sensor is aimed
to work in continuous flow which means that the Warburg impedance is of lesser
importance due to the advection of the ions in the medium. The solution resistance,
Rs, represents the resistance of the bulk solution. The geometrical capacitance, Cgeo,
models the capacitance of the electrode pair. Both the solution resistance and the
geometrical capacitance are components with e ect at high frequencies. The low
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Figure 2.12: Equivalent circuit model for an electrode pair in a solution. Ri:
Internal resistance of PEDOT:PSS, Rct: Charge transfer resistance, Cdl: Double-
layer capacitance, ZW : Warburg impedance, Cgeo: Geometrical capacitance, Rs:
Solution resistance
frequency components of the circuit are the charge transfer resistance, the double
layer capacitance, the Warburg impedance and the internal resistance. When a
reaction takes place on the electrode surface at the electrode-electrolyte interface,
e.g. aptamer immobilisation or target binding, it is these low frequency components
that are a ected. Thus, a target binding event on the electrode surface must be
expected to change either the charge transfer resistance and/or the double layer
capacitance.
2.3.3 Intrinsic conductive polymers for electrode material
Intrinsic conductive polymers have gained an increased interest for usage as elec-
trode materials in biosensors due to the ease of processing and low material costs
which enables low cost disposable devices. Furthermore, they possess other advan-
tages like good optical properties [63]. The properties of conductive polymers can
be chemically tailored to fit a specific application e.g. by di erent dopants or by
di erent chemical side chains. Conductive polymers have also been found usefull
in di erent fields e.g. flexible solar cells [64], organic light emitting diodes [65] and
analysis of cells [9, 66] as conductive polymers have proven to have good biocom-
patibility with cells.
Common for all intrinsic conductive polymers is the backbone structure of a con-
jugated system of ﬁ-bonds arising from double or triple bonds between atoms e.g.
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carbon. The conjugated system of ﬁ-bonds allows electron movement along the poly-
mer chain. Conductive polymers are semiconductors and like other semiconducting
materials a dopant is used to dope the polymer to increase the conductivity. In the
developed all-polymer aptasensor the electrode material is the intrinsic conductive
polymer poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS). By
doping the PEDOT with PSS to obtain PEDOT:PSS a conductivity of up to 103
S/cm can be obtained [67]. It is important to emphasise that conductive polymers
can not substitute metals as metals are superior in conductivity, around 105 S/cm,
but conductive polymers are an interesting class of materials for some applications.
Figure 2.13 shows the chemical structure of PEDOT:PSS. The dashed line in the
PEDOT structure illustrates the polymer backbone with the conjugated system of
ﬁ-bonds. Due to the high molecular weight of PSS the molecule is entrapped in the
PEDOT matrix which hinders di usion of PSS out of the matrix thus increasing
material stability [67, 68].
PEDOT:PSS is an interesting material choice as the material is commercially avail-
able and the conductivity of the material is relatively high. Furthermore, PE-
DOT:PSS is commercially available as an aqueous dispersion which means that
it is possible to directly print PEDOT:PSS patterns on chip substrates [67].
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Figure 2.13: Chemical structure of PEDOT:PSS
2.3.4 Advancements of electrochemical and impedimetric
aptasensors
In 1996, Davis et al. published the first work with aptamers as biorecognition el-
ements in a biosensor, in this case an optical aptasensor [69]. In their work they
compare the performance of flow cytometry with a fluorescently labelled antibody
2.3. BIO- AND APTASENSORS FOR VIRAL DETECTION 35
and a fluorescently labelled aptamer. The work demonstrates the feasibility of using
aptamers instead of, or combined with, antibodies in biosensing applications. Ap-
tamers as biorecognition elements in electrochemical aptasensors was introduced in
2004 by Ikebukuro et al., and further elaborated in 2005 [70] [71]. Radi et al. pub-
lished the first paper on an impedimetric aptasensor for electrochemical detection in
2005 [72]. In their work they used a thrombin binding aptamer to detect thrombin
with impedance spectroscopy by detecting a change in the charge transfer resistance
[72]. It has also been proven that the conformational change of the aptamer upon
target binding can be used in electrochemical sensing to increase the signal. This
was shown by Swensen et al., 2009, they used a cocaine binding aptamers tagged
with redoxable molecule methylene blue to detect cocaine in serum [73]. Upon tar-
get binding the aptamer folds into the folding conformation thereby bringing the
methylene blue in close proximity of the electrodes thus increasing electron transfer.
For electrochemical aptasensor applications the aptamer immobilisation on the elec-
trodes is of great importance in order to obtain a successful aptasensor. Since many
aptamers are selected in solution it is necessary to investigate that immobilisation
of the aptamers on a solid support does not interfere and a ect the aptamer target
interaction e.g. hindering the conformational change upon target binding [43]. Fur-
thermore, other important factors must also be considered like the the molecular
orientation of the aptamer and the surface coverage [43].
Since 2004 there has been a rapid increase in the number of published papers on
aptasensors and electrochemical aptasensors and recently impedimetric aptasensors
as well. This is illustrated by the graphs in figure 2.14 that show the increase in pub-
lications with the topic Aptasensor, Aptasensor + electrochemical and Aptasensor
+ impedimetric. The rapid increase in the number of publications verifies the impor-
tance and the interest for aptamers and aptasensors within the scientific community.
Electrochemical aptasensors for viral detection
Currently, only a limited number of published studies on electrochemical aptasensors
for viral detection exists. Recently, Kieboom et al., 2015, published an extensive
review of aptasensors for viral diagnostics [47]. From the review it is evident that
many of the currently published viral aptasensors are based on optical transducer
methods.
One of the interesting electrochemical aptasensors for viral detection was pub-
lished by Giamberardino et al., in 2013 [49]. In their study they selected a murine
NoV binding aptamer with the SELEX process and used this aptamer in their ap-
tasensor application. By applying square wave voltammetry to their electrochemical
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Figure 2.14: Number of papers published per year with the topics Aptasensor,
Aptasensor + electrochemical and Aptasensor + impedimetric. Data from Web of
Science, Analysis results tool, August 2016.
aptasensor they were able to detect murine NoV with a very low limit of detection
of approximately 180 viral particles.
Kiilerich-Pedersen et al., 2013, published an all-polymer electrochemical aptasensor
with interdigitated micro-electrodes for the detection of influenza A virus in saliva
[10]. The aptasensor was able to detect as low as 103 plaque forming units/mL in a
spiked saliva sample.
Labib et al., 2012, published a impedimetric aptasensor for the detection of intact
vaccinia virions [55]. With their sensor they reached a limit of detection of 60
virions/µL by using EIS as the detection method. Furthermore, they developed the
aptamer used in the sensor that was able to distinguish between intact and non-
intact virus.
The aim of this PhD thesis is the development of an aptasensor for viral detection
in environmental water samples. The following chapters of this thesis will describe
this development.
3
Virus preparation for aptamer
selection
This chapter concerns the experimental work related to the preparation of RV and
HAV samples for aptamer selection. In order to get a good starting point for the
aptamer selection a purified virus sample is needed. Thus, the work related to the
purification of RV from cell culture will be described in details in this chapter. The
HAV culture and purification was done by our collaborators at the Environmental
Virological Laboratory, Tor Vergata University, Italy.
The SELEX process for the RV and HAV aptamer selection is based on magnetic sep-
aration of the target bound aptamer candidates from the non-binders. The principle
of the SELEX process was described elsewhere, in chapter 2.2.1. In order to enable
magnetic separation in the SELEX process the viral particles must be immobilised
onto magnetic beads. Virus immobilisation on streptavidin functionalised magnetic
beads (purchased from a commercial supplier) is possible via a biotin linker, which
can be obtained by biotinylation of the viral particles. The work described in this
chapter will focus on the biotinylation of the RV and the HAV and the verification
of the biotinylation by real-time RT-PCR.
The SELEX aptamer selection will be performed by our collaborators at Fraunhofer
Institute for Cell Therapy and Immunology (IZI), Germany.
3.1 Viral genotypes of RV and HAV for aptamer
selection
Aptamer target binding is based on structural recognition of the target, in this case
a virus, by the folded ssDNA. Thus, the surface proteins of the virus determine the
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ability of the aptamer to bind to the virus. RV and HAV are both non enveloped
viruses with a icosahedral capsid morphology. Furthermore RV has a more complex
capsid structure than HAV since the RV capsid consists of three protein layers. In
order for a RV to be infectious all of the three protein layers must be intact. Chapter
2.1.1 describes the basic virology of the two viruses.
American Type Culture Collection (ATCC) is one of the world leading distributors
of standard reference biological material for the scientific community. It was thus
initially chosen to use ATCC as a supplier of RV and HAV for the aptamer selec-
tion as they can provide a broad range of di erent viral strains. As described in
chapter 2.1.1, two group A RV strains are responsible for most human rotavirus
infections: G1P[8], 52 % of all infections, and G2P[4], 11 % of all infections [3]. Due
to the high level of the infectious nature of these strains it was chosen to use these
rotavirus strains for aptamer development. Thus, both RV strains were purchased
from ATCC:
• RV strain Wa, sero-/genotype G1P[8], ATCC product number: VR-2018
• RV strain DS-1, sero-/genotype, G2P[4], ATCC product number: VR-2550
Both of these human RV strains, Wa and DS-1, have been adapted to cell culture
[74].
The HAV genotype I is responsible for most of the human infections [27]. Within this
genotype two subgenotypes exists, IA and IB, where IA is the dominating subtype
found in 80 % of isolates from infected individuals [28]. Thus, subgenotypes IA and
IB were purchased from ATCC:
• HAV strain HM 175 (uncloned), genotype 1B, ATCC product number: VR-
2093
• HAV strain HAS-15, genotype 1A, ATCC product number: VR-2281
Both of these HAV strains, HM 175 and HAS-15, have been involved in the devel-
opment of HAV vaccines [28]. Unfortunately it is not straight forward to culture
HAV in cell culture and due to time constrains it was decided that our collaborators
at the Environmental Virological Laboratory, Tor Vergata University, Italy, should
culture and purify a HAV virus sample for the aptamer selection. They were able
to supply a sample with the subgenotype IB.
3.2 Rotavirus A culture and purification
The work related to the culture and purification of RV in cell culture was divided
into six main steps, as illustrated in figure 3.1. The six steps were: 1) RV culture
in MA104 cells, 2) RV semi-purification on a sucrose cushion, 3) isopycnic gradient
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separation of TLP (infectious) and DLP (non-infectious) virus particles on a self-
forming cesium chloride (CsCl) gradient (see figure 2.3 for an illustration of the
structure of RV particles), 4) unloading of CsCl gradient into fractions, 5) Sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of fractions
and 6) dialysis of interesting fractions to remove CsCl. Each of these steps will be
described in the following sections.
1) Culture trypsin activated RV 
in MA104 cells without serum
2) RV semi-purification on a 
sucrose cushion.
Pellet virus by ultracentrifucation 
for 1.5 h  at 100000 xg, 4 C
Virus pellet
Triple layered particles (TLP) 
Double layered particles (DLP)
3) isopycnic gradient separation of
 TLP and DLP virus particles on
 a self-forming CsCl gradient
 for 18 h at 110000 xg, 12 C
  
6) Dialyze fractions with 
TLP RV for 24 h at 
4 C to remove CsCl
4) Unload fractions from 
the gradient
by puncturing the tube
 1  2  3  4  5  6  7
5) Analyze fractions by 
SDS-PAGE to verify fractions 
with TLP and DLP RV
Sucrose cushion
o o
o
Figure 3.1: Step by step method for rotavirus culture and purification.
3.2.1 Rotavirus A propagation in MA104 cells
RV was propagated in MA104 cells. The MA104 cell line is a rhesus monkey kid-
ney cell line. Before the cells were inoculated with virus the cell culture must be
maintained and passaged a few times to obtain a stable culture. The RV must be ac-
tivated with trypsin before they can be propagated in cells. The trypsin cleaves the
surface protein VP4 into the protein VP5* and the cell attachment protein VP8ú,
which allows for virus entry into cells [75]. During virus propagation it was very im-
portant to use serum free medium since serum inhibits trypsin and thus inhibits the
rotavirus activation [74]. The trypsin or any other reagent used for RV propagation
or further handling must not contain EDTA since EDTA strips the outer layer of
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the TLP RV particles which means that they are no longer infectious [74].
The protocol for RV propagation was based on protocols from the National
Veterinary Institute, DTU VET, and from Arnold et al., 2012 [74]. The step by
step protocol and material list for rotavirus A propagation can be found in appendix
A.1. MA104 cells were grown in a cell culture flask in Medium 199. When cells had
reached approximately 90 % confluence it was possible to inoculate the cell culture
with trypsin activated RV.
Infection of RV was done at a multiplicity of infection (MOI) between 0.1 and 1. The
MOI is the number of cells / mL divided by the plaque forming unit (PFU) / mL:
MOI = PFU needed
No.cells
The PFU is a measure of the number (or virus titer) of virus particles in a volume
that is able to cause an infection (a plaque) in a cell monolayer fixed in agarose.
Thus, it is not a measure of number of viral particles present in a sample volume.
The viral titer values for the RV virus stocks supplied from ATCC were not given
as PFU but as TCID50/mL at a time period. The virus titer value TCID50 is an
expression for the median tissue culture infective dose that causes a cytopathic e ect
(CPE) in 50 % of the cell cultures over a time period. The TCID50 assay is thus an
end-point assay. The titer values supplied by ATCC were 2.8 x 10≠6 TCID50/mL
in 6 days and 2.8 x10≠6 TCID50/mL in 8 days for the strain Wa (G1P[8]) and DS-1
(G2P[4]), respectively. Like PFU, the TCID50 assay was used to estimate the MOI
for virus propagation by an assumption of a theoretical correlation between the two
titer values where it was assumed that all conditions between the two assays were
the same. The theoretical correlation was: PFU/ml = 0.7 TCID50/mL [76].
The CPE caused by the activated RV on the MA104 cells was observed every day
post infection. The CPE was initially seen as a cell rounding, then detachment of
the cells from the flask and finally cell lysis. It was important to keep a control cell
culture under the same conditions and media but without virus to verify that the
observed CPE was indeed caused by virus infection and not caused by bad handling
of the cells or lack of nutrients due to the serum free medium. Figures 3.2, 3.3 and
3.4 show microscopic images of the control cell culture, propagation of RV strain
Wa in cell culture and propagation of RV strain DS-1 in cell culture, respectively.
Infection was started at time t = 0 h and the cell cultures were observed every day
post infection. The morphology of the control cell culture, figure 3.2, did not change
significantly over a time period of 120 hours (5 days) which verified that any CPE
observed in the cell cultures infected with RV was caused by the viral infection. In
the cell culture infected with RV strain Wa, figure 3.3, a CPE was observed after 24
h where cell rounding and detachment in discrete areas were observed. 48 hours post
infection almost all of the cells had detached from the cell flask and at 72 hours post
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(a) MA104 control cells - at 0 h (b) MA104 control cells - at 24 h
(c) MA104 control cells - at 96 h (d) MA104 control cells - at 120 h
Figure 3.2: Microscopic images of control cells for RV culture in MA104 cells at
di erent times: 0 h, 48 h, 96 h and 120 h post infection of the non-control cells
(Cells in figure 3.3 and 3.4). Scale bar (100 µm) is the same for all images.
infection all cells had detached and many of the cells were lysed. At this point in
time the RV propagation was stopped by 3 repetitive cycles of freezing and thawing.
The propagation of the RV strain DS-1 in the MA104 cells was not as fast as the
RV strain Wa. This was seen in figure 3.4 where the observed CPE did not evolve
as fast as RV strain Wa in figure 3.3. 24-48 hours post infection of the DS-1 strain
discrete areas of cell detachment and cell rounding were observed. 96 hours post
infection approximately half of the cell monolayer had detached and at 120 hours
post infection almost all cells had detached and lysed. The RV propagation was
stopped by 3 repetitive cycles of freezing and thawing when all cells had detached
and lysed.
The observed di erence in the evolved CPE of the two strains corresponded with the
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(a) RV inoculated MA104 cells - at 24 h (b) RV inoculated MA104 cells - at 48 h
(c) RV inoculated MA104 cells - at 72 h
Figure 3.3: Microscopic images of propagation of RV strain Wa (G1P8) in MA104
cells. MA104 cells were inoculated with RV at 90 % confluence at time 0 h (Cor-
responding to cell coverage in Figure 3.2a). 24 h after inoculation with RV a CPE
was observed as cells began to detach in discrete areas from the culture flask (Figure
3.3a). At 48 hours almost all cells had detached (Figure 3.3b). At 72 h post infection
all of the cells had detached from the cell flask and many of the cells had been lysed
which means that the RV was ready for further processing e.g. purification (Figure
3.3c). Scale bar (100 µm) is the same for all images.
reported titer values from ATCC where the same titer value of 2.8 x 106 TCID50/mL
was reached but at di erent time periods of 6 days and 8 days for RV strain Wa and
DS-1, respectively.
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(a) RV inoculated MA104 cells - at 24 h (b) RV inoculated MA104 cells - at 48 h
(c) RV inoculated MA104 cells - at 96 h (d) RV inoculated MA104 cells - at 120 h
Figure 3.4: Microscopic images of propagation of RV strain DS-1 (G2P4) in
MA104 cells. MA104 cells were inoculated with RV at 90 % confluence at time
0 h (Corresponding to cell coverage in Figure 3.2a). After 24 h of RV inoculation a
small CPE was observed (Figure 3.4a). Only a small increase in CPE was observed
at 48 and 96 hours post infection (Figure 3.4b and 3.4c). After 120 hours most of
the cells had detached from the cell flask and been lysed (Figure 3.4d). Scale bar
(100 µm) is the same for all images.
3.2.2 Rotavirus purification
The RV purification was divided into two steps: semi-purification on a sucrose
cushion and an isopycnic gradient separation of TLP and DLP virus particles on a
self-forming CsCl gradient. Both methods were performed by ultracentrifugation.
Ultracentrifugation is a method involving high forces Ø 100,000 ◊g [31]. The high
gravitational forces are needed due to the small size of the RV (? 75-100 nm [25]).
Protocols for both steps for RV purification were based on work done by Arnold et
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al., 2012 [74]. The step by step protocols and material lists for RV semi-purification
and CsCl gradient purification can be found in appendix A.2 and appendix A.3,
respectively.
The first purification step, the semi-purification on a sucrose cushion, was in-
tended to concentrate the RV sample and reduce the sample volume. The sample
volume was reduced by a factor of approximately 45, as the sample volume allowed
in the ultracentrifuge was 6 x 38 mL which was resuspended in a few millilitres after
centrifugation. In the bottom of each centrifuge tube, underlying the RV sample,
a cushion of a high concentration sucrose solution (35 %) was gently placed. The
high concentration of sucrose slowed down the RV particles when they pelleted in
the bottom of the tube. The pellet containing the RV was resuspended in a bu er
containing calcium. The calcium in the bu er ensured the stability of the outer cap-
sid (VP4 and VP7) of the RV which means that RV should always be maintained in
bu ers containing calcium [74]. The bu er used in this protocol was denoted TNC
bu er: 20 mM Tris-HCl, 100 mM NaCl, 1 mM CaCl2 at pH 8.0 [74]. In the RV
purification protocols by Arnold et al., [74], Freon was used as an initial step to sep-
arate the viral particles from the cell debris as many of the viral particles remained
associated with the cell debris after cell lyses. Freon can be used to release these
viruses from the debris [25]. Freon is highly toxic for humans and the environment
and work with Freon underlies restriction by international treaties. Due to these
restrictions it was not possible to use Freon for the RV purification of this thesis.
This may compromise the concentration of the recovered RV but it was assumed
that the outcome of the purification (i.e. the concentration) was su cient for the
aptamer selection.
The aptamer selection, which was the endpoint of the RV purification, was in-
tended to target the outer structural proteins of the RV virions as these proteins
will be present on the mature infectious virions (TLP). As described earlier, the
aptamer selection is thus targeting the outer structural proteins VP4 and VP7 of
the RV. In a RV cell culture both mature TLP and immature DLP are present.
The mature TLP RV particles must thus be separated from the immature DLP RV
particles. This was done by isopycnic gradient separation on a self-forming CsCl
gradient where a density gradient from the bottom to the top of a centrifuge tube
was self formed during ultracentrifugation. The relatively heavy Cs+ ions in the
solution were forced in the direction of the gravitational forces, towards the bottom
of the centrifuge tube, at the same time the Cs+ ions di used towards the top of the
centrifuge tube thus creating a density gradient from the bottom to the top of the
tube. Virus particles in the CsCl gradient separated according to their density since
they migrated to the position in the density gradient that matches their density,
the so called isopycnic point [31]. The density of the TLP and DLP RV particles
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were 1.36 g/cm3 and 1.38 g/cm3, respectively [74]. Figure 3.5 shows images of the
self formed CsCl gradient with two distinct bands containing the TLP and DLP
viral particles after ultracentrifugation of the two human RV strains. An inverted
(normal visual) light source was used to illuminate the viral particles. The images
showed that the two bands lie closer to each other in the DS-1 strain compared to
the Wa strain. This could be caused by a small di erence in the density of the TLP
of the two strains caused by the di erence in amino acid sequence of the structural
proteins. At the top of each centrifuge tube a third band containing RV viral parti-
cles (not possible to see in the image of the Wa strain) was present. This band may
contain aggregates of viral particles. As aggregates are more loosely packed it was
assumed that the density of the aggregates was lower than the single particles which
forced the aggregates to the top of the tube during centrifugation. Aggregates can
be removed by using a homogenizer after the semi-purification. Unfortunately, this
equipment was not available in the laboratory facilities used for the RV purification.
The purified RV were unloaded from the centrifuge tube in sample fractions. This
RV strain DS-1RV strain Wa
TLP
DLP
Figure 3.5: RV purified on a CsCl gradient. The two bands seen in the tube was
the separated TLP and DLP RV particles. The RV particles was separated due to
their di erence in density.
was done by puncturing a hole in the bottom of the centrifuge tube to allow the
sample to slowly drip into eppendorf tubes. The fractions containing the TLP and
DLP were carefully labelled. In order to verify the content of the collected frac-
tions the fractions were analysed by SDS-PAGE. The SDS-PAGE gel was stained
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by silver stain, which allowed visualisation of the protein bands. Coomassie blue
staining was initially tested for the band visualisation, but this staining method was
not sensitive enough. Figure 3.6 shows the SDS-PAGE gels for the two RV strains.
Table 3.1 lists the structural proteins of the RV, proteins in bold were the interesting
structural proteins of the TLP and DLP particles. In the figure 3.6 the positions
Table 3.1: Mass and location of structural proteins of RV [77]
Protein Mass (kDa) Location (no. of copies)
VP1 125 SLP (12)
VP2 95 SLP (120)
VP3 88 SPL (12)
VP4 (VP5* + VP8*) 85 (58 + 27) TLP (120)
VP6 45 DLP (780)
VP7 34 TLP (780)
of the structural proteins were calculated from the marker positions and the marker
mass. A logarithmic correlation between the displacement and the marker position
was assumed (See figure A.3 for elaboration of the logarithmic correlation). The
identified positions of the structural proteins were labelled in the figure. During
the unloading of the gradient it was intended to have the DLP and the TLP RV in
fraction 3 and fraction 5 of both RV strains, respectively. The SDS-PAGE gel of
RV strain Wa (figure 3.6a) revealed that RV was present in all fractions as bands
of VP6 were present in all fractions. Unfortunately, there was a small mixing in
the gradient during the unloading of the fractions which can explain the presence
of RV in all fractions. The fraction with the highest content of VP7 was fraction
5 as expected, indicating the presence of TLP in this fraction. It was not possible
to identify VP4, VP5* or VP8* in the gel. Fraction 8 contained the band that was
present at the top of the centrifuge tube. In this fraction a high concentration of
RV was present, seen by the high VP6 intensity, and all of the interesting structural
proteins could be identified.
The SDS-PAGE gel of the RV strain DS-1 (figure 3.6b) showed a high content of
VP6 in fraction 3 but fraction 5 contained a low concentration of VP6 and VP7 was
not visible in this fraction. From the unloading of the gradient it was known that
fraction 5 contained TLP RV but the gel revealed that the concentration of VP7 was
very low, below the detection limit of the silver stain. As seen with the RV strain
Wa fraction 8 contained a high concentration of RV. The marker position of the
marker diluted 1:50 (right side marker) did not match with the 1:10 diluted marker.
This was caused by an error during the running of the gel. Since the interesting
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proteins could be identified in the gel it was assumed that the misalignment could
be disregarded.
Both of the SDS-PAGE gels were performed before the CsCl was removed by dial-
ysis. It was not clear if the CsCl interfered with the gel but both gels required long
development times (approximately 3 min) and the protein bands seemed smeared
out to some extend. Figure A.2 shows a SDS-PAGE gel performed on a simian RV
strain after dialysis to remove the CsCl. This gel required less development time
than the gels in figure 3.6 and the protein bands appeared more confined and clear.
After the SDS-PAGE gel analysis the CsCl was removed from the interesting frac-
tions (3 and 5) by dialysis.
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(a) SDS-PAGE of RV, strain Wa, purified on CsCl gradient
(b) SDS-PAGE of RV, strain DS-1, purified on CsCl gradient
Figure 3.6: SDS-PAGE of RV, strain Wa and DS-1, purified on CsCl gradient.
The protein bands were stained with silver stain. VP4 (85 kDa), VP8ú (27 kDa),
VP7 (34 kDa) and VP5ú (58 kDa) were proteins specific to TLP virus particles. VP6
(45 kDa) was present in both DLP and TLP RV (see table 3.1). Marker and protein
positions are given in kDa. The protein positions were identified by calculating the
logarithmic relation between the marker position and the marker mass (in kDa) (See
figure A.3 for further elaboration).
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3.3 TEM images of the TLP and DLP RV
TEM images of the TLP and DLP virus particles for each RV strain were made by
Ramona Valentina Mateiu, DTU CEN, Center For Electron Nanoscopy, in order to
visually confirm the content of fraction 3 and 5 from the CsCl gradient. The samples
were negative stained with 2 % uranyl acetate and the imaging was performed in
bright field TEM in an FEI Tecnai G2T20 microscope.
Figure 3.7 shows the TEM images obtained of the TLP and DLP RV, strain Wa
and DS-1, respectively. ImageJ (National Institutes of Health, USA) was used to
measure the average diameters of the viral particles.
The average diameters of the RV strain Wa of TLP and DLP were measured to be
81.3 nm and 68.7 nm respectively. The figures 3.7a and 3.7b show a clear morpho-
logical di erence between the TLP and the DLP particles of strain Wa. The TLP
particles have a much smoother and more defined circular structure than the DLP.
Furthermore, it was seen that the sample was very clean since no impurities were
observed in the TEM images.
In the figures 3.7c and 3.7d the diameters of TLP and DLP, RV strain DS-1, were
measured to be 70.0 nm and 63.4 nm, respectively. The TEM images also showed
that the concentration of the particles was low since only a few viral particles were
present in the images. Thus, the number of particles used to determine the average
diameters was limited especially for the DLP where only two clear particles were
observed.
The TEM images confirms that the content of the two fractions, 5 and 3, was
indeed the TLP and the DLP RV particles for both strains. The diameter of the RV
particles were smaller than the diameter reported in the literature (? 75-100 nm
[25]). The TEM images showed that the diameters of the particles are strain depen-
dent, which could explain why there was a di erence compared to the literature.
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(a) TLP RV, strain Wa, average diameter:
81.3 nm
(b) DLP RV, strain Wa, average diameter:
68.7 nm
(c) TLP RV, strain DS-1, average diameter:
70.0 nm
(d) DLP RV, strain DS-1, average diame-
ter: 63.4 nm
Figure 3.7: TEM images of TLP and DLP RV, strain Wa and DS-1. Scale bar
in the lower left corner is 50 nm. Images were made by Ramona Valentina Mateiu,
DTU CEN, Center For Electron Nanoscopy.
3.4. TCID50 ASSAY OF FRACTION 5 FROM CSCL GRADIENT 51
3.4 TCID50 assay of fraction 5 from CsCl
gradient
50 % endpoint - TCID50 assays were performed in order to calculate the titer values
of fraction 5 of both RV strains. The assays were performed in 96 microtiter well
plates by culturing cells and inoculating with 50 µL activated virus for 1 hour
and then adding 200 µL serum free medium with 0.5 µg/mL trypsin, according
to protocol in appendix A.1. The CPE was observed every day post infection to
determine the 50 % end point dilution and at which point in time this was reached.
A 10 fold dilution series of fraction 5 of each virus strain was examined in the assay.
The calculation of the titer value for the assay was based on the Reed and Muench
method [78]. The titer values were calculated according to the following formula
[78]:
Di erence of logarithms = (mortality at dilution next above 50%)≠ 50%(mortality next above 50%)≠ (mortality next below 50%)
(3.1)
where the 50 % endpoint dilution is 10Di erence of logarithms, and the virus titer is
10Di erence of logarithms/(volume virus sample used).
Table 3.2 and table 3.3 shows the results of the TCID50 assay of RV strain Wa
and DS-1, respectively. Using equation 3.1 the titer values of fraction 5 were found
to be:
• RV strain Wa: 4.64 x 10≠6/50µL (9.28 x 10≠5/mL), after 6 days
• RV strain DS-1: 3.16 x 10≠4/50µL (6.32 x 10≠3/mL), after 8 days
The titer values of the purchased virus sample from ATCC were 2.8 x 10≠6/mL
after 6 and 2.8 x 10≠6/mL after 8 days of RV strain Wa and DS-1, respectively. As
the titer value of the TCID50 assay determines the dilution factor of the virus sample
where 50 % of the cell cultures contain dead cells, a virus titer value of e.g. 10≠3/mL
means a lower virus concentration compared to a titer value of e.g. 10≠8/mL. Thus,
concentrations of fraction 5 of both strains were lower than the initial sample from
ATCC. This means that a lot of virus material was lost during the purification of
the samples or the viral particles loose their infectious nature during purification.
Furthermore, the RV strain DS-1 showed a very low log10 virus dilution which means
that already at a log10 virus dilution of -4 there is no visible CPE.
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Table 3.2: TCID50 assay of fraction 5, RV strain Wa, after 6 days
Wells Cumulative total
Log10 virus dilution Dead Alive Dead Alive Total Percent mortality
-3 4 0 11 0 11 100
-4 4 0 7 0 7 100
-5 3 1 3 1 4 75
-6 0 4 0 5 5 0
-7 0 4 0 9 9 0
-8 0 4 0 13 13 0
-9 0 4 0 17 17 0
-10 0 4 0 21 21 0
Table 3.3: TCID50 assay of fraction 5, RV strain DS-1, after 8 days
Wells Cumulative total
Log10 virus dilution Dead Alive Dead Alive Total Percent mortality
-3 4 0 4 0 4 100
-4 0 4 0 4 4 0
-5 0 4 0 8 8 0
-6 0 4 0 12 12 0
-7 0 4 0 16 16 0
-8 0 4 0 20 20 0
-9 0 4 0 24 24 0
-10 0 4 0 28 28 0
3.5 Biotinylation of virus particles and coupling
to magnetic beads
The aptamer selection performed by our collaborator, Fraunhofer Institute for Cell
Therapy and Immunology (IZI), is based on magnetic bead manipulation. During
the aptamer development the ssDNA library is incubated with a target, in this case
a virus. For the aptamer selection the target is coupled to magnetic beads through a
biotin linker. The motivation of using magnetic beads separation is that it facilitates
the process of separating any unbound ssDNA from the target bound ssDNA in the
SELEX procedure. The following section will thus describe the experimental work
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related to biotinylation of the viral particles.
Initially, the viral particles were biotinylated and then linked to the streptavidin
coated magnetic beads as illustrated in figure 3.8. The diameter of the magnetic
bead was 2.8 µm which means that there was a possibility to immobilise several viral
particles on one bead. The principle of biotinylation was to covalently bind biotin
to the surface proteins of the viral particles. Two biotinylation mechanisms were
tested: one with Biotin-PEG4-Hydrazide (BPH) linker and one with (+)-Biotin N-
hydroxysuccinimide ester (BNHS) linker.
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Figure 3.8: Principle of biotinylation of virus particles with a BPH linker or BNHS
linker and coupling of biotinylated virus particles to streptavidin coated magnetic
beads.
The BPH linker molecule has a pegylated spacer arm to increase the hydrophilic
nature of the molecule (see figure 3.8 for molecular structure). The hydrazide bi-
otin linker (BPH linker) binds to aldehydes. However, with the use of 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) the hydrazide group can react with other
carboxyl groups, in this case with carboxylic acids [79]. Thus, the amino acids in
the protein backbone must contain carboxylic acids as side groups in order to bind
to the hydrazide terminal end of the linker molecule. The only two natural amino
acids that contain carboxylic acids as side groups are aspartic acid and glutamic
acid. It is also a possibility to bind the linker molecule to the terminal carboxylic
acid of the protein backbone.
The BNHS linker reacts with primary amines in the protein [80]. The amino acid
lysine and the N-terminus of the protein backbone can thus be biotinylated with
BNHS. Since the BNHS reacts with primary amines it is important to avoid bu ers
with amines or any protein content. The BNHS linker has a shorter spacer arm than
the BPH linker (see figure 3.8 for molecular structure).
The two biotinyaltion mechanisms were examined and analysed with real-time RT-
PCR to compare the performance of the two linkers. Furthermore, the infectivity
of the biotinylated virus was examined by a cell assay.
Step by step protocols and material lists for biotinylation and magnetic bead cou-
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pling of RV with the BPH linker and the BNHS linker can be found in appendix A.4
and appendix A.5. The protocols were based on protocols from Fraunhofer Institute
for Cell Therapy and Immunology (IZI) and from the National Veterinary Institute,
DTU VET.
3.6 Real-time RT-PCR analysis of biotinylated
RV and RV samples
Real-time RT-PCR analysis of the biotinylated RV (bRV) samples and samples of
the RV culture and purification was performed in order to quantify the yield of the
biotinylation and the subsequent coupling of the virus to the magnetic beads. The
principle of real-time RT-PCR was described in chapter 2.1.2.
The real time RT-PCR assay used for this PCR analysis was a one step reaction,
hence reverse transcriptase and the real time PCR were performed in the same
tube. Each sample was analysed in duplicates to get a repetition (average) Ct value
for a precise result. If one of the two samples showed up negative and the other
sample positive the Ct value was discarded for that particular sample and the result
was considered negative. The RNA of the virus samples was extracted beforehand
with a viral RNA extraction kit. The material list, primer/probe sequences and the
protocol are found in appendix A.6.
The bRV samples and samples of the purification of both RV strains were analysed
together with a dilution series of the RV strain Wa cell culture. PCR results of
samples listed in table 3.4, table 3.5 and table 3.6 were done in the same PCR run
together with negative controls containing nuclease free water. The negative controls
showed up negative. From the Ct values of the PCR analysis of the dilution series
of the cell culture (table 3.4) a relation between the Ct value and the dilution factor
was found. The relation is illustrated in figure 3.9 where the relation was found
from an exponential fit to be:
Sample dilution = 847666 · e≠0.754·Ct value (3.2)
This relation was used to calculate a (theoretical) dilution factor of the remaining
analysed samples.
Table 3.5 and table 3.6 shows the results of the real-time RT-PCR of the bRV
and the purified samples of RV strain Wa and DS-1, respectively. In each table an
explanation of the sample is given together with the repetition Ct value and the
calculated dilution factor (calculated from equation 3.2). The correlation between
the Ct values and the calculated dilution factors is displayed graphically in figure
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Table 3.4: Real time RT-PCR analysis of virus culture dilutions, RV strain Wa
Sample dilution Repetition Ct value Calculated dilu-
tion factor
10≠1 21,19 0.97 · 10≠1
10≠2 24 1.17 · 10≠2
10≠3 27,07 1.16 · 10≠3
10≠4 30,92 6.36 · 10≠5
10≠5 33,32 1.04 · 10≠5
10≠6 – –
10≠7 39,27 1.17 · 10≠7
10≠8 – –
10≠9 – –
y	=	847666e-0,754x
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Figure 3.9: Real time RT-PCR analysis of virus culture dilutions, RV strain Wa.
An exponential relation between the Ct values and the dilution factor was assumed
and a correlation between the two was found.
3.10. The data displayed in blue corresponds to the RV strain Wa samples and the
orange data points corresponds to the RV strain DS-1. From the figure it was evi-
dent that the sample concentration, i.e. the viral sample content, of the RV strain
Wa was relatively higher than the concentration of the RV strain DS-1. The titer
value of the TCID50 assay was added to the figure. The Ct value of the titer value
was calculated from equation 3.2. Since 140 µL was used for the RNA extraction of
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the PCR analysed samples the volume of the titer value was corrected accordingly
(1.3 x 10≠5/140µL after 6 days for RV strain Wa and 8.85 x 10≠4/140µL after 8
days for RV strain DS-1)
Table 3.5: Samples and result of real time RT-PCR analysis of bRV and RV culture
samples, strain Wa. Samples Wa 3 - 9 were diluted 10 times for the PCR analysis.
Sample
no.
Sample
label
Sample explanation Repetition
Ct value
Calculated
dilution
factor
Wa 1 cell
culture
Virus culture (with cell debris re-
moved)
18.1 1 · 100
Wa 2 1. Centri Supernatant of first ultracentrifu-
gation step
22.04 5.14 · 10≠2
Wa 3 fract. 5 Fraction 5 (diluted 1:10 - com-
pared to the original fraction 5
sample)
20.9 1.21 · 10≠1
Wa 4 bRV
BPH
Biotinylated virus with BPH (di-
luted 1:10)
23.18 2.18 · 10≠2
Wa 5 bRV
BNHS
Biotinylated virus with BNHS
(diluted 1:10)
22.62 3.32 · 10≠2
Wa 6 beads
BPH
Biotinylated virus with BPH,
bound to beads (diluted 1:10)
28.07 5.45 · 10≠4
Wa 7 beads
BNHS
Biotinylated virus with BNHS,
bound to beads (diluted 1:10)
29.13 2.45 · 10≠4
Wa 8 beads
BPH S
Supernatant of biotinylated virus
with BPH, bound to beads (di-
luted 1:10)
23.09 2.33 · 10≠2
Wa 9 beads
BNHS S
Supernatant of biotinylated virus
with BNHS, bound to beads (di-
luted 1:10)
22.12 4.84 · 10≠2
Real-time RT-PCR analysis of RV strain Wa
The correlation found in equation 3.2 was found from a dilution series of RV strain
Wa. As expected the cell culture sample, RV strain Wa, showed a calculated dilu-
tion factor of 1, i.e. a non diluted sample. Fraction 5, RV strain Wa, showed a 10
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Table 3.6: Samples and result of real time RT-PCR analysis of bRV and RV
culture samples, strain DS-1. Samples DS-1 3 - 9 were diluted 10 times for the
PCR analysis.
Sample
no.
Sample
label
Sample explanation Repetition
Ct value
Calculated
dilution
factor
DS-1 1 cell
culture
Virus culture (with cell debris re-
moved)
25.84 2.93 · 10≠3
DS-1 2 1. Centri Supernatant of first ultracentrifu-
gation step
27.00 1.22 · 10≠3
DS-1 3 fract. 5 Fraction 5 (diluted 1:10 - com-
pared to the original fraction 5
sample)
23.31 1.97 · 10≠2
DS-1 4 bRV
BPH
Biotinylated virus with BPH (di-
luted 1:10)
26.18 2.27 · 10≠3
DS-1 5 bRV
BNHS
Biotinylated virus with BNHS
(diluted 1:10)
24.87 6.09 · 10≠3
DS-1 6 beads
BPH
Biotinylated virus with BPH,
bound to beads (diluted 1:10)
29.9 1.37 · 10≠4
DS-1 7 beads
BNHS
Biotinylated virus with BNHS,
bound to beads (diluted 1:10)
29.43 1.95 · 10≠4
DS-1 8 beads
BPH S
Supernatant of biotinylated virus
with BPH, bound to beads (di-
luted 1:10)
26.60 1.65 · 10≠3
DS-1 9 beads
BNHS S
Supernatant of biotinylated virus
with BNHS, bound to beads (di-
luted 1:10)
25.03 5.39 · 10≠3
times dilution compared to the cell culture. It is important to notice that fraction
5 was diluted 10 times for the PCR analysis as 140 µL sample was required for the
RNA extraction and too much sample material would have been used if the sample
had not been diluted. Thus, the concentration of fraction 5 corresponded to the
concentration of the cell culture when corrected for the dilution. The PCR analysis
of the supernatant of first ultracentrifugation step (sample: 1. Centri) strain Wa,
revealed that the semi-purification was able to concentrate the virus with an e -
ciency of 95 % since the RV concentration of the supernatant was 20 times diluted
compared to the cell culture.
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Figure 3.10: Real time RT-PCR analysis of bRV and purification samples, RV
strain Wa and DS-1. The calculated dilution factor was found from equation 3.2.
The Ct values of the TCID50 assays were calculated from equation 3.2 using the
virus titer value as the dilution factor in the equation: 9.28 ·10≠5/mL ·0.14 mL and
6.32 · 10≠3/mL · 0.14 mL for RV strain Wa and DS-1, respectively. 0.14 mL was
used as this was the volume used for the RNA extraction. Further explanation of
the data labels can be found in table 3.5 and 3.6.
Samples from the biotinylation of the two biotin linkers BPH and BNHS were anal-
ysed, six samples in total were analysed: the bRV sample, bRV sample bound to
beads and the supernatant of the bRV sample bound to beads for each linker. All of
these samples were diluted 10 times for the PCR analysis, hence the dilution factors
must be 10 times higher to compensate for this. In general the concentration of the
bead supernatant samples were higher than the concentration of the bRV samples
coupled to beads. The relative concentration of the bead BPH supernatant sample
and the bead BPH sample was approximately 40 times higher for strain Wa. The
relative concentration of the bead BNHS supernatant sample and the bead BNHS
sample was approximately 200 times for strain Wa. From this it was concluded that
the BPH linker had a higher yield as more virus bound to the beads using the BPH
linker. It was still evident that only a fraction of the virus indeed did bind to the
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beads as the concentration of the bead BPH samples was 40 times lower than the
bRV BPH sample. The relative concentrations are summarised in table 3.8.
Table 3.7: Relative concentrations of RV strain Wa samples
Samples Relative concentration
Fraction 5 / bRV BPH 56
Fraction 5 / bRV BNHS 47
bRV BPH / BPH bead 40
bRV BNHS / BNHS bead 135
bead BPH S / BPH bead 43
bead BNHS S / BNHS bead 197
Real-time RT-PCR analysis of RV strain DS-1
The calculated dilution factors of RV strain DS-1 were relative to the RV strain Wa
since the relation (equation 3.2) was made from a dilution series of RV strain Wa.
As the amount of genomic material (i.e. 11 dsRNA per RV virus) and the real-time
RT-PCR assay with primers and probe were the same for the two strains it was
assumed that the relation (equation 3.2) could be used for RV DS-1. In general, the
concentrations of the DS-1 strain samples were lower than the samples of the Wa
strain as illustrated in figure 3.10. The first centrifugation step, the semi-purification
on a sucrose cushion, was not as e cient for the DS-1 strain as 42 % of the RV was
present in the supernatant of the first centrifugation step (1. Centri/Cell culture *
100). On the other hand fraction 5 of the CsCl purification had a 67 times higher
RV concentration than the cell culture, taken into account that the fraction 5 was
10 times diluted for the PCR analysis. Comparison of fraction 5 of the RV strain
DS-1 with the RV strain Wa revealed that the DS-1 strain had a 6 times lower RV
concentration than the Wa strain.
The relative concentrations of the bRV samples and fraction 5 are listed in table 3.8.
The relative concentration of the supernatant of the bead BPH sample was 12 times
higher than the BPH bead sample. For the BNHS linker the relative concentration
of the two sample was 28. This indicated that the relative amount of immobilised
RV DS-1 on the beads was relatively higher than for the RV Wa strain where the
relative concentrations were 43 and 197 for the BPH and BNHS linkers, respectively.
The relative concentrations of the RV DS-1 bRV bPH and BNHS compared to the
BPH bead and BNHS bead samples were 17 and 31, respectively. Again, this showed
that the relative amount of immobilised bRV DS-1 onto the beads was higher than
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the RV strain Wa. Thus, it seemed like the biotinylation of the DS-1 strain was more
e cient than the RV Wa strain. It is still important to note that the concentration
of RV Wa was higher than the concentration of the RV DS-1 strain, which may have
an impact on the results.
Table 3.8: Relative concentrations of RV strain DS-1 samples
Samples Relative concentration
Fraction 5 / bRV BPH 87
Fraction 5 / bRV BNHS 32
bRV BPH / BPH bead 17
bRV BNHS / BNHS bead 31
bead BPH S / BPH bead 12
bead BNHS S / BNHS bead 28
The di erence between the two biotin linkers was most predominant in the RV
strain Wa where the BPH linker performed best. Since the most interesting RV
strain was strain Wa, based on the high level of infectious nature of this strain, and
the highest yield of the RV strain Wa coupled to the beads was obtained using the
BPH linker it was chosen to use this linker for the biotinylation for the aptamer
selection.
3.6.1 Control of passive absorption of RV onto beads
The passive absorption of the two RV strains, Wa and DS-1, was tested in order
to compare the passive absorption to the biotin-strepatvidin binding of the bRV to
the beads. Fraction 5 for both RV strains were diluted 1:50 and incubated with the
magnetic beads as described in appendix protocol A.4 but without the biotinylation
step. The rationale behind diluting the fraction 5 samples 1:50 was based on a
relative concentration of 56 of samples, RV strain Wa, fraction 5 compared to the
bRV BPH sample (see table 3.8). After incubation of the RV with the beads the
supernatant of the bead suspension was collected and the beads were washed 3
times before RNA extraction. Table 3.9 shows the results of the real-time RT-PCR
analysis. The calculated dilution factor was calculated from equation 3.2. The real-
time RT-PCR analysis was performed according to the protocol A.6 in the appendix.
The negative PCR control was negative and the positive PCR control had a Ct value
of 26.21. The relative concentrations of the analysed samples are listed in table 3.10.
The relative concentration of samples Frac. 5, RV Wa, 1:50 / beads neg. Wa
was 0.97, which means that almost all of the virus was present in the bead sample.
3.6. REAL-TIME RT-PCR ANALYSIS OF BIOTINYLATED RV AND RV
SAMPLES 61
Table 3.9: Samples and result of real time RT-PCR analysis of control of passive
absorption of RV onto beads
Sample label Sample explanation Repetition
Ct value
Calculated
dilution
factor
Frac. 5, RV Wa, 1:50 Original fraction 5 sample, RV
strain Wa diluted 1:50
23.37 1.89 · 10≠2
Beads neg. Wa Sample Frac. 5, RV Wa, incu-
bated with beads
23.33 1.94 · 10≠2
Neg. bead S Wa Supernatant of sample Beads neg.
Wa
24.23 9.86 · 10≠3
Frac. 5, RV DS-1, 1:50 Original fraction 5 sample, RV
strain DS-1 diluted 1:50
25.65 3.38 · 10≠3
Beads neg. DS-1 Sample Frac. 5, RV DS-1, incu-
bated with beads
28.04 5.58 · 10≠4
Neg. bead S DS-1 Supernatant of sample Beads neg.
DS-1
26.21 2.22 · 10≠3
Table 3.10: Relative concentrations of PCR analysis of control of passive absorp-
tion of RV onto beads. Samples: Frac. 5, RV Wa and DS-1, were the original
fraction 5 samples analysed in table 3.5 and 3.6, corrected for the 10 times dilution
for the PCR analysis.
Samples Relative concentration
Frac. 5, RV Wa / frac. 5, RV Wa, 1:50 64
Frac. 5, RV Wa, 1:50 / beads neg. Wa 0.97
Neg. bead S Wa/ beads neg. Wa 0.51
Frac. 5, RV DS-1 / frac. 5, RV DS-1, 1:50 58
Frac. 5, RV DS-1, 1:50 / beads neg. DS-1 6.1
Neg. bead S DS-1/ beads neg. DS-1 4.0
The relative concentration of the supernatant sample compared to the bead sample
was 0.51, which indicates that the concentration of the bead sample was twice as
high as the supernatant sample. The analysed samples og the DS-1 strain showed
a relative concentration of 6 for the diluted fraction 5 compared to the bead sample
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and a relative concentration of 4 for the supernatant of the bead sample compared
to the bead sample.
The results indicated that the passive absorption of the non-biotinylated virus sam-
ples onto the magnetic beads was quite large compared to the bRV samples immo-
bilised onto the beads. It was unclear how strong this binding was since the RNA of
the virus samples were extracted just after the incubation. It was thus a possibility
that the viral particles can disassociate with the bead over a period of time since
it must be assumed that the biotin-streptavdin binding is stronger than the passive
absorption.
3.7 Examining the infectivity of bRV
Information about the infectivity of the bRV samples is important, especially in
relation to the aptamer development as infectious material must be handled with
extra precautions and requires classified laboratory settings. The infectivity of the
bRV, RV strain Wa and DS-1, with either the BNHS and BPH linker was tested
along with a control of purified RV without biotinylation (results of the purified
RV sample was described in the TCID50 assay, section 3.4). The infectivity assays
were performed in the same way as the TCID50 assay in 96 microtiter well plates
with cultured MA104 cells by inoculating 50 µL activated virus per well for 1 hour
and then adding 200 µL serum free medium with 0.5 µg/mL trypsin, according
to protocol in appendix A.1. A dilution series, compared to the concentration of
fraction 5, ranging from 10≠3 to 10≠10 of the bRV BPH and bRV BNHS of each RV
strain was tested. The infectivity study was done on bRV samples without coupling
the bRV to magnetic beads, i.e. no magnetic beads were added to the cell culture.
The CPE was observed on a daily basis post infection. Before infection at day 0 the
cell culture had reached a confluence of approximately 90 %.
Tables 3.11 and 3.12 shows the results of the bRV strain Wa with the BPH and
the BNHS linker, respectively. The results for the bRV strain DS-1 for the BPH
and BNHS linker is listed in tables 3.13 and 3.14, respectively. All of the results
of the four tables are the same: none of the infected wells of the titer plates for
all of the analysed samples showed any CEP caused by a viral infection. Thus,
it was concluded that the bRV was not infectious. The lack of infectivity of the
virus could be caused by a too low concentration of the activated virus samples.
This explanation is not likely since the highest concentration of bRV samples used
was 10≠3/50µL, which was higher than the titer values of the TCID50 assay(4.64 x
10≠6/50µL, after 6 days for RV strain Wa and 3.16 x 10≠4/50µL, after 8 days for
RV strain DS-1). Another plausible explanation of the lack of infectivity could be
that the biotin linker binds to the structural viral protein VP4 and thereby blocks
the ability of the virus to enter into the host cell, which means that the virus looses
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its infectivity.
Table 3.11: Infectivity assay of bRV BPH, strain Wa, 8 days post infection
Wells Cumulative total
Log10 virus dilution Dead Alive Dead Alive Total Percent mortality
-3 0 4 0 4 0 0
-4 0 4 0 8 0 0
-5 0 4 0 12 0 0
-6 0 4 0 16 0 0
-7 0 4 0 20 0 0
-8 0 4 0 24 0 0
-9 0 4 0 28 0 0
-10 0 4 0 32 0 0
Table 3.12: Infectivity assay of bRV BNHS, strain Wa, 8 days post infection
Wells Cumulative total
Log10 virus dilution Dead Alive Dead Alive Total Percent mortality
-3 0 4 0 4 0 0
-4 0 4 0 8 0 0
-5 0 4 0 12 0 0
-6 0 4 0 16 0 0
-7 0 4 0 20 0 0
-8 0 4 0 24 0 0
-9 0 4 0 28 0 0
-10 0 4 0 32 0 0
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Table 3.13: Infectivity assay of bRV BPH, strain DS-1, 8 days post infection
Wells Cumulative total
Log10 virus dilution Dead Alive Dead Alive Total Percent mortality
-3 0 4 0 4 0 0
-4 0 4 0 8 0 0
-5 0 4 0 12 0 0
-6 0 4 0 16 0 0
-7 0 4 0 20 0 0
-8 0 4 0 24 0 0
-9 0 4 0 28 0 0
-10 0 4 0 32 0 0
Table 3.14: Infectivity assay of bRV BNHS, strain DS-1, 8 days post infection
Wells Cumulative total
Log10 virus dilution Dead Alive Dead Alive Total Percent mortality
-3 0 4 0 4 0 0
-4 0 4 0 8 0 0
-5 0 4 0 12 0 0
-6 0 4 0 16 0 0
-7 0 4 0 20 0 0
-8 0 4 0 24 0 0
-9 0 4 0 28 0 0
-10 0 4 0 32 0 0
3.8 Biotinylation of HAV samples
The HAV sample prepared for the aptamer selection was cultured and purified by
ultracentrifugation and resuspended in phosphate-bu ered saline (PBS) at the Envi-
ronmental Virological Laboratory, Tor Vergata University, Rome, Italy. Inactivation
of the HAV was performed before the biotinylation. Inactivation was done to re-
duce the risk related to work with HAV and to ease shipment of samples to our
collaborators at the Fraunhofer Institute for Cell Therapy and Immunology (IZI).
According to Wang et al., 2015, [30], inactivation of HAV with formaldehyde did
not show any structural modifications of the virus. They based their conclusion
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on high resolution X-ray crystallography. Inactivation of HAV was performed with
formaldehyde diluted 1:2000 and left for 8 days at 4 ¶C as described by Wang et al.
[30]. Material list and protocol for HAV inactivation can be found in appendix A.7.
After inactivation, biotinylation of the HAV was performed with the BPH linker
based on the same principle as the biotinylation of the RV. Protocol and material
list can be found in appendix A.8.
3.8.1 Real-time RT-PCR analysis of biotinylated
inactivated HAV samples
The biotinylated HAV (bHAV) samples were analysed with real-time RT-PCR. The
PCR assay used for this purpose was a two step reaction, i.e. the reaction was
divided into the reverse transcription followed by the real-time PCR in two separate
tubes. We did not have a fluorescent probe for the real-time PCR and Sybr Green
was used instead. Sybr Green binds to all dsDNA and is not sequence specific like
a probe. This means that this assay was more sensitive to false positive results
caused by primer-dimer formation or wrong primer annealing. The protocol, primer
sequences and material list for the real-time RT-PCR analysis of the HAV can be
found in appendix A.9.
Due to the small amount of HAV sample provided (approximately 4 mL) it was not
beneficial to make a dilution series of the HAV sample like it was done with the
RV strain Wa. In total, 5 HAV samples were analysed in duplicates with real-time
RT-PCR, results are listed in table 3.15. Negative samples containing nuclease free
water were analysed together with the HAV samples and they showed up negative.
From the results listed in table 3.15 it was clear that the concentration of the original
HAV sample was low as a Ct value of 28.13 corresponds to a low concentration. A
Ct value of 33 or higher was considered negative. As a general rule, a three step re-
duction of Ct value corresponds to a 1-log reduction in concentration. The Ct value
of the inactivated HAV sample was 31.15 which corresponds to a 10 times lower
virus concentration than the original HAV sample. This reduction in concentration
can either be caused by the formaldehyde that may disrupt the DNA during the
inactivation or a physical reduction of the amount of virus during the dialysis. The
inactivated bHAV sample showed a Ct value of 36.61, which was above the threshold
of 33 and was considered negative. This was confirmed in the melting point analysis
where the melting point for the duplicate samples were 83.0 ¶C and 81.0 ¶C. The
melting point of the to samples must be the same and equal to the original HAV
sample (82.7 ¶C) since the amplified genomic material was the same. The samples
of the inactivated bHAV coupled to beads and the supernatant of inactivated bHAV
coupled to beads did not show up positive in the PCR analysis. Thus, the concen-
trations of the samples were below the detection point of the PCR analysis. The low
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concentration of the inactivated bHAV coupled to beads may be a hindrance in the
aptamer selection as a certain amount of target must be present on the magnetic
beads in order for the selection to be specific to the HAV.
Table 3.15: Real-time RT-PCR analysis of biotinylated inactivated HAV samples
with melting point data. Sample A and sample B correspond to the duplicate samples
used for the analysis.
Sample Repetition Ct value Melting point - ¶C
[Sample A / Sample B]
Original HAV sample 28.13 82.7 / 82.7
Inactivated HAV 31.15 82.7 / 82.7
Inactivated bHAV 36.61 83.0 / 81.0
Inactivated bHAV
coupled to beads
– –
Supernatant of inacti-
vated bHAV coupled
to beads
– –
3.9 Conclusion
The main purpose of the experimental work described in this chapter was to prepare
viral samples for the aptamer selection. For the RV, the preparation involved virus
propagation in cell culture, purification, biotinylation and analysis of the yield with
real-time RT-PCR. The HAV sample was cultured and purified by our collaborators
at the Environmental Virological Laboratory, Tor Vergata University, Rome, Italy
and the experimental work related to the sample preparation involved inactivation,
biotinylation and analysis of the yield with real-time RT-PCR.
The yield of the bRV and the bHAV samples was low compared to the original cell
culture samples. For the bRV coupled to the magnetic beads with the BPH biotin
linker the concentration was 40 (RV strain Wa) and 17 (RV strain DS-1) times lower
compared to the bRV samples. The bRV samples with the BPH linker showed a
56 and 87 times lower concentration for the RV strains Wa and DS-1 compared to
fraction 5 of the CsCl purification, respectively. This indicated that the coupling of
the bRV to the magnetic beads was ine cient or it could be caused by low e ciency
of the biotinylation. Furthermore, the control of the passive absorption of the non-
biotinylated beads to the beads showed a high level of passive absorption. It was
unclear how stable this passive absorption was compared to the biotin-streptavidin
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binding of the bRV and the beads as this would require further testing.
For the HAV sample it was not possible to calculate a relative concentration of the
original HAV sample compared to the inactivated bHAV coupled to beads since the
latter was negative in the PCR analysis. Furthermore, the sample of the inactivated
bHAV showed a Ct value above 33 and was considered negative.
The low concentration of the bRV and the bHAV samples may be problematic
during the aptamer selection, especially for the aptamer selection against the HAV.
The samples were shipped to our collaborators at the Fraunhofer Institute for Cell
Therapy and Immunology (IZI), Berlin, Germany. In the time of this writing, the
aptamer selection is still proceeding by the Fraunhofer Institute for Cell Therapy
and Immunology (IZI).

4
All-polymer aptasensor design and
fabrication development
Sensor development requires considerations of many di erent parameters that are
usually intercorrelated. Some of the important considerations related to design in-
puts are choice of materials, fabrication methods, electrode design, possibility of
multiplexing, electrical interface, transducer method etc. The di erent design in-
puts and their correlations are listed in figure 4.1. The transducer method for the
viral aptasensor was initially decided to be electrochemical impedance spectroscopy
(EIS). The principle of EIS was described in chapter 2.3.2. EIS was chosen as
the transducer method since impedimetric biosensors are able to directly convert a
biological recognition event into an electrical signal, thus enabling real-time label-
free measurements. Furthermore, it was initially decided to make an all-polymer
aptasensor, i.e. both sensor substrate and electrodes should be made of polymer
materials. The choice of using polymer materials was based on a desire for cheap
and easy fabrication and unit price of each sensor chip. By using polymer materials
instead of noble metals and silicon based devices, expensive materials and fabrica-
tion methods that require clean room facilities could be avoided. Clean room chip
fabrication enables advantages like low size limitations in the sub micrometer range
due to the clean environment. For the viral aptasensor development the smallest
structures of the electrodes were estimated to be around 100 µm, therefore the clean
room fabrication was not necessary and was a disadvantage due to the high costs and
complicated processes. Furthermore, polymer materials can be casted and moulded
in almost all shapes not limited to two dimensional (2D) structures, which is usually
the case for silicon fabrication methods.
This chapter will describe di erent important design inputs, requirements and spec-
ifications related to the design and development of the viral aptasensor. The chapter
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will focus on the iterative development for the aptasensor design, choice of materials
and fabrication methods.
All-polymer 
impedimetric 
aptasensor
Material
Fabrication
Biorecognition
immobilisation
Sampe matrix
Salinity
Target
Materials
Fabrication
Mulitplexing
Interpretation of 
output signal
Frequency range
Interface to 
electrical connections
Sensor substrate EIS signal
Sample Electrodes 
Real-time
Size 
Design
Figure 4.1: Considerations for design inputs for the viral aptasensor development.
Many of the di erent design inputs are intercorrelated (grey dashed arrows).
4.1 Initial design requirements for the viral
aptasensor
These following initial design and fabrication requirements were defined in order to
frame the further design and fabrication phases of the aptasensor development.
Multiplexing platform
The overall long term goal of the viral aptasensor is to do real-time detection of the
three di erent enteric viruses: NoV, RV and HAV, in a water sample, simultane-
ously. It was thus necessary to design the sensor as a multiplex sensing platform
that allowed for the detection of several targets in one sample. Hence, the sensor
design required at least three electrode pairs for viral detection and a control/ref-
erence electrode pair for di erential impedance measurements in order to subtract
the control baseline signal. Subtraction of the baseline signal from the signal of the
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sensing electrodes made it possible to remove any unwanted external signal e ects
and interferences that did not originate from the actual viral detection.
PEDOT:PSS as electrode material
In order to avoid noble metals in the sensor an alternative conducting material for
the sensing electrodes had to be found. PEDOT:PSS was chosen as the electrode ma-
terial since this intrinsic conducting polymer is one of the best conducting polymers
and our group at DTU Nanotech had experience in using PEDOT based materi-
als for biosensing applications. Furthermore, as a printing material PEDOT:PSS is
available as a commercial aqueous dispersion paste for screen-printing. PEDOT:PSS
was described in chapter 2.3.3.
In the initial design phases we were exploring di erent methods for electrode fab-
rication. Previously, our group at DTU Nanotech had experimented with agarose
stamping as a fabrication method for PEDOT doped with tosylate (PEDOT:TsO)
biosensor electrodes [11]. It was found that the agarose stamping had several dis-
advantages in the form of di culty in electrode size reproduction, which resulted
in great size variation. Furthermore, the agarose stamping method was a slow fab-
rication method, which was not suitable for large scale production. In the early
prototyping of the viral aptasensor, CO2 laser ablation was used as a fabrication
method to define electrodes by removing the unwanted areas of a PEDOT:TsO dry
film on a polymer substrate. This turned out to be di cult as the CO2 laser beam
burned the PEDOT and the polymer substrate to an extend where an electrically
insulating film was deposited on top of the electrodes. This insulating film origi-
nated from condensed vapours from the laser ablated polymers. Furthermore, the
diameter of the laser beam was around 140 µm, which meant that fabrication of
reproducible electrode structures of 100 µm in size was not possible. Finally, the
fabrication method was changed to screen-printing since this method suited many
of the requirements related to the electrode size and material choice. As men-
tioned earlier, PEDOT:PSS is available as a commercial aqueous dispersion paste
for screen-printing which makes electrode fabrication by screen-printing a highly
interesting method. Furthermore, screen-printing is a fabrication method that is
suitable for large scale production with a size limit of printable structures of around
100 µm. Using screen printing, the changes in the electrode design can easily and
inexpensively be performed, since a new design only requires preparation of a new
screen.
Polymer substrate material
The aptasensor chip substrate material was decided to be a polymer material. Many
di erent polymer materials are suitable as a chip substrate and they all have ad-
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vantages and disadvantages. The requirements for the polymer substrate material
was thus related to the chosen fabrication method but also the adherence of the
PEDOT:PSS paste had an impact on the material choice. In the early design iter-
ations, CO2 laser ablation was used as the fabrication method for fast prototyping.
Poly(methyl methacrylate) (PMMA) was used as substrate material since this ma-
terial was suitable for this fabrication method. In the later design iterations the
fabrication method was changed to injection moulding where di erent substrate
materials, Cyclic Olefin Copolymer (COC) and Polycarbonate (PC) were tested for
substrate material. Injection moulding is a suitable method for cheap large scale
production but the tools used for the mould are expensive, which explains why
laser ablation was applied in the initial design phases before design-lock of the chip
substrate. The injection moulding was made by our external collaborator Michael
Lundbech A/S, Denmark.
4.2 Iterative design and fabrication development
of the viral aptasensor chip
The iterative design process of the viral aptasensor can be divided into two main
designs based on the electrical interface:
1. The Universal Serial Bus (USB) chip
2. The Secure Digital (SD) card chip
All of the chip designs were designed using the Autodesk AutoCAD software. The
following sections will describe the di erent design iterations and the evolvement of
the design from the USB chip to the final SD card chip design. A detailed description
of the chip fabrication will only be described for the SD card chip, version 2, in
section 4.3 and 4.5.
4.2.1 The USB chip
The USB chip design was the initial design for the viral aptasensor with two electrode
pairs. The two electrode pair configuration did not meet the design requirements
for multiplexing as described in section 4.1 of this chapter. The main purpose of
this chip design was to investigate the di erent fabrication methods for the polymer
substrate and the electrodes and to do initial EIS testing of the electrodes. The
USB chip design iterations were divided into three phases:
1. USB chip, version 1: laser cut PMMA, laser ablated PEDOT:TsO, no lid for
liquid interface
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2. USB chip, version 2: injection moulded COC chip, screen-printed PEDOT:PSS,
lid with wells
3. USB chip, version 3: laser cut PMMA, screen-printed PEDOT:PSS, poly-
dimethylsiloxane (PDMS) liquid channels
USB chip, version 1: laser cut PMMA, laser ablated PEDOT:TsO, no
lid for liquid interface
The USB chip, version 1, was made by laser ablation with a CO2 laser. Both
electrodes and chip substrate were defined by laser ablation. The substrate material
was PMMA since this material was suited for laser ablation. Figure 4.2 shows
the technical drawing, images of the chip, microscope image of chip surface and
the sensor principle for USB chip, version 1. The chip was made to fit into a 1.5
Ver
1.2
11.0 mm
14.3 mm25.7 mm
(a) Technical drawing (b) Images of USB chips
(c) Microscope image of chip sur-
face
+
-
(d) Sensor principle of the
USB sensor system
Figure 4.2: USB chip, version 1: laser cut PMMA, laser ablated PEDOT:TsO, no
lid for liquid interface.
mL Eppendorf tube and dipped directly into the sample solution with a wireless
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connection to a mobile device as illustrated figure 4.2d.
The electrode material was PEDOT:TsO. The electrodes were made by spin coating
a thin layer of PEDOT:TsO onto a 10 x 10 cm, 2 mm thick, PMMA sheet and then
removing the PEDOT:TsO in the unwanted areas by laser ablation. PEDOT:TsO
was used since our group had previous experience in spin coating this material.
Figure 4.2a shows the technical drawing of the chip, the blue areas are PEDOT:TsO
and the beige areas are removed by laser ablation. Figure 4.2b shows an image
of two of the USB chip, version 1. As described earlier the diameter of the laser
beam of the CO2 laser was around 140 µm, which proved to be a challenge in the
fabrication process. Two di erent settings were used for defining the electrode with
the laser: vector and raster setting. The vector setting was used to cut the lines
between the electrodes and the raster setting was used to remove the surrounding
material. Figure 4.2c shows a microscope image of the electrode surface. The
image illustrates several problems with this fabrication method: limited spacial
resolution of the laser, large diameter of the laser compared to electrode structures
and sputtering of evaporated material on top of the electrode surface. Especially,
the sputtering of evaporated material turned out to be a large hindrance as the
electrode became electrically isolated, which meant that electric connection to the
electrodes was impossible. Based on the observations and the problems with the
CO2 laser ablation the fabrication of the electrodes was changed for the USB chip,
version 2, to screen-printing and a chip substrate was made by injection moulding
to avoid the CO2 laser.
USB chip, version 2: injection moulded COC chip, screen-printed
PEDOT:PSS, lid with wells
The substrate of the USB chip, version 2, was fabricated in COC by injection mould-
ing and the electrodes were screen-printed PEDOT:PSS. Figure 4.3 shows the tech-
nical drawing of the electrodes, the two injection moulded parts: chip substrate
and lid and an image of the disassembled chip with PEDOT:PSS electrodes. The
PEDOT:PSS electrodes are very hard to see in the image as the PEDOT:PSS has
a light blue transparent colour.
The active part of the electrode pair was the part of the PEDOT:PSS directly in
contact with the sample. The active part of each electrode pair was designed as two
concentric circles with an outer diameter of 700 µm and 500 µm with a thickness og
100 µm spaced 100 µm apart. Like the USB chip, version 1, the electrode design was
made as a three electrode configuration in such a way that the centre electrode was
shared between the two electrode pairs. This was changed in future designs as it was
a disadvantage that the electric signal from the electrode pairs was intercorrelated.
The lid was designed with a simple sample/liquid interface, which had two small
wells for addition of sample with a pipette. In this way it was possible to control
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13.7 mm
11.0 mm
(a) Technical drawing
(b) The two injection moulded chip
parts: chip substrate (light green)
and lid (dark green)
(c) Image of the disas-
sembled chip with PE-
DOT:PSS electrodes
Figure 4.3: USB chip, version 2: injection moulded COC chip, screen-printed
PEDOT:PSS, lid with wells
the electrode area directly in contact with the sample and the sample volume.
The small area of the chip substrate limited the possibility of channels for continu-
ous liquid flow. This led to the USB chip, version 3, where this issue was solved.
During the development of the PEDOT:PSS screen-printing process, it was observed
that a spacing of 100 µm between the electrodes often led to a short circuit between
the electrodes, hence a low yield of usable chips was obtained. The development of
the screen-printing process for the electrode print is described in details in section
4.3. The development was made partly at DTU Nanotech and partly in cooperation
with Vesterbro Serigrafi A/S, Denmark, at their facilities.
76
CHAPTER 4. ALL-POLYMER APTASENSOR DESIGN AND FABRICATION
DEVELOPMENT
USB chip, version 3: laser cut PMMA, screen-printed PEDOT:PSS,
PDMS liquid channels
The USB chip, version 3, solved some of the previous problems concerning the shared
centre electrode and the liquid interface. Figure 4.4 shows the technical drawing of
the chip, the chip substrate with printed electrodes and an image of four assembled
chips with liquid tubings connected in series.
E1 PMMA 
Connectors in USB interface
w: 100 µm
dis: 200 µm PEDOT:PSS
12.0 mm
39.8 mm
14.7 mm
11.0 mm
E2
Channel formed in PDMS 
(a) Technical drawing
(b) Chip substrate with printed
electrodes
(c) Four assembled chips with liquid tub-
ings connected in series
Figure 4.4: USB chip, version 3: laser cut PMMA, screen-printed PEDOT:PSS,
PDMS liquid channels
The chip substrate was fabricated in PMMA by CO2 laser ablation. Laser abla-
tion was used for fabricating the substrate as this method allowed for fast prototyp-
ing and experimenting with the design of the substrate. The PEDOT:PSS electrodes
were printed onto the substrate by screen-printing. The design of the active part of
the electrodes was the same as for the USB chip, version 2, but the spacing between
the electrodes was increased to 200 µm to avoid short circuit of the electrode paris.
The area of the chip substrate was increased in this design iteration in order to
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allow enough space for a liquid channel. The liquid channel was casted in PDMS
and clamped between the substrate and a laser cut PMMA lid. It was thus possible
to experiment with EIS measurements with continuous sample flow. The assembly
of the chips with the PMMA substrate, the PDMS channel and the PMMA lid was
a cumbersome process. For the next design iterations this was intended solved.
As pointed out earlier the USB chip did not suit the requirements for the multiplex-
ing platform. As a consequence of this, the designs of the substrate and electrodes
were changed to fit an SD card interface for the next design iteration.
4.2.2 The SD card chip
In order to meet the design requirements of a four electrode pair multiplexing config-
uration the electrical interface and substrate design was changed to a design based
on a SD card interface. The SD card electrical interface has nine electrical connector
pins which suited our need for eight connectors. Furthermore, the SD connector is
designed to insert a chip by a click-and-lock system where the chip is locked inside
the connector once it is mounted. This ensures that the chip is fixed inside the con-
nector and reduces the possibility that the chip is accidentally dismounted during
measurements. Figure 4.5 illustrates a cross section of an SD card chip mounted
inside a SD card connector.
Chip substrate
Chip lid
PCB
Metal cover
Metal
connector
pin Electrode
Plastic
Insert chip
Remove chip
Figure 4.5: Illustration of a cross section of an SD card chip mounted in a SD
card connector.
The design phases of the SD card chips were divided into three design versions:
1. SD card chip, version 1: laser cut PMMA, screen-printed PEDOT:PSS, double
sided adhesive tape channels
2. SD card chip, version 2: laser cut PMMA, screen-printed PEDOT:PSS, double
sided adhesive tape channels
3. SD card chip, version 3: injection moulded COC or PC, screen-printed PE-
DOT:PSS, injection moulded lid with channel and tubing connectors, assem-
bled with screen-printing glue
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The technical drawings and images of the three SD card chip versions can be seen
in figure 4.6. The figure also shows the relative position of the SD card connector
and the original dimensions of a SD card (green and purple line in figure 4.6a,
respectively). The three designs will be described below.
Relative position of SD Card connector 
Original SD Card dimensions
PEDOT:PSS
SD card chip substrate
Fluidic interface
M0M1M2M3
5mm
45
 m
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33
 m
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50
 m
m
20
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12345678
9
55
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42
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24 mm
Ver. 1 Ver. 3Ver. 2
(a) Technical drawings of SD card chip, version 1-3
(b) Images of SD card chip, version 1-3
Figure 4.6: Technical drawings and images of the SD card chip, version 1-3. A
zoom of an electrode pair of SD card chip version 3 can be found in figure 4.7.
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The active part of the electrodes (PEDOT:PSS in contact with liquid sample)
for all of the SD card chips had the same design with two concentric circles with an
outer diameter of 750 µm and 500 µm with a thickness og 100 µm spaced 150 µm
apart. A spacing of 150 µm was found suitable for obtaining a good electrode print
with a high yield of usable chips. A zoom of the technical drawing (figure 4.6a)
showing the active part of the electrodes and the liquid channel of the SD card chip,
version 3, is illustrated in figure 4.7.
1.7 mm
3
2
1
100 um
500 um
750 um3
2
1
Active part of 
electrode pair
Figure 4.7: Zoom on an electrode pair, SD card chip, version 3
SD card chip, version 1: laser cut PMMA, screen-printed PEDOT:PSS,
double sided adhesive tape channels
The substrate of the SD card chip, version 1, was made from 1.5 mm PMMA sheets
by laser ablation. A channel for sample flow was defined in double sided adhesive
tape and sealed with a lid of 1 mm thick PMMA with through holes for the sample
introduction into the chip. Both channels and lid were made by laser ablation. Tub-
ings for the sample were connected to the channel through a PDMS gasket on top of
the lid which was clamped between two PMMA sheets. This methods of assembling
the chip required many di erent parts and time.
The chip and the electrodes were both relatively long, 42 and 55 mm, respectively.
This design was made in order to fit the liquid interface of the chip outside of the SD
card connector. It was not possible to fit the liquid interface inside the connector
since the total thickness of the chip was 2.5 mm and the maximum thickness of a
chip inside the connector could not exceed 2.1 mm. The long electrodes were found
to be a disadvantage since the electrodes had a high electrical resistance caused by
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the relatively low conductivity of PEDOT:PSS compared to metal conductors.
SD card chip, version 2: laser cut PMMA, screen-printed PEDOT:PSS,
double sided adhesive tape channels
The fabrication principle of the SD card chip, version 2, was the same as SD card
chip, version 1. The di erence between the chips was the length of the electrodes
and the liquid interface. The length of the electrodes was reduced to 33 mm and the
width of the electrodes were wider until the active part of the electrodes in order to
reduce the electrical resistance of the electrodes. The principle of assembly of the
chips was the same as SD card chip, version 1. The cumbersome assembly of the
chips was solved for the next design iteration.
Section 4.3 and 4.5 of this chapter describes the chip fabrication for the SD card
chip, version 2.
SD card chip, version 3: injection moulded COC or PC, screen-printed
PEDOT:PSS, injection moulded lid with channel and tubing
connectors, assembled with screen-printing glue
The substrate for the SD card chip, version 3, was injection moulded in order to
have a thickness of 1.2 mm, corresponding to a slightly thinner thickness compared
to the thickness of an original SD card of 1.4 mm (thickness inside the connector
over the metal connector pins). The SD card chip, version 1 and 2, were both made
from 1.5 mm thick extruded PMMA sheets. Often, a variance of the thickness of
the extruded sheets of up to 0.2 mm was observed. This meant that some of the
chips were thicker than intended and the SD card connector pins were damaged.
The lid of the SD card chip, version 3, was injection moulded and designed with an
integrated channel and connectors for the tubing. Once assembled, the thickness of
the chip was 2.1 mm, which suited the demands of the SD card connector.
The total thickness of 2.1 mm of the assembled chip allowed a design where the
liquid interface was partly placed inside the SD card connector once the chip was
mounted. This meant that the length of the electrodes could be reduced to 20 mm,
which was an advantage in relation to the electrical resistance of the electrodes. The
liquid channel and tubing connectors were designed as part of the lid. This design
proved the advantage of injection moulding since this design would have been im-
possible to make with laser ablation due to the 3D structures. The height of the
channel was 100 µm with a width of 1.7 mm around the electrodes. With the tubing
connectors integrated as part of the lid, chip assembly was possible to do without
any PDMS gasket and clamping. Figure 4.8 shows a 3D illustration of the assem-
bled SD card chip, version 3, with tubings. Di erent approaches for chip assembly
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Figure 4.8: 3D illustration of the assembled SD card chip, version 3, with tubings
were tested. Initially, the chips were assembled by double sided adhesive tape. This
approach was discarded since it required careful alignment of the channel and the
tape. Furthermore the tape increased the thickness of the chip with approximately
100 µm. The second approach for assembling the chip was done with a UV curable
glue. The glue was spotted onto the chip with a micro spotting robotic system
(Autodrop Professional Positioning System for spotting is described in section 4.5).
This method was very labour intensive and the glue had a tendency to flow into the
channels and block the flow. The final assembling approach was based on screen-
printed glue. This method was fast to do and the glue sealed the chip nicely with
out any blockage of the flow.
We experimented with two di erent substrate materials: COC and PC. Initially,
COC was tested but the PEDOT:PSS did not adhere well to this material, which
resulted in easily damaged electrodes. This issue had previously been observed with
the PMMA substrate. Di erent approaches to overcome this problem was tested by
applying air plasma, corona treatment or a hydrophilic surface coating. The best
surface treatment was the air plasma where both the adherence and the shape of
the electrodes were found to be best. The substrate material was changed to PC
and a good adherence of the PEDOT:PSS was observed using the air plasma. Thus,
the final material choice for the chip substrate and lid was PC.
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4.3 Screen-printing
Screen-printing is an old printing technique where the desired design is printed, or
transferred, through an ink permeable screen to an underlying substrate. Screen-
printing can be performed either by hand or by large advanced screen-printing ma-
chines that can control all of the parameters in the printing process. Figure 4.9
illustrates the principle of the screen-printing process of the aptasensor chips.
Substrate holder
PMMA substrate
Frame with screen: Mesh 150, 22o
Squeegee 
Print direction
PEDOT:PSS paste
Print pattern
Screen - substrate spacing 
approx. 3mm
Screen
Figure 4.9: Principle of screen-printing
Three di erent PEDOT:PSS screen-printing pastes were tested in order to find
the best suited paste for our electrode design and substrate material. The three
di erent pastes were:
1. Clevios TM S V3
2. Clevios TM S V3 HV
3. Clevios TM S V4 STAB
The latter paste was UV, heat and damp stabilised by the commercial supplier
(hence: STAB). All of the pastes were purchased from Heraeus Precious Metals
GmbH & Co. KG, Germany. Clevios TM S V3 was used in the initial screen-
printing tests but it was soon realised that this paste was not suited for our 100 µm
structures as the structures of the print were flowing together. Thus, the Clevios
TM S V3 HV paste was used instead as this paste was suited for fine line structures.
During our printing development the commercial supplier ended the production of
the Clevios TM S V3 HV paste and we found that the Clevios TM S V4 STAB was
a suitable replacement.
Protocol and material list for manual screen-printing of PEDOT:PSS electrodes,
SD card chip version 2, can be found in the publication Screen-printed all-polymer
aptasensor for impedance based detection of influenza A virus, in section 4.5 of this
chapter.
The following section describes the development of the screen-printing process.
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4.3.1 Development of the PEDOT:PSS screen-printing
process
The size limitation of the PEDOT:PSS printable structures was initially tested with
a test print illustrated in figure 4.10 on COC sheets. The test print was designed to
test the USB chip, version 1 and 2, parallel lines and concentric circles with a width
and distance ranging from 100 µm to 500 µm. The PEDOT:PSS Clevios TM S V3
was used for the test. The test print was done at the facilities of Vesterbro Serigrafi
A/S, Denmark, using their professional screen-printing machines.
100 um200 um300 um400 um500 um
Figure 4.10: Screen-printing test layout with the USB chip, versions 1 and 2,
parallel lines and concentric circles with a width and distance ranging from 100 µm
to 500 µm
Figures 4.11 and 4.12 shows the result of the test print. Figure 4.11 shows the
active part of the electrode area of USB chip, version 1 and 2. The left (4.11a and
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(a) First print test of USB chip, version
2, electrode
(b) Second print test of USB chip, ver-
sion 2, electrode
(c) First print test of USB chip, version
1, electrode
(d) Second print test of USB chip, ver-
sion 1, electrode
Figure 4.11: Screen-print test of USB electrodes, version 1 and 2
4.11c) images shows the first print while the right (4.11b and 4.11d) images illustrates
the printed structures of the second print where the screen-printing parameters were
altered to obtain a better print. The parameter alterations were performed by the
printing expert at Vesterbro Serigrafi A/S. The di erence between the first and
second prints convinced us that screen printing of 100 µm structures indeed was
possible. The width of the electrodes of USB, version 2, was 100 µm according
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to the technical drawing. The width of the printed electrode in figure 4.11b was
ranging between 65 and 105 µm which was considered good for a first print but it
left room for improvement.
(a) Print test of vertical lines, width 100
µm, spaced 100 µm apart
(b) Print test of vertical lines, width 200
µm, spaced 200 µm apart
(c) Print test of concentric circles, width
100 µm, spaced 100 µm apart
(d) Print test of concentric circles, width
200 µm, spaced 200 µm apart
Figure 4.12: Screen-print test of parallel lines and concentric circles.
Figure 4.12 shows the 100 µ and 200 µm printed parallel lines and concentric
circles. The images of the parallel lines shows that it was possible to print parallel
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lines with a distance of 100 and 200 µm but the lines with 100 µm apart had a
tendency to collapse with each other. The same tendency was observed for the
concentric circles.
The surface properties of the COC film was not altered for these first prints which
mean that the the hydrophobicity of the film was quite high. As described in section
4.2 of this chapter, di erent approaches to alter the hydrophobicity of the substrates
and the adherence of the PEDOT:PSS to the substrates were tested in order to
obtain a better print. The adherence of the PEDOT:PSS of test prints (figures 4.11
and 4.12) to the substrate was very bad. By looking carefully at the prints small
scratches can be observed. The prints had been handled with great care in order
to avoid any scratches but it was not possible to avoid damage. After the first
test prints the PEDOT:PSS was changes to the PEDOT:PSS Clevios TM S V3 HV,
which was better suited for small fine line structures. Unfortunately, the production
of this PEDOT:PSS was terminated by the manufacturer and we changed to the
Clevios TM S V4 STAB PEDOT:PSS. The PEDOT:PSS Clevios TM S V4 STAB
was found successful for printing small structures. Figure 4.13 shows the final print
of the active part of the electrodes of the SD card chip, version 3, after optimising
the printing procedure and surface treatment. This electrode print was in good
agreement with the technical drawing, figure 4.7. The substrate material was PC
and an air plasma treatment was applied to the substrate before printing.
Figure 4.13: Screen-print of SD card chip, version 3, electrode pair
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4.4 Conclusion
After several design iterations the final chip design that suited the design inputs
and requirements of the viral aptasensor was based on a SD card interface with
four electrode pairs. The active part of the electrode pairs was designed as two
concentric circles with width of 100 µm, spaced 150 µm apart. The chip substrate
and the chip lid were fabricated in PC by injection moulding. A channel (100 µm
high) and tubing inter connectors were integrated into the lid for easy assembly. The
assembly was done with screen-printing glue. The best method for fabricating the
PEODT:PSS electrodes was found to be screen-printing where printed structures
of 100 µm in size were possible to reproduce. The best suited substrate material
was found to be PC with an air plasma treatment of the substrate before printing
the electrodes. The air plasma reduced the hydrophobicity of the substrate and
increased the adherence of the PEDOT:PSS to the substrate.
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4.5 Screen-printed all-polymer aptasensor for
impedance based detection of influenza A
virus
This book chapter was submitted for second revision, March 2016, to:
Biosensors and Biodetection
Methods and Protocols
Methods in Molecular Biology series, Springer
Editors: Avraham Rasooly and Ben Prickril
The submitted book chapter is a methods chapter intended to describe all de-
tails of the experimental methods involved in the described experimental setup.
The methods described involve the chip fabrication, aptamer immobilisation and
EIS measurements of water samples containing influenza A virus (IAV). Thus, the
di erent fabrication steps of the SD card chip, version 2, are described in detail in
the book chapter.
N.b. Chapter not included in online version of this PhD thesis.
5
Exploring the surface
immobilisation of aptamers
Immobilisation of a biorecognition element in a biosensor application is crucial and
of pivotal importance in order to get a successful and reliable sensor. The surface
coverage, orientation and stability of the biorecognition elements all a ect the per-
formance of the sensor [43]. The final design iteration of the all-polymer aptasensor
described in chapter 4 uses PEDOT:PSS as electrode material and PC as substrate
material. Surface immobilisation of aptamers, or ssDNA, onto solid surfaces is usu-
ally done through a chemical modification of the 5’ or 3’ end of the ssDNA. Physical
absorption of the aptamer onto the substrate can also be used but this simple method
is not suitable due to low stability of the electrostatic interactions leading to desorp-
tion of the ssDNA [43]. For gold substrates, chemisorption of ssDNA with a 3’ or 5’
end thiol linker is the preferred method for immobilisation as this method creates
a self assembled monolayer of covalently bound ssDNA on the gold surface while
assuring correct orientation of the ssDNA [81] [82]. Biotin labelling of aptamers
can also be used to link aptamers to a modified substrate surface. In this case, the
surface of the substrate is modified with a coverage of avidin, streptavidin or neu-
travidin and subsequently linked with the biotinylated aptamer [43]. The biotin -
avidin/streptavidin/neutravidin complex is a large molecular complex which will in-
crease the distance between the target recognition (or bioreaction) and the electrode
surface. If this immobilisation approach is used in an electrochemical biosensor the
output signal from the sensor will be reduced, leading to a lower sensitivity. Another
possibility is to modify the aptamer with a primary amine group at the end of the
oligonucleotide sequence. The amine group covalently binds to functional groups on
the substrate, e.g. carbonyl groups.
In the literature, immobilisation of ssDNA onto di erent polymer materials has
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been done by di erent approaches, e.g. Fixe et al., 2004, described a method for
immobilising amine modified ssDNA onto aminated PMMA sheets with the use of
glutaraldehyde [83]. Dufva et al., 2004, described a method for UV cross-linking of
unmodified ssDNA onto an agarose film coated on a solid support of glass for DNA
microarrays [12]. The UV cross-linking of ssDNA probes on agarose films was further
improved by Dufva et al., 2006, by an addition of a terminal poly(T)10-poly(C)10
tag (TC-tag) on the ssDNA [13]. In their study they showed a significant signal
improvement in DNA hybridisation experiments with the addition of the TC-tag on
the cross-linked ssDNA compared to unmodified ssDNA and other tags (Poly(T)10,
Poly(T)20, Poly(C)10). The chemical mechanism behind the UV cross-linking is
unknown, but it is suggested by Dufva et al., 2006, that the TC-tag is directly
involved in the crosslinking [13]. Kimura, 2006, investigated the UV cross-linking
method and immobilisation of poly(dT) modified ssDNA onto unmodified PMMA,
PC and PET substrates [84]. Sun et al., 2011 [14], used the TC-tag described by
Dufva et al., 2006, to immobilise ssDNA probes on unmodified COC, PC, PMMA
and PDMS substrates. They demonstrated an application of the UV crosslinking in
a COC microfluidic biochip for DNA hybridisation experiments [14]. Furthermore,
UV cross-linking of ssDNA has been demonstrated on unmodified glass substrates
[85] and the UV cross-linking method has been used to immobilise an aptamer on a
polyester cloth for thrombin detection [86].
PEDOT:PSS is a chemically inert polymer material with no direct available reactive
groups for thiol or amine linking for immobilising aptamers to the polymer surface.
The UV cross-linking approach for immobilising ssDNA onto polymer substrates is
an interesting approach for aptamer immobilisation on PEDOT:PSS due to the in-
ertness of the material and the simple method of the UV cross-linking. Furthermore,
unmodified DNA is considered more cost e ective than modified DNA (e.g. amino
modified DNA) as it is estimated that unmodified DNA sequences cost up to 300
times less than amino modified DNA [13]. In the following sections of this chapter
the UV cross-linking method will be experimentally investigated for immobilising
aptamers on PEDOT:PSS based on the method described by Dufva et al., 2006 [13].
Figure 5.1 illustrates a UV immobilised aptamer with the TC-tag and a spacer and
the target recognition. The TC-tag binds to the electrode surface and is linked to
the aptamer sequence by a spacer. The spacer increases the distance between the
tag and the aptamer, thus increasing the possibility that the aptamer will be ori-
ented away from the electrode surface and thus folds correctly upon target binding.
When a target comes into close proximity of the aptamer, the target is recognised
and bound to the aptamer.
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TC-Tag linker
Spacer
Aptamer
Target
Electrode surface
Figure 5.1: Theoretical principle of a cross-linked UV immobilised aptamer on an
electrode surface and target recognition.
5.1 UV cross-linking of aptamers onto di erent
polymer substrates
The UV cross-linking of ssDNA onto a solid support is a rather simple approach
compared to chemical immobilisation, which usually requires many and long incu-
bation steps. The UV cross-linking procedure can be divided into four main steps
as illustrated in figure 5.2: 1) A clean and dry surface is prepared, 2) A droplet
Substrate
PEDOT:PSS
Clean and dry 
PEDOT:PSS surface
Droplet with disolved 
aptamers is spotted 
onto the PEDOT:PSS 
surface
Dry droplet on the 
PEDOT:PSS surface
UV exposure followed 
by a wash
1 2 3 4
Figure 5.2: Illustration of the four main steps involved in aptamer immobilisation
onto a solid support, in this case PEDOT:PSS, by the UV cross-linking method
with an aptamer solution (typically 0.1 - 10 µM) is spotted onto the surface, 3) The
droplet is dried onto the surface and 4) The surface with the dried aptamer solution
is exposed to UV illumination (typically 1-10 min) and subsequently thoroughly
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washed to remove any unbound aptamers.
As described above, the aptamer is labelled with a TC-tag and a spacer between the
tag and the aptamer. Ideally, only the TC-tag binds to the surface of the substrate
but this is unknown since the chemical reaction, or modification, during the UV ex-
posure is unknown. Of the four DNA bases, the molecular structure of T and C can
be changed by UV exposure, as they may form dimers upon UV radiation. Hence,
it makes sense to have a TC rich label that can become "chemically activated" by
UV exposure and thereby bind to the substrate. This also means that if an aptamer
sequence is rich in T or C bases, parts of the aptamer may be linked to the surface or
create dimers. This can potentially alter the chemistry of the aptamer, which leads
to reduced or impossible target recognition. Thus, several important aspects must
be examined experimentally in order to determine if the UV immobilisation method
is an appropriate method for aptamer immobilisation. The critical aspects to be
determined in order to evaluate the applicability of the procedure are the adherence
of the aptamer and the subsequent interaction between the reverse complementary
DNA (rcDNA) strand or the target. The interaction of the rcDNA with the aptamer
is a more simple interaction than the aptamer-target recognition, which depends on
a conformational change of the aptamer. Thus, the rcDNA interaction was used
to test the adherence and the DNA interaction since, logically, the complex target
recognition would not be possible if the simple DNA interaction did not work.
The adherence and the interaction of the aptamer onto di erent polymer substrates
were examined by di erent approaches. Initially, a fluorescently labeled rcDNA was
used to investigate the adherence and interaction of the UV immobilised aptamer
spotted onto PEDOT:PSS and PC. The aptamer adherence and interaction were
further investigated by a colorimetric enzyme linked aptasorbent assay (ELASA)
onto PEDOT:PSS, di erent microtiter plates and PC. A PCR based assay was at-
tempted used for the investigation of the adherence of aptamers onto PMMA and
COC. The subsequent interaction with the primers used in the aptamer selection
was tested with both conventional PCR and real-time PCR. It was not possible to
make a PCR assay that did not result in false positive due to problems with the
assay and the sample preparation in the lab, hence, the PCR assay was discarded.
The following sections of this chapter will describe the experimental work related to
the investigation of UV cross-linked aptamers by fluorescently labeled rcDNA and
ELASA.
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(a) Spotting on PEDOT:PSS, wet (b) Spotting on PEDOT:PSS, dry
(c) Spotting on PC and PE-
DOT:PSS, wet
(d) Spotting on PC and PE-
DOT:PSS, dry
(e) Illustration of
where images was
acquired on chip.
Figure 5.3: Wet and dry images of the aptamer spotting process with the Autodrop
system. A horizontal drop distance 0.15 mm was used to spot the droplets in the
images.
5.2 UV cross-linking of aptamers and detection
with a fluorescent label
The immobilisation of aptamers onto PEDOT:PSS and PC by the UV cross-linking
method was examined by immobilising aptamers onto the surface and subsequently
hybridising a fluorescently labeled rcDNA to the aptamer. The aptamers were spot-
ted onto SD card chips, version 3, with a robotic spotting system: the Autodrop Pro-
fessional Positioning System. UV exposure was done in a Stratagene UV Stratalinker
2400 UV illuminator. A confocal microscope was used to measure the fluorescence.
The purposes of these experiments were to determine if the PEDOT:PSS and the
PC substrate bound aptamers di erently and to see if the adherence could be im-
proved by tuning di erent parameters in the immobilisation process. Figure 5.3
shows microscopic images of the wet and dry stages of the spotting process. The
PEDOT:PSS is a hydrophilic material while the PC is hydrophobic. The aptamer
solution was nicely spread on the PEDOT:PSS electrodes (see figure 5.3a). Due to
the small amount of spotted solution (only a few nL/electrode), the solution dried
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fast within one minute. The wet and dry stages of a linear droplet array is seen
in figures 5.3c and 5.3d. Each spot had a volume of approximately 300 pL. The
spots on the PEDOT:PSS dried before it was possible to acquire an image of the
wet stage. This indicated that the spots were spread out on the PEDOT:PSS and
the larger surface area made the droplets evaporate faster.
The step by step protocol and material list for the UV cross-linking of aptamers
spotted with the Autodrop system onto chips and subsequent rcDNA hybridisation
can be found in appendix A.10.
5.2.1 Examining the adherence of cross-linked aptamers
and rcDNA hybridisation - before and after washing
and after hybridisation
The first experiment was performed to test the adherence of a fluorescently labelled
aptamer with a target specificity towards ampicillin, herein denoted as Amp3 (see
appendix B.5 for the aptamer sequence). The Amp3 aptamer was used for this
purpose as our group had previous experience in working with this aptamer. The
aptamer was labelled with an ATTO550 dye (Absorption (Abs): 554 nm, emission
(Em): 576 nm), the TC-tag and a spacer at the 5’ end.
Aptamers were diluted to a final concentration of 5 µM in a spotting bu er solution
of 50 % dimethyl sulfoxide (DMSO) and 50 % MilliQ water (ultrapure water). The
DMSO was added to the spotting bu er to increase the evaporation time. Spotting
layout for the Amp3 aptamer is illustrated in figure 5.4. The red lines in the figure
illustrate where the aptamers were spotted. 6 chips were spotted in total. After
1 2 3 4 5 6 7 8
Electrode #
Substrate: PC
Electrodes: PEDOT:PSS, SV 4 STAB
Figure 5.4: Spotting layout for Amp3 aptamer. Red lines represents where on the
chip the aptamers were spotted. The concentric electrode area and a linear droplet
array with two parallel lines were spotted.
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(a) Full spotting layout
(b) Zoom of electrode pair 5-6. Bottom image in-
cludes an outline of the PEDOT:PSS electrode.
Figure 5.5: Fluorescent microscope images of PEDOT:PSS electrodes and PC
substrate with Amp3 spotted aptamer before the first washing step. The fluorescent
aptamer is visible on the concentric circles of the electrode pairs but not in the linear
spotting array that is only visible on the PC substrate.
spotting, the aptamers were cross-linked with 5 minutes of UV illumination. One
of the chips was imaged after the spotting and the UV illumination but before the
wash. The chip was imaged before the washing step to visualise the fluorescence on
the PEDOT:PSS as it was suspected that the PEDOT:PSS might have a quenching
e ect on the fluorescence. Figure 5.5 shows a fluorescent microscope image of the
spotted area of the chip before the washing step. Figure 5.5a shows the full area
with spotted aptamers. As it is di cult to see the fluorescence and the structures
in the image a zoom of electrode pair 5-6 is seen in figure 5.5b. The bottom im-
age includes an outline of the PEDOT:PSS electrode pair. From figure 5.5b we
could elucidate that the linear spotting arrays were only clearly visible on the PC
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substrate. By looking careful at the original full scale image (image too large for
the thesis layout) the linear array could be seen on the PEDOT:PSS as a smeared
out cloudy structure. On the concentric circles of the electrodes it was possible to
observe the fluorescent aptamers. From this, it was concluded that the fluorescence
indeed was possible to see on the PEDOT:PSS but the fluorescence signal was not
homogeneous over the whole electrode surface. Thus, It could not be rejected that
the PEDOT:PSS had a tendency to quench the fluorescence.
After the UV cross-linking three di erent washing procedures with di erent
bu ers were tested, denoted first washing step. Saline-sodium citrate (SSC) was
used in two of the three washing bu ers as this bu er is a commonly used bu er
for DNA hybridisation. One of the washing bu er contained 0.1 x SSC with 0.1 %
Sodium dodecyl sulfate (SDS) since this was the washing bu er used by Sun et
al., 2012, [14] in their UV cross-linking experiments. The three di erent washing
procedures were:
• Chip 1+2: Quick rinse with MilliQ water after UV exposure
• Chip 3+4: Wash for 10 min in 2 x SSC bu er after UV exposure
• Chip 5+6: Wash for 10 min in 0.1 x SSC with 0.1 % SDS after UV exposure
The Amp3 rcDNA with a Cy3 dye (Abs: 550 nm, Em: 570 nm) label at the 3’
end was hybridised to the Amp3 aptamer and washed with three di erent washing
procedures with di erent bu ers, denoted second washing step:
• Chip 1+2: Quick rinse with 2x SSC and MilliQ water after rcDNA hybridisa-
tion
• Chip 3+4: Quick rinse with 2x SSC followed by a 10 min wash with 2 x SSC
after rcDNA hybridisation
• Chip 5+6: Quick rinse with 2x SSC followed by a 10 min wash with 0.1 x SSC
with 0.1 % SDS after rcDNA hybridisation
Figure 5.6 shows fluorescent microscope images of one electrode pair of chips 1,
3 and 5. Chips 1+2, 3+4 and 5+6 were repetitions and showed the same tendency
after the washing steps, thus only one of each repetition is shown in the figure. Left
images show the chips after the first washing step and right images show the chips
after hybridisation and the second washing step. The florescent dye on the rcDNA
strand has the same absorption and emission as the dye on the aptamer. Hence, the
same filters were used to acquire the di erent images. This also means that it was
not possible to distinguish the two DNA dyes from each other but it was possible
to compare the amount of fluorescence before and after hybridisation.
The first wash of chip 1 was only a brief washing step with a quick rinse with MilliQ
water. Figure 5.6a clearly showed the fluorescence of the linear spotting array and
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(a) Chip 1 - after the UV illumination and
first washing step
(b) Chip 1 - after second washing step and
after hybridisation
(c) Chip 3 - after the UV illumination and
first washing step
(d) Chip 3 - after second washing step and
after hybridisation
(e) Chip 5 - after the UV illumination and
first washing step
(f) Chip 5 - after second washing step and
after hybridisation
Figure 5.6: Fluorescent microscope images of PEDOT:PSS electrodes and PC
substrate with Amp3 spotted aptamer after the first washing step (left images) and
after hybridisation and second washing step (right images). Only one of the electrode
pairs of each chip is shown as this was representative of all of the electrode pairs for
each chip.
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the concentric electrode circles which means that a lot of aptamer was present on
the chip. After the first wash of chip 3 (figure 5.6c) and chip 5 (figure 5.6e) it was
not possible to see any fluorescence on the concentric electrode circles and only a
weak fluorescent signal was visual on the linear spotting arrays. It was thus possible
to conclude that a brief wash with MilliQ was not su cient to remove the unbound
excess aptamers on the chip.
After the second wash and the rcDNA hybridisation a weak fluorescent signal was
visible in chip 1 (figure 5.6b). This indicated that the excess aptamers were washed
away during the hybridisation and the second wash. It was thus a possibility that the
rcDNA had bound to the excess unbound aptamers and was subsequently washed
away, which could explain the lower fluorescent signal. The fluorescent signal from
the spotting array on chip 3 (figure 5.6d) was increased after the hybridisation and
second wash which indicated that the rcDNA had bound to the aptamer. The fluo-
rescent signal of chip 5 (figure 5.6f) after the hybridisation and second wash was very
low. The ionic concentration of the washing bu er was 20 times lower for chip 5 than
the washing bu er for chip 3. It was thus a possibility that the ionic strength of the
chip 5 washing bu er was too weak to keep a stable hybridisation between the two
DNA strands and they had disassociated during the wash. It was concluded that
thorough washing steps were needed in order to remove unbound excess aptamers
but a low ionic concentration of the wash bu er could compromise the DNA hy-
bridisation. Common for all chips was that no fluorescent signal was present on the
PEDOT:PSS after the hybridisation and the second washing step. Three possible
reasons could explain this: either the PEDOT:PSS quenched the fluorescent signal,
the amount of immobilised aptamer was below the detection limit of the microscope,
or it was not possible to immobilise the aptamers onto the PEDOT:PSS by the UV
cross-linking method. To investigate these theories further, experiments were made
where di erent parameters, the UV illumination time and the aptamer concentra-
tion, of the cross-linking method were altered. This experiment is described in the
following section.
5.2.2 Examining the rcDNA hybridisation with di erent
aptamer concentrations and UV exposure times
The purpose of this experiment was to explore how changes of two parameters in
the cross-linking method could alter the aptamer immobilisation onto PEDOT:PSS
and PC. The two parameters which were changed during the experiments were: the
UV illumination time and the aptamer concentration. In the previous hybridisation
experiment (section 5.2.1) it was not possible to test for unspecific hybridisation
as only one aptamer and the rcDNA were used. In this experiment, unspecific hy-
bridisation was included. Two arrays on the chip were prepared: one with a known
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aptamer and one with a random aptamer mix with the TC-tag at the 5’ end. The
known aptamer used for this experiment was an aptamer with a target specificity
towards VP1 of the human NoV, herein denoted HNV-VP1 (see appendix B.1 for
the aptamer sequence). The HNV-VP1 aptamer has a long sequence (90 bases) as
it includes the primers used in the aptamer selection process. The rcDNA to the
HNV-VP1 aptamer was labelled with a Quasar 570 dye (Abs: 548 nm, Em: 566
nm) at the 5’ end.
Three di erent aptamer concentrations were tested: 1 µM, 0.5 µM and 0.05 µM. All
of the aptamers were diluted in a spotting bu er containing 2 % DMSO in MilliQ
water. Furthermore, two di erent UV exposure times were tested: 1 minute and 5
minutes. Four chip repetitions of each parameter combination were made. Figure
5.7 illustrates the aptamer spotting layout and the experimental layout. A total of
1 2 3 4 5 6 7 8
Electrode #
Substrate: PC
Electrodes: PEDOT:PSS, SV 4 STAB
HNV-VP1
Aptamer mix
(a) Spotting layout for HNV-VP1 aptamer and ran-
dom aptamer mix
Aptamer
concentration
UV 
illumination
time
Chip
repetitions
1 µM0.5 µM0.05 µM
1 min5 min
1 2 43 1 2 43
1 min5 min
1 2 43 1 2 43
1 min5 min
1 2 43 1 2 43
(b) Experimental layout
Figure 5.7: Experimental and spotting layout for examining the adherence and
rcDNA hybridisation with di erent aptamer concentrations and UV exposure times.
Red lines in figure 5.7a represent where on the chip the aptamers were spotted.
The concentric electrode area and a linear droplet array with two parallel lines were
spotted.
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24 chips were examined. The washing bu er was PBS with 2 mM MgCl2 and each
washing step (1: after UV exposure and 2: after hybridisation) was carried out for
10 minutes. Bright-field and fluorescent images of the chips were acquired after the
hybridisation and second wash by a confocal microscope. The ImageJ software was
used to process and analyse the images. To remove the background signal of the
fluorescent images, an average grey value background signal (grey value: 28) was
calculated for all images and subsequently subtracted the images. The results of
1 µM spotted aptamer concentration for 1 and 5 minutes of UV illumination are
illustrated in figure 5.8. It is di cult to see the fluorescent spots in the images since
one spot has a diameter of around 10 µm and the images are approximately 9000µm
wide. The hybridisation of the rcDNA of the HNV-VP1 aptamer was possible to
see in both figure 5.8b and figure 5.8d where it was expected to be. In figure 5.8d
unspecific hybridisation of the rcDNA to the aptamer mix solution was present. The
results of 0.5 µM and 0.05 µM, 1 and 5 minutes did not show any fluorescence in
either the concentric circle electrode area or in the linear spotted arrays (covering
both PC and PEDOT:PSS areas). The images of these results can be found in ap-
pendix A.10, figure A.4 and figure A.5.
In order to quantify the fluorescence of the images in figure 5.8, an area of 9000 x
200 µm was defined and the grey values along the longest axis of the box were cal-
culated using the Plot Profile function in ImageJ. The profile plots were only made
for the spotted linear arrays of the chips imaged in figure 5.8 as the arrays of the
rest of the chips were not present in the fluorescent image due to lack of immobilised
aptamers. The yellow boxes in figure 5.9 explain where on the fluorescent images the
profile plot arrays were acquired. The plots of the array profiles for 1 µM spotted
aptamer solution and 1 or 5 minute UV exposure are found in figure 5.10 and figure
5.11, respectively. The first 2-3000 µm of all plots represent the grey value profile
of the PEDOT:PSS, while the remaining distance up until 9000 µm represents the
grey value profile of the PC substrate. The arrays: E2-1 and E2-2, are values of the
HNV-VP1 aptamer and arrays: E4-1 and E4-2, are plots of the aptamer mix arrays.
E2 and E4 refer to the electrode numbers in figure 5.7a.
The grey value peaks in the profile plots of 1 µM spotted aptamer solution and
1 minute UV exposure (figures 5.10a and 5.10b) revealed specific binding of the
rcDNA to the immobilised HNV-VP1 aptamer on the PC. It was not possible to
identify any fluorescent signal in the area of the PEDOT:PSS. Only a weak sig-
nal from unspecific hybridisation was seen on the immobilised aptamer mix (figures
5.10c and 5.10d).
The plots of the 1 µM aptamer concentration and 5 minutes UV exposure (fig-
ure 5.11) revealed many grey value peaks representing both specific and unspecific
hybridisation of the rcDNA in the PC area. No peaks, hence no aptamer immobili-
sation, were present on the PEDOT:PSS.
It was concluded from the experiment that the aptamer concentration and time of
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(a) 1 µM, 1 min, bright-field (b) 1 µM, 1 min, fluorescence
(c) 1 µM, 5 min, bright-field (d) 1 µM, 5 min, fluorescence
Figure 5.8: Bright-field and fluorescent images of spotted aptamers after rcDNA
hybridisation, aptamer concentration: 1 µM, 1 or 5 min UV exposure. The fluo-
rescent signal of the linear spotting array of HNV-VP1 aptamer is visible in both
fluorescent images. A fluorescent signal of unspecific hybridisation of the rcDNA to
the spotted aptamer mix solution was visible in figure 5.8d.
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Array: E2-1
Array: E2-2
Array: E4-2
Array: E4-1
Box area: 9000 x 200 µm
Figure 5.9: Profile plot array area explanation for the plots in figure 5.10 and 5.11.
the UV exposure were important parameters in the UV cross-linking method. An
aptamer concentration below 1 µM was not suitable for the cross-linking method
when fluorescent microscopy was used as the method for detection. It was not possi-
ble to see the fluorescent signal from the cross-linking and subsequent hybridisation
of the aptamers on the PEDOT:PSS. It was still not clear if this was caused by
quenching of the fluorescent signal by the PEDOT:PSS, if the aptamer concentra-
tion was too low or if the fluorescent signal was below the detection limit of the
confocal microscope. Thus, a di erent method based on colorimetric amplification
and not dependent on fluorescent labelling of the aptamers was thought of. This
method will be described and examined in the following section.
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(d) 1 µM, 1 min, Array: E4-2, aptamer mix
Figure 5.10: Grey value profile plots, aptamer concentration: 1 µM, 1 min UV
exposure. See figure 5.9 for elaboration on where on the chips the arrays were
measured. The grey value peaks are peaks of high fluorescent signal in the measured
image (figure 5.8b). The first 2-3000 µm of all plots represents the grey value profile
of the PEDOT:PSS, while the remaining distance up until 9000 µm represents the
grey value profile of the PC substrate.
104
CHAPTER 5. EXPLORING THE SURFACE IMMOBILISATION OF
APTAMERS
um
0 2000 4000 6000 8000 10000G
re
y 
va
lu
e
0
50
100
(a) 1 µM, 5 min, Array: E2-1, HNV-VP1 aptamer
um
0 2000 4000 6000 8000 10000G
re
y 
va
lu
e
0
50
100
(b) 1 µM, 5 min, Array: E2-2, HNV-VP1 aptamer
um
0 2000 4000 6000 8000 10000G
re
y 
va
lu
e
0
50
100
(c) 1 µM, 5 min, Array: E4-1, aptamer mix
um
0 2000 4000 6000 8000 10000G
re
y 
va
lu
e
0
50
100
(d) 1 µM, 5 min, Array: E4-2, aptamer mix
Figure 5.11: Grey value profile plots, aptamer concentration:1 µM, 5 min UV
exposure. See figure 5.9 for elaboration on where on the chips the arrays were
measured. The grey value peaks are peaks of high fluorescent signal in the measured
image (figure 5.8d). The first 2-3000 µm of all plots represents the grey value profile
of the PEDOT:PSS, while the remaining distance up until 9000 µm represents the
grey value profile of the PC substrate.
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5.3 ELASA hybridisation assay for examining
the UV immobilisation of aptamers on
polymer substrates
To experimentally test the immobilisation of aptamers with the UV cross-linking
method without the usage of a fluorescent label a colorimetric ELASA was devel-
oped. The ELASA is equivalent to an ELISA but aptamers are used instead of
antibodies. The principle of ELISA was described in chapter 2.1.2.
The developed ELASA tested the hybridisation of the rcDNA strand to the immo-
bilised aptamer. The UV cross-linking method was used to immobilise aptamers in
96 microtiter well plates, on PC substrates and on PEDOT:PSS in order to test the
method on di erent substrates. Two di erent aptamers specific to NoV were used in
the experiments: VP1T and SMV25, sequences are found in appendix B.2 and B.3.
Figure 5.12 illustrates the principle of the developed ELASA. The aptamers were
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Biotinylated rcDNA - aptamer specific
Biotinylated ssDNA 
TMB substrate 
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Subs
trate
Blue
Subs
trate
Blue
Subs
trate
Blue
No
hybridisation
Figure 5.12: Principle of the developed ELASA.
immobilised in the wells of the microtiter plate and the rcDNA or a non specific
ssDNA were incubated with the aptamer. Both the rcDNA and the ssDNA were
biotinylated. The unbound rcDNA and ssDNA were washed away in the subsequent
washing step. In the figure the ssDNA is present in the well, but this is only to
clarify that it does not hybridise to the aptamer. A streptavidin HRP conjugate
was added to the wells. If biotin was present in the wells the streptavidin HRP
conjugate would bind to this. The detection was done with a TMB substrate that
reacts with the HRP and develops a blue colour. The development was stopped with
a stop solution and the blue colour turned yellow. The optical density (OD) of the
light absorption of the assay was read with a plate reader at 450 nm. The protocol
and material list for the ELASA hybridisation assay can be found in appendix A.11.
In a normal ELISA a standard curve is made for each experiment and the OD values
of the analyte are compared to the standard curve in order to compare the result to
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other equivalent ELISA or determine the analyte concentration. This is not possible
with the ELASA as no standard curve exists for this assay since it is not the analyte
but the method we are testing. It is thus not possible to directly compare the OD
values of the experiments to each other but it is possible to compare the OD values
within each experiment and compare the trends between experiments. All of the
OD values for the described experiments can be found in appendix A.11.1.
The ELASA experiments were divided into two main parts: 1) experiments in
microtiter plates and 2) experiments on PC SD card chips with or without PE-
DOT:PSS. The two parts will be described below.
5.3.1 ELASA hybridisation experiments in microtiter
plates
The first ELASA hybridisation experiments were done in microtiter plates to test
the applicability of the assay in standard microtiter plates. Two di erent microtiter
plates were tested, herein denoted Nunclon plates and PolySorp plates:
• Nunclon plate: Nunc MicroWell 96-Well Microplates, nunclon delta surface,
Surface Coating: Cell Culture (Thermo Fisher Scientific)
• PolySorp plate: Nunc-Immuno MicroWell 96 well solid plates, PolySorp, flat
bottom plate, pinchbar design (Sigma-Aldrich)
The Nunclon plates were hydrophilic and were intended used for cell culture while
the PolySorp plates were hydrophobic and intended used for ELISA.
Comparison of wet and dry stage of aptamer solution during the UV
exposure
The importance of the drying step of the aptamers onto the substrate before the UV
exposure was investigated. To test this, the UV cross-linking method was performed
in a wet liquid stage rather than drying the aptamers in the microtiter well. A
volume of 50 µL, 1 µM - 10 nM, aptamer solution was added to the wells of Nunclon
microtiter plates and UV exposed for 5 minutes. After the UV exposure the ELASA
was performed according to protocol A.11. Table 5.1 illustrates the experimental
layout of the tested plates. Nunclon plates were used as test substrates in this
experiment. The plate layout and data can be found in appendix A.11.1 figure A.7.
The results revealed that the UV cross-linking method did not work in liquid. The
results also revealed that there seems to be no di erence between no-UV and UV
exposure of the dry stage aptamers on the Nunclon plates. This could be caused
by the hydrophilic surface treatment of the Nunclon plates. No signal was detected
from the incubation of rcSMV25 with VP1T or rcVP1T with SMV25, indicating
that the hybridisation assay was specific.
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Table 5.1: Experimental layout of comparison between wet and dry stage of aptamer
solution during the UV exposure
Plate no. Plate type Wet/Dry UV exposure
1 Nunclon plate Dry UV
2 Nunclon plate Dry no UV
3 Nunclon plate Wet UV
4 Nunclon plate Wet no UV
Comparison of the UV cross-linking on Nunclon and PolySorp plates
and Nunclon plates with PEDOT:PSS
The UV cross-linking method was tested on two types of microtiter plates: Nunclon
and PolySorp plates, to compare the method on the two plates. To test the UV
cross-linking on PEDOT:PSS, PEDOT:PSS was spray-coated inside the wells of the
microtiter plates and dried overnight at 60 ¶C. The PEDOT:PSS was diluted 1:2.5
in MilliQ water and filtered with a syringe filter (5 µm) before spray-coating. It
was not possible to get a complete and homogeneous PEDOT:PSS coverage on the
PolySorp plates due to the hydrophilic surface of these plates. Hence, only Nunclon
plates were tested with PEDOT:PSS coating. The tested concentrations of the
VP1T and SMV25 aptamers were: 1 µM, 100 nM and 10 nM. The experimental
layout of the plates used in the experiment is given in table 5.2. The OD data
Table 5.2: Experimental layout of comparison of the UV cross-linking on Nunclon
and PolySorp plates and Nunclon plates with PEDOT:PSS
Plate no. Plate type PEDOT:PSS coating UV exposure
1 Nunclon plate PEDOT:PSS UV
2 Nunclon plate PEDOT:PSS no UV
3 Nunclon plate – UV
4 Nunclon plate – no UV
5 PolySorp – UV
6 PolySorp – no UV
values and plate layout for each plate can be found in appendix A.11.1 figure A.8
and A.9. The results confirmed the previous observations of the Nunclon plates,
where no di erence between UV an no-UV exposure was observed (plates 3 and 4).
It was thus concluded that the Nunclon plates were not suitable for the testing of
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the UV cross-linking method. Conversely, the UV cross-linking worked as intended
on the PolySorp plates. The OD signals of 1 µM and 100 nM aptamer solution were
high in the plate that had been UV exposed (plate 5). The OD values of the VP1T
aptamer was slightly higher than the OD values of the SMV25 aptamer. A low
insignificant OD signal was seen in the PolySorp plate with no UV exposure (plate
6). The OD values of the UV exposed Nunclon plates coated with PEDOT:PSS
(plate 1) revealed positive OD values of the VP1T aptamer at a concentration of
1 µM that indicated that the method worked on PEDOT:PSS surfaces. Although,
the OD values of plate 1 were half or lower than the PolySorp plate. The Nunclon
plates coated with PEODT:PSS and with no UV exposure (plate 2) revealed a low
OD signal at 1 µM for both aptamers. It was thus not possible to conclude if the
UV cross-linking method worked on the PEDOT:PSS. There was a possibility that
some of the aptamers were immobilised onto the underlying Nunclon plate if the
PEDOT:PSS coverage was inhomogeneous. It could be concluded that the method
worked on the Polysorp plates. Thus, the PolySorp plates were used for the next
experiment.
Comparison of the UV cross-linking on PolySorp plates with or without
PEDOT:PSS and with or without TC-tag
The ELASA was performed on PolySorp plates with or without PEDOT:PSS. As
mentioned above, it was not possible to get a good coverage of PEDOT:PSS on
the plates without a pre-treatment. Thus, oxygen plasma treatment was applied to
the plates before spray-coating the plates with PEDOT:PSS. The oxygen plasma
increased the hydrophilicity of the plates and ensured a good coverage of the PE-
DOT:PSS. Furthermore, the importance of the TC-tag in the UV cross-linking
method was examined. The experimental layout is listed in table 5.3. The OD
data values and plate layout for each plate can be found in appendix A.11.1 figure
A.10 and A.11. As expected, the PolySorp plates with UV exposure and TC-tag
(plate 5) showed high OD values. Again, the OD values of the VP1T aptamer were
higher than the SMV25 aptamer. The PolySorp plate with UV exposure and no
TC-tag (plate 7) showed very low OD values for the VP1T aptamer but OD values
comparable to the plate 5 for the SMV25 aptamer. It thus seemed like the TC-tag
made a greater di erence in the UV cross-linking of the VP1T aptamer than the
SMV25 aptamer. The PolySorp plates, with and without TC-tag, and no UV expo-
sure (plates 6 and 8) showed no OD values of significance.
The PolySorp plates with PEDOT:PSS coverage and UV exposure, with and with-
out TC-tag (plates 1 and 3) revealed a positive trend. The di erence between the
plates, and thus the di erence between the UV cross-linking with and without the
TC-tag, was low. The plates without UV exposure (plates 2 and 4) revealed lower
OD values than the UV exposed plates. It was thus concluded that a positive trend
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Table 5.3: Experimental layout for the comparison of the UV cross-linking on
PolySorp plates with or without PEDOT:PSS and with or without TC-tag
Plate no. Plate type Pre-treatment PEDOT:PSS
coating
Aptamer tag UV exposure
1 PolySorp O2 Plasma PEDOT:PSS TC-tag UV
2 PolySorp O2 Plasma PEDOT:PSS TC-tag No UV
3 PolySorp O2 Plasma PEDOT:PSS No TC-tag UV
4 PolySorp O2 Plasma PEDOT:PSS No TC-tag No UV
5 PolySorp – – TC-tag UV
6 PolySorp – – TC-tag No UV
7 PolySorp – – No TC-tag UV
8 PolySorp – – No TC-tag No UV
of the UV cross-linking of aptamers onto PEDOT:PSS was observed. There was
a clear di erence between the applicability of the UV cross-linking method on the
PolySorp plates and on the PEDOT:PSS. From this experiment, and the previ-
ous experiment in the Nunclon microtiter plates, we observed a di erence of the
functionality of the UV cross-linking depending on the underlying substrate of the
PEDOT:PSS coating. Since our aptasensor chip substrate was PC, it was obvious
to test this material and the PC coated with PEDOT:PSS. These experiments are
described in the following section.
5.3.2 ELASA hybridisation experiments on PC SD card
chips with or without PEDOT:PSS
The UV cross-linking was tested with the right combination of materials for the
final aptasensor design: PEDOT:PSS on PC. Unfortunately, it was not possible to
purchase PC microtiter plates. Instead, we used the SD card chip substrates and
designed a well layout that resembled a 96 microtiter well plate. The PEDOT:PSS
was applied to the SD card chip substrates with a paint applicator in 1 or 2 layers
and dried at 60 ¶C for 15-30 minutes. The PEDOT:PSS was allowed to dry between
layers when 2 layers were applied. To do ELASA on the chips, an array of 2 x 5 well
per chip was designed to fit on one SD card chip. The wells were made in PMMA
with the CO2 laser and assembled with the chip by double sided adhesive tape. The
wells were 10 mm deep and had the same diameter (i.e. 7 mm) as the wells of a 96
microtiter plate. Figure 5.13a shows the chip substrate coated with PEDOT:PSS
and an image of the assembled chip. Figure 5.13b shows an assembly of four chips,
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(a) (b)
Figure 5.13: Image of the PEDOT:PSS coated PC chip substrate and micro wells.
(a) SD card chip substrate with 1 layer of PEDOT:PSS applied by the paint appli-
cator and the chip substrate assembled with the well array. (b) An assembly of four
chips with wells for ELASA experiments, herein denoted a chip plate.
herein denoted a chip plate.
In the ELASA hybridisation assays on PC substrates and PEDOT:PSS coated
chips several parameters were investigated:
• The UV exposure time (1 min, 5 min or 10 min ) and no UV exposure
• Di erence between blank PC substrate and 1 or 2 layers of PEDOT:PSS on
the substrate
• TC-tag or no TC-tag on the aptamer
In general the UV immobilisation of the VP1T aptamer showed a higher OD
signal than the SMV25 aptamer. It is unknown why this occurs, as the TC-tag and
spacer is the same of the two strands. It must thus be concluded that the reason
must be sequence specific. It could also be that the hybridisation conditions were
better for the VP1T strand than for SMV25, thus leading to a higher hybridisation
e ciency and hence a higher signal. The following section will describe the data
and results for the VP1T aptamer only.
UV exposure time dependence
The dependence of the UV exposure time (0, 1, 5 or 10 minutes) was experimentally
tested on the PC chips. Furthermore, chips with 1 and 2 layers of PEDOT:PSS on
the PC substrate were compared in this experiment. Two repetitions were made
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and the OD data for each experiment was normalised to the OD value of the PC
chips, 5 µM aptamer, 1 µM rcVP1T, 5 min UV exposure after subtraction of the
background. This OD value was chosen for the normalisation as it was assumed that
the e ciency of the UV cross-linking was relatively constant on the PC substrate
and the 5 µM aptamer concentration was present in both repetitions. Figure 5.14
lists the normalised data for the time exposure dependence experiment. The data
was coloured accordingly: <0.1 white, >1.0 dark. The full data set (not normalised
data) can be found in appendix A.11.1, figures A.12, A.13 and A.14. The UV cross-
linking method was successful on the PC chips and the two repetitions corresponded
to each other. It was possible to detect the immobilised VP1T aptamer down to a
concentration of 100 nM with 5 or 10 min UV exposure. There was a clear signal
dependence between the UV exposure time and the VP1T aptamer concentration.
The di erence between 5 and 10 minutes was low but there was a clear signal
reduction for 1 minute UV exposure. A low degree of passive absorption of the
aptamer onto the PC was observed when the aptamers were not cross-linked (0
minutes UV). The negative controls with the biotinylated rcSMV25 were negative
for the PC chips, showing the specificity of the ELASA.
The UV cross-linking of 1 layer of PEDOT:PSS showed no clear dependence between
the di erent UV exposure times. Although, a positive trend was observed at the
high aptamer concentrations. There was a clear di erence between the experiments
with the rcVP1T and the negative controls with the rcSMV25. The experiments
with the 2 PEDOT:PSS layers were not as convincing as the 1 PEDOT:PSS layer
experiment. The normalised data values were low compared to both the PC chips
and the 1 layer PEDOT:PSS. Between the two repetitions, the data were poorly
reproducible. The di erence between the 1 or 2 layers PEDOT:PSS indicates that
the thickness of the PEDOT:PSS layer has an influence on the availability of the
immobilised aptamers for hybridisation with the complementary strand or that the
1 layer PEDOT:PSS was not covering the PC chip substrate homogeneously. The
negative controls for the 2 layers PEDOT:PSS were indeed negative.
Based on these experiments it was concluded that 5 minutes of UV cross-linking
was su cient for the aptamer immobilisation. The concentration for the aptamer
immobilisation should be as high as possible, preferably 10 µM or higher. The
high aptamer concentration is not an advantage in the viral aptasensor fabrication
process as higher concentrations increase the amount of material needed.
Dependence of TC-tag, UV exposure and PEDOT:PSS layers
The dependence of the TC-tag in the cross-linking was examined together with the
UV exposure (0 or 5 minutes) and 1 or 2 layers of PEDOT:PSS on the PC substrate.
The conditions were examined by three experimental repetitions listed in figure 5.15.
The OD data for each repetition was normalised to the OD value of the PC chips,
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First	repetition Second	repetition
rcVP1T:	1	µM rcVP1T:	1	µM
PEDOT:PSS,	1	layers
10	µM 5	µM 1	µM 100	nm
No	UV	(0	min) 0,109 0,330 0,198 0,135
UV	(1	min) 0,903 0,761 0,263 0,094
UV	(5	min) 0,399 0,212 0,166 0,112
UV	(10	min) 0,509 0,214 0,290 0,218
PEDOT:PSS,	2	layers PEDOT:PSS,	2layers
5	µM 1	µM 100	nM 10	nm 10	µM 5	µM 1	µM 100	nm
No	UV	(0	min) 0,079 0,078 0,068 0,062 No	UV	(0	min) 0,544 0,070 0,107 0,120
UV	(1	min) 0,150 0,122 0,107 0,076 UV	(1	min) 0,163 0,021 0,043 0,043
UV	(5	min) 0,211 0,205 0,102 0,061 UV	(5	min) 0,154 0,171 0,105 0,001
UV	(10	min) 0,124 0,253 0,182 0,062 UV	(10	min) 0,390 0,205 0,214 0,208
PC	chips PC	chips
5	µM 1	µM 100	nM 10	nm 10	µM 5	µM 1	µM 100	nm
No	UV	(0	min) 0,327 0,382 0,039 0,003 No	UV	(0	min) 0,544 0,366 -0,001 -0,032
UV	(1	min) 0,914 0,603 0,078 0,011 UV	(1	min) 0,563 0,447 0,181 -0,026
UV	(5	min) 1,000 0,984 0,748 0,113 UV	(5	min) 0,937 1,000 1,116 0,713
UV	(10	min) 1,182 1,038 0,789 0,130 UV	(10	min) 1,115 1,011 1,089 0,647
(a)
First	repetition	-Negative	controls Second	repetition	-	Negative	controls
rcSMV25:	1	µM rcSMV25:	1	µM
PEDOT:PSS,	1	layers
10	µM 5	µM 1	µM 100	nm
No	UV	(0	min) -0,060 -0,074 -0,076 -0,078
UV	(1	min) -0,074 -0,083 -0,076 -0,088
UV	(5	min) -0,033 -0,087 -0,091 -0,094
UV	(10	min) -0,105 -0,118 -0,114 -0,123
PEDOT:PSS,	2	layers PEDOT:PSS,	2layers
5	µM 1	µM 100	nM 10	nm 10	µM 5	µM 1	µM 100	nm
No	UV	(0	min) 0,005 0,001 0,064 -0,010 No	UV	(0	min) -0,124 -0,089 -0,117 -0,123
UV	(1	min) 0,030 -0,012 -0,001 0,005 UV	(1	min) -0,104 -0,103 -0,118 -0,118
UV	(5	min) -0,026 -0,028 -0,023 -0,025 UV	(5	min) -0,127 -0,133 -0,128 -0,140
UV	(10	min) 0,011 -0,007 -0,002 -0,022 UV	(10	min) -0,098 -0,143 -0,142 -0,143
PC	chips PC	chips
5	µM 1	µM 100	nM 10	nm 10	µM 5	µM 1	µM 100	nm
No	UV	(0	min) 0,086 0,013 -0,001 -0,002 No	UV	(0	min) -0,040 -0,039 -0,039 -0,038
UV	(1	min) 0,172 0,526 0,012 -0,005 UV	(1	min) -0,048 -0,048 -0,047 -0,047
UV	(5	min) 0,132 0,252 0,001 -0,003 UV	(5	min) 0,038 -0,022 -0,025 -0,024
UV	(10	min) 0,110 0,129 0,063 0,003 UV	(10	min) -0,017 -0,018 0,012 -0,020
(b)
Figure 5.14: Normalised OD data for VP1T aptamer, UV exposure time depen-
dence. The data was normalised from PC chips, 5 µM, 5 min UV exposure. Two
repetitions of the 2 layers PEDOT:PSS and PC chips were made. The second rep-
etition included concentrations of 10 µM VP1T aptamer solution. Colour scheme:
<0.1 white, >1.0 dark. The full data set can be found in appendix A.11.1, figures
A.12, A.13 and A.14. (a) Experiments with the rcVP1T. (b) Negative controls with
the rcSMV25.
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First	repetition Second	repetition Third	repetition
rcVP1T:	1	µM rcVP1T:	1	µM rcVP1T:	1	µM
PC,	TC-tag PC,	TC-tag PC,	TC-tag
5	µM 1	µM 100	nM 10	nM 5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 1,000 0,799 0,536 0,020 UV	(5	min) 1,000 0,829 0,642 0,181 UV	(5	min) 1,203 1,000 0,764 0,641
No	UV 0,201 0,020 -0,001 -0,003 No	UV 0,277 0,299 0,013 -0,001 No	UV 0,193 0,276 -0,051 -0,097
PC,	no	TC-tag PC,	no	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,387 0,484 0,296 0,092 UV	(5	min) 0,238 0,336 0,203 0,028
No	UV 0,080 0,314 0,103 0,051 No	UV 0,019 0,000 0,004 -0,015
PEDOT:PSS,	1	layer,	TC-tag PEDOT:PSS,	1	layer,	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,249 0,335 0,186 0,090 UV	(5	min) 0,761 0,676 0,378 0,214
No	UV 0,296 0,179 0,132 0,094 No	UV 0,286 0,252 0,255 0,067
PEDOT:PSS,	1	layer,	no	TC-tag
10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,412 0,609 0,287 0,075
No	UV 0,836 0,333 0,129 0,066
PEDOT:PSS,2	layer,	TC-tag PEDOT:PSS,2	layers,	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,154 0,152 0,089 0,048 UV	(5	min) 0,436 0,376 0,316 0,177
No	UV 0,069 0,057 0,055 0,087 No	UV 0,145 0,155 0,130 0,067
PEDOT:PSS,2	layer,	no	TC-tag PEDOT:PSS,2	layers,	no	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,115 0,062 0,070 0,053 UV	(5	min) 0,323 0,260 0,183 0,102
No	UV 0,130 0,076 0,086 0,073 No	UV 0,022 0,007 0,005 0,004
(a)
First	repetition	-	Negative	controls Second	repetition	-	Negative	controls Third	repetition	-	Negative	controls	
rcSMV25:	1	µM rcSMV25:	1	µM rcSMV25:	1	µM
PC,	TC-tag PC,	TC-tag PC,	TC-tag
5	µM 1	µM 100	nM 10	nM 5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,041 -0,024 -0,032 -0,031 UV	(5	min) 0,028 0,013 0,009 0,004 UV	(5	min) -0,031 -0,075 -0,059 -0,095
No	UV 0,031 -0,039 -0,023 -0,031 No	UV 0,020 -0,004 -0,002 -0,006 No	UV -0,039 -0,103 -0,099 -0,100
PC,	no	TC-tag PC,	no	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,153 0,002 0,009 -0,003 UV	(5	min) 0,014 -0,016 -0,017 -0,018
No	UV 0,011 0,006 -0,003 -0,005 No	UV -0,014 -0,017 -0,016 -0,015
PEDOT:PSS,	1	layer,	TC-tag PEDOT:PSS,	1	layer,	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,455 0,016 -0,005 -0,008 UV	(5	min) -0,053 -0,036 -0,041 -0,052
No	UV 0,099 -0,004 -0,007 -0,005 No	UV -0,058 -0,055 -0,054 -0,057
PEDOT:PSS,	1	layer,	no	TC-tag
10	µM 5	µM 1	µM 100	nM
UV	(5	min) -0,018 -0,043 -0,052 -0,056
No	UV -0,034 -0,039 -0,040 -0,037
PEDOT:PSS,2	layer,	TC-tag PEDOT:PSS,2	layers,	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) 0,020 -0,008 -0,009 -0,011 UV	(5	min) 0,040 -0,003 -0,020 -0,040
No	UV 0,026 -0,003 0,020 -0,022 No	UV -0,012 -0,031 -0,034 -0,038
PEDOT:PSS,2	layer,	no	TC-tag PEDOT:PSS,2	layers,	no	TC-tag
5	µM 1	µM 100	nM 10	nM 10	µM 5	µM 1	µM 100	nM
UV	(5	min) -0,016 -0,009 -0,006 -0,012 UV	(5	min) -0,019 -0,049 -0,051 -0,059
No	UV -0,004 -0,011 -0,011 -0,004 No	UV -0,005 -0,057 -0,058 -0,066
(b)
Figure 5.15: Normalised OD data for VP1T aptamer, dependence of TC-tag, UV
exposure and PEDOT:PSS layers. The data was normalised from PC chips, 5 µM,
5 min UV exposure and TC-tag. Three independent experiments were made with
repetitions of the 1 or 2 layers PEDOT:PSS and PC chips. The third repetition
included concentrations of 10 µM VP1T aptamer solution. Colour scheme: <0.1
white, >1.0 dark. The full data set can be found in appendix A.11.1, figures A.15,
A.16 A.17 and A.18. (a) Experiments with the rcVP1T. (b) Negative controls with
the rcSMV25.
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5 µM aptamer, 1 µM rcVP1T, 5 min UV exposure, TC-tag. The data in the figure
was coloured accordingly: <0.1 white, >1.0 dark. The full data set (non-normalised
data) can be found in appendix A.11.1, figures A.15, A.16 A.17 and A.18.
The data for the PC chips confirmed the previous observations that the UV cross-
linking worked on this material with a low degree of passive absorption on the
material when no UV exposure was applied. The TC-tag made a clear di erence on
the PC substrate, hence a low signal was seen when the TC-tag was missing on the
aptamer. The signal with TC-tag was approximately 2.7 times higher than without
TC-tag. The negative controls were all negative for the PC chips.
The normalised OD data of the chip with 1 PEDOT:PSS layer indicated that ex-
posure to UV light lead to a specific binding of the aptamer on the PEDOT:PSS
(approximately 2 times higher signal with UV compared to no UV). However, we
did not observe any clear di erence of signal between the aptamers with TC-tag
and the ones without the TC-tag. The 2 layers PEDOT:PSS showed the same trend
as the 1 layer PEDOT:PSS but with reduced signal intensity. This confirms the
previous observations between 1 or 2 layers PEDOT:PSS. Hence, this indicates that
covering the PC chip substrate with 1 layer PEDOT:PSS is not su cient to get
a homogeneous coverage. Thus, the results of the 2 layer PEDOT:PSS must be
assumed to represent the most accurate PEDOT:PSS surface. Furthermore, there
was a clear di erence between the experiments with the rcVP1T and the negative
controls. It must be concluded that the aptamers were indeed immobilised onto the
PEDOT:PSS but the exact mechanism is still not clear.
It can be concluded that the aptamer concentration was a very important factor
as the OD signal increased for higher aptamer concentrations. The results indicate
that immobilisation of aptamers onto PEDOT:PSS was possible and a positive trend
of the UV cross-linking of aptamers onto PEDOT:PSS was observed. It must be
assumed that some passive absorption is involved in the aptamer immobilisation as
the immobilisation works without UV light and the TC-tag.
5.4 Conclusion
This chapter described the experimental work related to the testing of the UV
cross-linking method for aptamer immobilisation onto di erent polymer substrates
including PEDOT:PSS. Two detection methods were applied to analyse the usability
of the method: fluorescent labelling and colorimetric amplification. The fluorescent
labelling did not show any fluorescent signal of the hybridised rcDNA of the UV
cross-linked aptamers and it was thus not possible to conclude that the method
could be used on PEDOT:PSS. The method seemed to work on PC substrates. It
was concluded that the lack of fluorescent signal on the PEDOT:PSS could be a
consequence of quenching of the fluorescent signal by the PEODT:PSS, or a high
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detection limit of the confocal microscope above the fluorescent signal or finally it
was a possibility that the used parameters were not optimal for the method. A
colorimetric ELASA was developed to test the UV cross-linking method without
fluorescent labelling. The ELASA showed good adherence of the UV cross-linked
aptamers on the PolySorb plate and the PC substrate. The aptamer immobilisa-
tion onto the PEDOT:PSS showed a positive trend to which it was concluded that
the UV cross-linking of aptamers onto PEDOT:PSS works but with lower e ciency
than on PC. Furthermore, it was concluded that passive absorption onto the PE-
DOT:PSS was involved in the aptamer immobilisation.
The work with the aptamer immobilisation with the UV cross-linking method should
continue to find the best conditions for the immobilisation of aptamers onto PE-
DOT:PSS. The method should be compared with known functionalisation methods
e.g. amino functionalisation. This will give an indication of whether or not the
UV cross-linking method works as e cient as other immobilisation methods. Fur-
thermore, the method should be tested with the target for which the aptamer was
selected and not only the rcDNA since the target recognition is a much more complex
mechanism.

6
Aptasensor characterisation and
EIS measurements
Electrical characterisation of the stability of the measurement system is important
for the success of the sensor development. The longterm purpose of the developed
viral aptasensor is to measure the virus content of the water at the water intake of
water treatment plants or upstream from the intake. The characteristics of the wa-
ter at either the intake or upstream from the intake changes during the day or from
day to day. This means that the sensor must be stable at di erent water conditions
e.g. changes in salinity, over a time period or at di erent pH values.
Impedimetric detection by EIS is used as the characterisation and detection method
for the viral aptasensor. In some EIS measurements it is an advantage to introduce
redox mediators (e.g. the ferric ferrocyanide redox couple) in the sample to e.g.
increase or obtain an EIS signal. Redox mediators are commonly used when the re-
action is a bulk reaction, i.e. not a reaction on the electrode surface. Furthermore,
the detection of redox mediators requires a di erent detection method e.g. ampero-
metric detection where the redox potential is reached. The target recognition of the
viral aptasensor takes place on the electrode surface. Furthermore, it is not possi-
ble to introduce redox agents in an environmental sample during a continuous flow.
Hence, impedimetric detection, without redox mediators, is the method best suited
for the viral aptasensor. The basic theoretical background of impedimetric detec-
tion by EIS and an equivalent circuit model for an electrode pair in solution were
described in chapter 2.3.2. The equivalent circuit model is redisplayed in figure 6.1.
During a target binding event on the electrode surface the electrical characteristics
of the surface change. The charge transfer resistance, Rct, increases as the target
binds to the aptamers on the electrode surface and thereby hindering the transfer
of ions in the bu er solution to the electrode surface. The double layer capacitance
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Figure 6.1: Proposed equivalent circuit model for the viral aptasensor. Ri: Inter-
nal resistance of PEDOT:PSS, Rct: Charge transfer resistance, Cdl: Double-layer
capacitance, ZW : Warburg impedance, Cgeo: Geometrical capacitance, Rs: Solution
resistance.
Cdl will change as charges will be redistributed. The Cdl is commonly represented
as a constant phase element (CPE) as it is not an ideal capacitor. Furthermore,
the Warburg impedance, ZW , which represents the di usion of ionic species in the
polymer film and media will also change to a certain degree. It is thus anticipated
that the charge transfer, the double layer capacitance and the Warburg impedance
are the most important elements in the impedimetric detection. These elements
are all part of a larger circuit for the viral aptasensor, which means that it is not
possible only to measure the specific elements separately but rather the whole cir-
cuit. The whole impedance spectra must thus be acquired and the changes in the
impedance must be identified in the spectra. It is not straight forward to describe
and model these three elements in a electrode system with conducting polymers. It
is anticipated that the impedance changes upon target binding are found in the low
frequency regime ( < 5 Hz) where the surface elements are dominating. It is possible
to measure the impedance change over time at a fixed frequency after identification
of the frequency where the e ect of the target binding is clearly observable.
The following sections of this chapter will describe a circuit model, the system setup
for EIS measurements and the characterisation of the impedance system. The elec-
trical characterisation was done by a commercial potentiostat with a home-build
multiplexer to change between electrode pairs. The electrical characterisation was
done by measuring the impedance response of the viral aptasensor chip at di er-
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ent salinity and pH values and the stability of the aptasensor chip over a period
of 2 weeks in continuous flow. This characterisation was done without immobilised
aptamers on the electrode surface.
6.1 Modelling of a circuit of the acquired data
To evaluate the equivalent circuit model for the viral aptasensor an impedance sweep
from 0.5 Hz to 100 kHz was acquired in a 1:1000 PBS dilution. The measurements
were done on a IM6, company Zahner elektrik potentiostat with an amplitude of
100 mV. The recorded data was fitted to a circuit model using the EIS Spectrum
Analyser software (Research Institute for Physical-Chemical Problems, Belarusian
State University). Figure 6.2 shows the circuit model that showed the best fit,
together with the element values, and the Nyquist plot of both the acquired data
and the circuit model. The model and the data were plotted with MATLAB, the
script can be found in appendix A.13. The Bode plots of both the acquired data
and the model is found in figure 6.3.
The impedance of the di erent model elements were found to be:
ZCgeo =
1
j Ê 1.16nF
Rs = 190 k 
Rct = 61 k 
ZW = 1.1 M  s≠1/2(Ê)≠1/2(1≠ j)
ZCEP =
1
(j Ê)0.93 3.7µF
The total impedance of the model circuit was found to be:
Ztotal =
1
1
ZCgeo
1
Rs
+ 11
ZW
1
Rct
+ ZCEP (6.1)
The di erence between the circuit model and the proposed equivalent circuit is
visible in the di erent configuration of the low frequency elements. In the circuit
model the Rct is found in parallel rather than in series with the ZW . Furthermore
the CPE is found in series with the parallel connection of Rct and ZW . The pro-
posed equivalent circuit was made from the assumption that the electrode material
is a metal conductor. The intrinsic conductive polymer does not behave as an ideal
conductor and the electrode solution interface is not a clear physical boundary. This
could explain the di erence between the two circuits.
The Nyquist plot of the data and circuit model (Figure 6.2b) showed good agreement
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Figure 6.2: Circuit model and Nyquist plots of both the model circuit and data ac-
quired of the SD card chip. The measurement was done with a 1:1000 PBS dilution.
between the model and the data. The data points in the plot represent a specific
frequency within the measured frequency range of both the data and modelled cir-
cuit. The di erence between the frequency points of the data and model was small.
The Bode plots are plotted in figure 6.3. The Bode phase plot of the data and
the model was in good agreement. The phase of the low frequency range (< 5 Hz)
showed a capacitive behaviour as the phase decreased towards a phase shift of - 60
degrees. In the frequency range between 101 ≠ 103 Hz the phase was close to 0 de-
grees which means that a resistive behaviour was present. This resistive behaviour
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Figure 6.3: Bode plots of modelled data and data acquired of the SD card chip.
The measurement was done with a 1:1000 PBS dilution.
originated from the solution resistance of the diluted PBS. At higher frequencies
the phase shifted to negative values approximating -90 degrees which represented
the geometrical capacitance and eventually the parasitic capacitance of the whole
system. The Bode modulus plot did not show as good of a fit as the Bode phase and
the Nyquist plot. The shape of the model and data plot were the same but there was
a shift in the modulus through out the entire plot but mainly in the frequency range
dominated by the solution resistance. This shift could be explained by the di erence
between the simplified model compared to the real life circuit. It is important to
state that the model circuit is a simplified version of the real system. The real life
circuit is much more complex which means that it can not be truly modelled by a
few circuit elements. The model circuit helps in understanding the behaviour of the
system and gives a good approximation to the real circuit.
6.2 System setup for EIS measurements
The system setup for the EIS measurements was composed of three main parts:
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• SD card chip
• Homebuilt multiplexer (made by Noemi Rozlosnik)
• Potentiostat: VersaSTAT 3, Princeton Applied Research, USA
Figure 6.4 illustrates a schematic overview of the setup. The potentiostat was con-
nected to the home-build multiplexer and the SD card chip was mounted in the
multiplexer. Furthermore, it was possible to connect tubings and a peristaltic pump
to the SD card chip to enable sample flow. A computer with the VersaStudio soft-
ware controlled the potentiostat. The multiplexer was controlled by an Arduino
micro board and a home made script (made by Noemi Rozlosnik). The potentiostat
applied a voltage of 10 mV and a small AC current to the system and recorded the
current response. The current range of the AC signal was set to change automat-
ically on the potentiostat in the range of 0.1-1 µA. The current response and the
potential were used by the potentiostat to calculate the impedance of the system.
We made two di erent impedance measurements: fixed frequency measurements
over time and impedance spectra from 0.5 Hz to 10 kHz (or higher).
The sensor had four electrode pairs: three electrodes to detect the viral targets
CE
RE
WE
Sample 
folw
Sense
Homebuildt 
multiplexer
SD card 
sensor chip
E1
E4
E3
E2
Multiplexer changes between 
E1-E4 at a user defined timestep
Figure 6.4: EIS measurement setup. The potentiostat was connected to the home-
build multiplexer and the SD card chip was mounted in the multiplexer. The mul-
tiplexer changed between electrode pairs E1-4 at a user defined time frame. The
applied voltage was 10 mV.
and an electrode pair for reference measurements. The multiplexer was designed to
change between these electrode pairs (E1-4) during the impedance measurements
with a user defined time frame.
The data analysis was done using the MATLAB software, MathWorks, with a home
written script. The three main steps involved in the data analysis of data acquired
at a fixed frequency over time are illustrated in figure 6.5. The script used for the
data analysis can be found in appendix A.12. The raw data from the potentiostat
consisted of 16 data columns (See appendix A.12 for elaboration of data content).
The first step in the data analysis was to calculate the modulus (|Z|) and the phase
(phase(Z)) of the impedance and plot the data. Second, the electrode specific data
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Figure 6.5: Overview of the three main steps involved in the EIS data analysis
with MATLAB
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was extracted from the raw data. Identification of the electrodes in the data was
done by setting the multiplexer time frame di erent in one of the electrodes, which
enabled identification of that specific electrode. The multiplexer always changed
between electrodes in numerical order. The extracted data was filtered by a running
average filter and drift was removed. Third, the data was normalised to the first,
e.g. 100, data points and the relative change in percent of the signal was calculated.
6.3 Electrical characterisation of the viral
aptasensor system
Testing of the electrical characterisation of the viral aptasensor system was needed to
ensure a stable system for the viral measurements. The two parts to be tested were
the multiplexer and the SD card chip. The multiplexer was tested with a capacitor
and resistor with known capacitance and resistance. The SD card chip was tested
with sample solution of di erent salinity and pH values. Furthermore, the SD card
chip was tested in continuous flow over a two week period at a fixed frequency of
1 Hz. The following section describes the characterisation. The chips used for the
characterisation were all the SD card chip version 3, which was described in chapter
4.2.2.
6.3.1 Stability of the home-build multiplexer
The stability of the multiplexer was tested with a known resistor and capacitor in
parallel. The parallel configuration was tested as this configuration was relevant
for the aptasensor where the Rct and Cdl are connected in parallel according to the
equivalent circuit model. Four di erent combinations of RC circuits were tested:
• E1: 3.3 µF and 470 k 
• E2: 1 nF and 470 k 
• E3: 10 nF and 470 k 
• E4: 100 nF and 470 k 
Figure 6.6 illustrates the output of the data analysis of the stability measurements
of the multiplexer measured at 1 Hz over a period of 120 minutes/electrode pair.
The relative change in percent for all electrode pairs was between -0.02 and 0.02 %.
It can be argued that a sinusoidal with a period > 60 minutes can be observed in
the plot but it must be considered insignificant due to the small change in percent.
It must be concluded that the multiplexer does not introduce any significant noise
components during the measurements or when it changes between electrode pairs.
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Figure 6.6: Multiplexer characterisation with RC circuits. A fixed frequency of
1 Hz was used.
6.3.2 Salinity measurements with the aptasensor
The characterisation of the SD card chip with di erent salinity of the media was per-
formed with dilutions of PBS. A ten-fold dilution series of PBS in MilliQ water was
prepared: 1:1000, 1:100, 1:10, 1:1 and 10:1. The conductivities of the 1:1 PBS and
MilliQ water were 15.83 mS/cm and 0.00 mS/cm, respectively. EIS measurements
of the PBS dilutions in the chip were measured from low to high concentration and
the measurements were done without sample flow. Five impedance spectra from
0.5 Hz to 10 kHz were acquired for each dilution. The average impedance values for
each dilution were calculated and plotted. The Nyquist plots and Bode plots are
displayed in figure 6.7. The 50 Hz noise component, originating from the electrical
power supply, was removed from the plots. The Nyquist plot of the 1:1000 PBS
dilution (blue line) was the only dilution that showed parts of the semicircle at high
frequencies. As described in chapter 2.3.2, a semicircle in a Nyquist plot represents
a capacitor and a resistor in parallel. The high frequency data is represented to
the left and low frequency data to the right in a Nyquist plot. The high frequency
components in the aptasensor circuit model are the solution resistance, Rs and the
geometrical capacitance, Cgeo. Hence, as the solution resistance decreases, due to
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Figure 6.7: Nyquist and Bode plots of the salinity measurements of the PBS serial
dilution. The data represents measurements of one electrode pair on an SD card
chip. A total of five impedance sweeps were acquired for each PBS dilution and
the average values were calculated and displayed on the plots. The 50 Hz noise
component originating from the power supply was removed.
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an increase in the ionic content of the media, the diameter of the semi-circle de-
creases and the plot is shifted to the left in the Nyquist plot. The low frequency
components of the circuit model, i.e. Rct, ZW and Cdl (or CPE) were identified in
the Nyquist plot as the linear part of the plot, from 400 to 525 k  in the real part
of the impedance, ZRe. As the capacitive low frequency components do not act as
ideal capacitors the linear part is not a vertical line but slightly tilted.
As the PBS dilution increased the Bode modulus plots were shifted towards higher
impedance in the frequency range from 101 ≠ 104 Hz. This was caused by the
higher solution resistance of the diluted PBS. The Bode phase plots all showed re-
sistive behaviour (phase close to 0 degrees) in the same frequency range. In the low
frequency range ( < 5 Hz) the phase decreased towards a capacitive behaviour. The
phase did not reach -90 degrees, which confirmed that the system did not behave
as an ideal capacitor at low frequencies. From the Bode phase plots it was evident
that the ionic content of the solution had an impact on the behaviour of the low
frequency components as the Bode phase plots were shifted to the left at lower PBS
concentrations.
From the salinity measurements it was concluded that the system and the chip
behaved as expected as a consequence of changes in the salinity of the media.
6.3.3 pH measurements with the aptasensor
The characterisation of pH changes in the measured solution in the chip was mea-
sured by a pH series from 4 to 9. The pH series was made by pH adjusting PBS with
NaOH or HCl. The measured pH values and conductivities of the pH series are listed
in table 6.1. The conductivity of the di erent pH solutions was approximately the
Table 6.1: pH values and conductivities of the samples for the pH measurements
with the aptasensor chip.
pH series Measured pH Conductivity [mS/cm]
pH 4 3.94 15.99
pH 5 4.80 15.85
pH 6 6.03 15.83
pH 7 7.00 15.80
pH 8 7.80 15.80
pH 9 9.03 15.80
same, which meant that any observable di erences in the Nyquist and Bode plots
did not originate from changes in conductivity of the solutions. The Nyquist plots
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Figure 6.8: Nyquist and Bode plots of the pH measurements of the pH series. The
data represents measurements of one electrode pair on an SD card chip. A total of
five impedance sweeps were acquired for each pH value and the average values were
calculated and displayed on the plots. The 50 Hz noise component originating from
the power supply was removed.
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and Bode plots of the measured pH series are found in figure 6.8. Both the Nyquist
plots and the Bode plots did not show any significant behavioural changes or shift
caused by the pH changes. The only small observable change in the plots was related
to the pH 9 but this change was considered insignificant.
It was concluded from the pH measurements that the pH change did not alter the
EIS signal to a degree where it was significant.
6.3.4 Stability of the SD card chip over a period of two
weeks in continuous flow
The stability of the SD card chip was characterised by a long term measurement
over time in continuous flow with a 1:20 PBS dilution in MilliQ water. The conduc-
tivities of tap water and PBS were measured to be 0.82 mS/cm and 15.83 mS/cm,
respectively. This means that tap water is 20 times less conductive than PBS, hence
a 1:20 PBS dilution was prepared. In order to have a clean sample with no pos-
sibility of biofilm formation on the electrodes the 1:20 PBS dilution was chosen as
the measurement media instead of tap water. The measurements were done on four
electrode pairs on the same SD card chip with a fixed frequency of 1 Hz. A total of
5000 data points were measured for all four electrode pairs each day. The electrode
specific data from each day was extracted as illustrated in figure 6.5 and the average
and standard deviation of the 1 Hz impedance for each electrode were calculated
using MATLAB. Figure 6.9 shows the plots of the stability analysis of each elec-
trode pair with the standard deviation for each day over a period of two weeks. The
average impedance of the four electrode pairs lies within a range of 180 and 290 k .
Common for all electrode pairs were a large impedance change from day 0 to day
one between 10 to 27 k  . Electrode pairs E1-3 showed a constant impedance after
day 1, where the impedance of electrode pair E4 showed a small drift towards higher
impedance. Furthermore, the standard deviation of all electrode pairs for each day
was low which meant that the impedance of the electrode pairs were constant during
the daily measurements.
The stability measurement showed that the SD card chip was stable in flow over a
two week period. It was thus concluded that the PEDOT:PSS electrodes were not
degrading due to the flow. The initial impedance change within the first day must
be kept in mind for further measurements and development of the viral aptasensor
system. Especially, if the measurements are to be done as short term measurements.
The dynamics of the initial impedance change should thus be examined further.
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Figure 6.9: Characterisation of the stability of the SD card chip over a two week
period in continuous flow at a fixed frequency of 1 Hz.
6.4 Conclusion
The long term aim of the viral aptasensor is to do impedimetric detection of virus
in environmental water samples. In this chapter, the characterisation and the sta-
bility of the multiplexer and the SD card chip were experimentally investigated.
Furthermore, a circuit model was proposed based on an EIS measurement of the
SD card chip. The model circuit was in good agreement with the acquired data. It
was concluded that the model was a good representation of the real circuit but it
was acknowledged that di erences did occur since the real life circuit is much more
complex than a simple model.
The stability of the multiplexer was measured with RC circuits with known resis-
tance and capacitance. The multiplexer showed good stability and it was concluded
that no significant noise disturbances were introduced in the EIS signal as a conse-
quence of the multiplexer.
The SD card chip was characterised by measurements with di erent media salinity
and di erent pH values. The salinity measurements showed the expected tendency
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where the greatest changes were observed in the frequency range representing the
solution resistance. No significant changes caused by di erence in pH was observed
in the measurements. The stability of the SD card chip was investigated in a con-
tinuous flow over two weeks, where daily EIS measurements were made on four
electrode pairs of an SD card chip. The average impedance and standard deviation
at a fixed frequency of 1 Hz were calculated for each electrode pair, each day. The
chip showed good stability and it was concluded that the electrodes did not degrade
during the two weeks of constant flow. The largest change of the impedance was
observed from day 0 to day 1.
The next step of the EIS measurements will be to immobilise virus specific aptamers
on the electrodes and make EIS measurements of spiked virus samples. Good ap-
tamer surface immobilisation is of pivotal importance for successful viral detection.
The surface immobilisation is still under development as described in chapter 5.
Eventually, environmental water samples should be measured with the SD card
chip. Furthermore, the chip to chip variations should be investigated to assure a
good reproducibility of the measurements.

7
Conclusion and perspective
The overall aim of this PhD thesis was the development of an aptasensor which
was intended for the use of detection of waterborne viruses: NoV, RV and HAV, in
environmental water samples. The process involved di erent aspects of the develop-
ment of the aptasensor. The developed aptasensor was an impedimetric all-polymer
sensor.
This PhD thesis aimed at preparing samples of RV and HAV for the selection
of aptamers targeting these viruses. Aptamers selected against NoV were already
published in the literature. The actual aptamer selection was performed by an ex-
ternal collaborator, where the SELEX was based on magnetic bead separation of the
target and non-binders. Two di erent RV strains, Wa and DS-1, were purified and
biotinylated for the aptamer selection. The RV was biotinylated to be immobilised
onto streptavidin coated magnetic beads. Two di erent biotinylation linkers were
tested and it was found that the BPH biotin linker showed the highest yield. Con-
trol experiments of non-biotinylated RV to the magnetic beads showed a high degree
of passive absorption. It was thus concluded that further testing and optimisation
were required to ensure a better binding of the bRV, compared to the RV, to the
beads.
A HAV sample, purified by an external collaborator, was inactivated and biotiny-
lated with the BPH linker. Unfortunately, the initial concentration of the HAV
sample was very low and it was not possible to estimate the yield of the biotinyla-
tion. The bRV and bHAV samples were shipped to our external collaborator for the
aptamer selection.
The iterative design phase of the viral aptasensor was divided into two main
designs based on an USB and SD card interface. The USB chip was designed with
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two electrode pairs and di erent approaches of liquid interfaces. The USB chip did
not meet the multiplexing requirements for detection of three di erent viral targets
simultaneously. Thus, the SD card chip was designed with four electrode pairs, three
for virus detection and one reference/control electrode. The chip substrate and the
lid of the final viral aptasensor, the SD card chip version 3, were made by injec-
tion moulding of PC and the electrodes were made by screen-printing PEDOT:PSS
directly onto the substrate. A channel, integrated in the lid, ensured a liquid con-
nection and allowed continuous sample flow in the chip.
The aptamer immobilisation onto di erent polymer substrates was tested in this
PhD thesis. It was important to investigate the immobilisation of aptamers onto
PEDOT:PSS as this was crucial for a successful aptasensor. The tested immobili-
sation method was based on UV cross-linking of the aptamers through a TC-tag.
This method was chosen due to the chemical inertness of the PEDOT:PSS which
hindered immobilisation by e.g. thiol or amine linking. The UV cross-linking was
initially tested by a hybridisation assay based on fluorescent labelling. The flores-
cent detection did not show any clear conclusion of the aptamer immobilisation and
a colorimetric hybridisation ELASA was tested instead. The ELASA was tested
in microtiter plates and on the PC SD card chip substrate, both with and with-
out PEDOT:PSS. The UV cross-linking worked very convincingly on the PolySorp
microtiter plate and on the PC card chip substrate. The PC card chip substrate
coated with 1 or 2 layers of PEDOT:PSS showed a positive trend. It was concluded
that immobilisation of aptamers with UV cross-linking method was possible on PE-
DOT:PSS but with lower e ciency compared to the PC substrate. Furthermore,
passive absorption of the aptamers onto the PEDOT:PSS was observed in experi-
ments without the TC-tag on the aptamers and without UV exposure.
In the future the UV cross-linking method should be further optimised. Further-
more, the UV cross-linking method should be compared to known immobilisation
methods such as amino functionalisation in order to investigate the applicability of
the method. The UV cross-linking method should also be tested with the specific
aptamer targets and not only hybridisation of the rcDNA, as the latter method is
a simplified process compared to target recognition. This will also clarify whether
or not the UV exposure damages the aptamers to a degree where target binding is
reduced or impossible.
The electrical characterisation of the aptasensor and the system setup involved a
circuit model and impedimetric characterisation of the multiplexer and the SD card
chip, version 3.
A circuit model was made based on an impedance sweep of the SD card chip filled
with a solution of diluted PBS. The model and the data showed good agreement
and the model was accepted as a representation of the SD card chip.
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The EIS characterisation of the multiplexer revealed that the multiplexer did not
introduce any significant noise and it was concluded that the multiplexer could be
used without noise concerns.
The EIS characterisation of di erent media salinity and pH values was performed
in the SD card chip. The impedimetric measurements of the di erent salinity of the
media behaved as expected with the greatest change present in the region repre-
senting the solution resistance. The pH measurements did not show any significant
signal changes and it was concluded that the chip was stable in the measured pH
range. Furthermore, the stability of the SD card chip was measured over a 2 week
period with a continuous flow of diluted PBS. The measurements confirmed that
the electrodes were not degraded or damaged by the flow. The largest change in
impedance was observed between day 0 and day 1.
Future work should focus on integration of the di erent steps involved in the
viral aptasensor development described in this thesis. The aptamers, once selected,
targeting the enteric viruses should be immobilised onto the electrodes. The char-
acterisation and development of the immobilisation method must be complete to
ensure a good coverage and orientation of the aptamers on the electrodes. When
the immobilisation of the aptamers onto PEDOT:PSS is a controlled process the
e ciency of the target binding must be determined. Finally, impedimetric mea-
surements and detection of spiked virus samples and environmental water samples
should be done.
When the listed development aspects of the aptasensor work in coherence with each
other an e cient aptasensor will be obtained for the detection of virus in water, in
the future.
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A
Step by step protocols and
material lists
All reagents are from Sigma-Aldrich, Denmark, unless otherwise stated.
A.1 Protocol for MA104 cell culture and
rotavirus A propagation in MA104 cells
Material list
• MA104 cell line, kindly provided by Katharina Lahl, DTU Vet, National Vet-
erinary Institute, Denmark
• Human rotavirus A strains from ATCC
– Strain Wa, Serotype G1, genotype P8: Rotavirus A (ATCC VR-2018)
– Strain DS-1, Serotype G2, genotype P4: Human rotavirus (ATCC VR-
2550)
• T75 and T175 cell culture flasks with filter cap
• M199 medium (Thermo Fisher Scientific, cat. no. 11150-059)
• Penicillin-Streptomycin-Glutamine (Thermo Fisher Scientific, cat. no. 10378-
016)
• Fetal bovine serum (FBS) (Biowest SAS, France)
• Trypsin-EDTA solution, 1x, sterile, sterile-filtered
• Dulbecco’s Phosphate Bu ered Saline, Modified, without calcium chloride and
magnesium chloride (PBS)
• Trypsin from Porcine Pancreas, Type IX, lyophilized powder
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• Incubator set to 37 ¶C, 5 % CO2
• Centrifuge that fits 15 and 50 mL falcon tubes
All media and reagents for cell culture and virus propagation must be sterile and
should be heated to 37 ¶C before usage.
Full cell culture medium: M199 medium supplemented with 5 mL/500mL
Penicillin-Streptomycin-Glutamine and 5 % fetal bovine serum
Protocol for MA104 cell culture
1. Thaw a 1 mL MA104 cell line vial and mix cells with 10 mL full cell culture
medium. Spin down cells and discard supernatant and resuspend cells in 10
mL full cell culture medium.
2. Seed cells in a T75 cell culture flask with a total of 40 mL full cell culture
medium and place flask in the incubator at 37 ¶C, 5 % CO2.
3. After 2-3 days, or when cells have reached 90 % confluence, the cells are split
into 3 T75 flasks. Wash cells with 10-20 mL 0.025 % (w/v) trypsin-EDTA
solution (diluted in PBS) to remove any FBS. Cells are released from the
culture flask by briefly flushing cells with 10-20 mL 0.025 % (w/v) trypsin-
EDTA solution (diluted in PBS), in order to have only a thin film of trypsin-
EDTA covering the cells, and placed in the incubator for 3-5 min. When all
cells have detached 10 mL full cell culture medium is added to the flask and
divided into 3 new T75 flasks. Flasks are filled with full cell culture medium
to a total of 40 mL in each flask.
4. Cell culture is continued as described in point 3. Cells from a 1 T75 flask can
be split into 3-5 T75 flasks or passaged to 1 T175 flask when the cell culture
is running.
5. Cells are frozen in 10 % DMSO in 1 mL stocks in cryo tubes. Keep cells at
-140 ¶C.
Protocol for rotavirus propagation in MA104 cells
1. Culture MA104 cells in T175 flasks with full cell culture medium. When cells
have reached 90 % confluence after approximately two days they are ready for
inoculation. One T175 flask, cultured with same medium and conditions, with-
out virus should be kept in parallel of the T175 flasks with virus propagation
as a cell control.
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2. A multiplicity of infection (MOI) of 0.1 - 1 is used to propagate the virus in
the cell culture. In order to calculate the MOI one need to know the number
of cells in the flask and the plaque forming unit (PFU) of the virus:
No.cells · MOI = PFU needed
3. Aliquot the amount of virus needed into a 2 mL tube and add serum free
medium (Medium 199 with 5 mL/500mL Penicillin-Streptomycin-Glutamine)
to a final volume of 1 mL. Add 2.5 µL trypsin from Porcine Pancreas (2 mg/mL
stock diluted in M199) to get a final concentration of 5 µg/mL. Incubate at
37¶C for 15-20 min.
4. Wash cell culture with serum free medium to remove any serum.
5. Add 4 mL of serum free medium to the activated virus to a total volume of 5
mL. Add the activated virus to the flask and incubate at 37¶C for 45-60 min.
6. Add 20 mL serum free medium with 0.5 µg/mL trypsin from Porcine Pancreas
and allow the virus to propagate in the cells at 37¶C 5 % CO2.
7. The cytopathic e ect (CPE) should be observed every day until complete cell
death - usually 2-5 days post infection.
8. Freeze-thaw the flask 3 times. Freeze at -80 ¶C and thaw at room temperature.
Collect the lysate in a clean tube.
9. Remove cell debris from the lysate by low speed centrifugation (3500 ◊g) for
10 min. Collect the clarified cell supernatant in a clean tube.
10. Store the clarified cell supernatant containing the virus stock at -80 ¶C.
A.2 Protocol for semi-purification of RV on a
sucrose cushion
Materials list
• Approximately 240 mL of clarified rotavirus cell lysate without large cell debris
is thawed from -80 ¶C to room temperature in a hot water bath.
• Ultra-clear centrifuge tubes 25 x 89 mm (Beckman Coulter, Item No: 344058)
• SW 28 Ti Rotor (Beckman Coulter, Item No: 342204)
• Optima XE 90k Ultracentrifuge (Beckman Coulter)
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• Scale with 3 digits precision
• TNC bu er (20 mM Tris-HCl, 100 mM NaCl, 1 mM CaCl2 at pH 8.0, store
at 4 C¶)
• 35 % sucrose in TNC bu er
• Long needle, e.g. 0.90 x 70 mm, 20 G x 2 3/4
• 25 gauge needle and 10 mL syringe
Protocol
1. Fill 35 mL of rotavirus cell lysate in three Ultra-clear centrifuge tubes.
2. Gently underlay 2 mL of 35 % sucrose in TNC bu er with a long needle in
each centrifuge tube and fill tube up 3 mm from top.
3. Balance the centrifuge tubes by weight down to an accuracy of the second
decimal.
4. Centrifuge tubes at 100000 ◊g at 4 ¶C for 2.0 h.
5. Discard supernatant and resuspend each pellet in 0.5 mL TNC bu er.
6. Pool the pellets and fill up with TNC bu er to a total volume of 4 mL.
7. Pass the virus suspension several times in a 25 gauge needle and syringe to
ensure a homogenous suspension of virus particles.
8. Store the virus suspension at 4 ¶C.
A.3 Protocol for cesium chloride gradient
purification of RV
Materials list
• Semi-purified RV prepared according to protocol A.2
• Cesium chloride, ReagentPlus®, 99.9 %
• SW 65 rotor (Beckman Coulter)
• Refractometer
• LB-70M Ultracentifuge (Beckman Coulter)
• Ultra-clear centrifuge tubes, 13 x 51 mm (Beckman Coulter, Item No: 344057)
• Light source, e.g. a light-emitting diode
A.3. PROTOCOL FOR CESIUM CHLORIDE GRADIENT PURIFICATION OF
RV 149
• Slide-A-Lyzer Dialysis Cassettes, 10K MWCO, 0.5-3 mL Capacity(Thermo
Fisher Scientific)
• SDS-PAGE reagents (from Bio-Rad, USA):
– Mini-PROTEAN Tetra Vertical Electrophoresis Cell and voltage supply
– Any kD Mini-PROTEAN TGX Precast Protein Gels, 15-well, 15 µl, cat
no.4569036
– 2x Laemmli Sample Bu er, cat no. 1610737
– 10x Tris/Glycine/SDS, cat no. 1610732
– Precision Plus Protein All Blue Prestained Protein Standards, cat no.
161-0373, control: 350001702
• Pierce Silver Stain Kit (Thermo Fisher Scientific)
• Rack heater, e.g. Eppendorf Thermomixer R
• Flatbed scanner
Protocol
1. Dissolve 2 g CsCl in the 4 mL semi-purified RV sample to obtain a density of
1.37 g/cm3. A refractive index of 1.3684 equals a density of 1.37 g/cm3 at 25
¶C, see table A.1 (Check with a refractometer).
2. Fill one Ultra-clear centrifuge tube with the virus suspension and balance the
rotor with centrifuge tubes with TNC bu er with CsCl, density 1.37 g/cm3.
3. Balance the centrifuge tubes by weight down to an accuracy of the second
decimal.
4. Centrifuge tubes at 110000 ◊g (35500 RPM) at 12 ¶C for 18 h.
5. Remove the rotor from the centrifuge without shaking or in other way disturb-
ing the gradient.
6. Place the centrifuge tube with the virus suspension over an inverted light
source and inspect the gradient. Two bands should be visible as seen in figure
A.1. The upper band is the TLP RV and the lower band the DLP RV.
7. Gently unload the gradient from the bottom of the tube by puncturing a small
hole in the bottom. Unload fractions of approximately 500 µL or the volume
needed to get fractions with TLP and DLP.
8. Analyse the fractions on a SDS-PAGE gel to verify the protein content of the
TLP and the DLP fractions. See table 3.1 for mass and location of the RV
structural proteins. See figure A.2 for an example of the silver stained gel with
the structural proteins identified.
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a) Mix 5 µL 2 x Laemmli Sample Bu er with 5 µL virus sample and denature
sample on a rack heater for 5 min at 90-100 ¶C. Spin down sample.
b) Prepare 1 x Tris/Glycine/SDS bu er. Remove protective film and comb
from the Any kD Mini-PROTEAN TGX Precast Protein Gel and mount
this into the electrophoresis cell. Add the bu er to the bu er chamber.
c) Load 10 µL 10 x diluted Precision Plus Protein All Blue Prestained Pro-
tein Standards (marker) to the first well and add 10 µL 50 x diluted
marker to the last well. Load 10 µL denatured sample to the wells.
d) Run gel at 200 V for approximately 30 min until the dye reaches the
reference line.
e) Disassemble the gel cassette and stain the gel with Pierce Silver Stain
Kit according to manufactures manual.
f) Scan the gel in a flatbed scanner and calculate the relation (assume an
exponential relation) between the position of the marker and the mass
(in kDa) of the marker as done in figure A.3 . Use the relation to identify
the structural proteins of the RV.
9. Dialyse the interesting fractions containing the TLP (and DLP) RV particles
in TNC bu er against CsCl for 24 h with 3 bu er changes, after approximately
2 h, 8h and 14 h.
Table A.1: Refractive index (RI) and density (ﬂ) of CsCl at 25 ¶C. The density
and refractive index is linear dependent by: RI = 0.0946ﬂ + 1.2388
Density [g/cm3] Refractive index
1.35 1.3665
1.36 1.3675
1.37 1.3684
1.38 1.3694
1.39 1.3702
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Figure A.1: Simian RV purified on a CsCl gradient. The two bands seen in the tube
is the separated TLP and DLP RV particles. The RV particles have been separated
due to their di erence in density.
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Figure A.2: SDS-PAGE of simian rotavirus purified on CsCl gradient (from fig-
ureA.1). The protein bands are stained with silver stain. Samples #10 ≠ 13 and
#18≠21 are fractions from the CsCl gradient with TLP and DLP, respectively. The
samples were dialysed before performing the SDS-PAGE. VP8ú (27 kDa), VP7 (34
kDa) and VP5ú (58 kDa) are proteins specific to TLP virus particles (see table 3.1)
and these protein bands are only visible in samples #10≠ 13 as expected. Marker is
in kDa. The protein positions are calculated from the position of the marker.
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Figure A.3: Plot of the correlation between marker proteins mass (in kDa) and
marker displacement of human RV strains Wa and DS-1. The displacement is mea-
sured using the di erence between the position of the 15 kDa marker and the re-
maining markers in Adobe Illustrator. The displacement is given in arbitrary units
(AU). The position of the structural proteins is calculated from the logarithmic fit
and draw in the SDS-PAGE gel images of figure 3.6a and figure 3.6b
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A.4 Protocol for rotavirus biotinylation with
BPH linker and subsequent coupling to
magnetic beads
Materials list
• TLP Rotavirus particles purified on a CsCl gradient prepared according to
protocol A.3
• BPH linker: EZ-Link Hydrazide-PEG4-Biotin (Thermo Fisher Scientific)
• Dimethylsulfoxid (DMSO)
• 0.1 M MES-bu er supplemented with 1 mM CaCl2 (to stabilise RV) (pH 4.7-
5.5) (Thermo Fisher Scientific)
• 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)
• Streptavidin-coated magnetic beads: Dynabeads M-280 Streptavidin (Thermo
Fisher Scientific)
• Slide-A-Lyser Dialysis Cassette 10k MWCO, 0.5-3 mL Capacity (Thermo
Fisher Scientific)
• 1 mL syringes
• 19-gauge 1.5 inch needles
• Magnetic separation rack
• TNC bu er for rotavirus (20 mM Tris-HCl, 100 mM NaCl, 1 mM CaCl2 at
pH 8.0)
Protocol
Prepare a 250 mM linker stock solution by dissolving the BPH linker (mw: 505.26
g/mol) in DMSO. Keep the stock at -20¶C. The EDC must not be dissolved before
immediate usage, thus weigh o  appropriate amount to make a 100 mg/mL EDC in
MES bu er solution.
1. Dilute virus samples in 0.1 M MES-bu er supplemented with 1 mM CaCl2 to
a final volume of 1 mL. Use at least a dilution of 1:10 virus to MES bu er.
2. Dilute the BPH linker stock solution in a ration of 1:5 in MES bu er and add
25 µL to each virus suspension.
3. Dissolve the EDC to a concentration of 100 mg/mL EDC in MES bu er and
add 12.5 µL to each virus suspension.
4. Incubate for 2 h at room temperature with continuous mixing.
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5. Stop reaction by dialysing samples against the BPH linker with Slide-A-Lyser
Dialysis Cassettes, 10k MWCO, at 4 ¶C. Load samples into the dialysis cham-
ber with a 1 mL syringe and 19-gauge 1.5 inch needle. Change the dialysis
bu er (0.1 M MES-bu er with 1 mM CaCl2) after 2 h, 4 h and dialyse over
night.
6. Wash 25 µL Dynabeads M-280 Streptavidin, for each virus suspension, with
1 mL TNC bu er on a magnetic separator rack and discard supernatant. Re-
suspend beads in 25 µL TNC bu er.
7. Add the dialysed biotinylated virus samples to the magnetic beads in separate
tubes.
8. Incubate virus particles with the magnetic beads for 30 min at room temper-
ature with continuous mixing.
9. Separate the magnetic beads from the supernatant on a magnetic rack sepa-
rator. Keep the supernatant for PCR analysis to analyse the ratio of unbound
to bound virus particles.
10. Wash the virus bound magnetic beads with TNC bu er three times to remove
any unbound virus particles and resuspend in the original volume. Store at 4
¶C.
A.5 Protocol for rotavirus biotinylation with
BNHS linker and subsequent coupling to
magnetic beads
Materials list
• TLP Rotavirus particles purified on a CsCl gradient prepared according to
protocol A.3
• Dimethylsulfoxid (DMSO)
• BNHS: (+)-Biotin N-hydroxysuccinimide ester
• 0.1 M NaHCO3, pH 8.2 with 1 mM CaCl2
• Slide-A-Lyser Dialysis Cassettes, 10k MWCO (Thermo Fisher Scientific)
• 1 mL syringes
• 19-gauge 1.5 inch needles
• Streptavidin-coated magnetic beads: Dynabeads M-280 Streptavidin
• Magnetic separation rack
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• TNC bu er for rotavirus (20 mM Tris-HCl, 100 mM NaCl, 1 mM CaCl2 at
pH 8.0)
Protocol
1. Dilute virus samples in 0.1 M NaHCO3, pH 8.2 with 1 mM CaCl2 to a final
volume of 1 mL.Use at least a dilution of 1:10 virus to bu er.
2. Dilute BNSH in DMSO immediately before use, 10 mg/mL, and add 0.1 mL
to each virus suspension.
3. Incubate for 2 h at room temperature with mixing
4. Stop reaction by dialysing samples against the BNSH linker with Slide-A-
Lyser Dialysis Cassettes, 10k MWCO, at 4 ¶C. Load samples into the dialysis
chamber with a 1 mL syringe and 19-gauge 1.5 inch needle. Change the dialysis
bu er (0.1 M NaHCO3, pH 8.2 with 1 mM CaCl2) after 2 h, 4 h and dialyse
over night.
5. Wash 25 µL Dynabeads M-280 Streptavidin, for each virus suspension, with
1 mL TNC bu er on a magnetic separator rack and discard supernatant. Re-
suspend beads in 25 µL TNC bu er.
6. Add the dialysed biotinylated virus samples to the magnetic beads in separate
tubes.
7. Incubate virus particles with the magnetic beads for 30 min at room temper-
ature with continuous mixing.
8. Separate the magnetic beads from the supernatant on a magnetic rack sepa-
rator. Keep the supernatant for PCR analysis to analyse the ratio of unbound
virus particles.
9. Wash the virus bound magnetic beads with TNC bu er three times to remove
any unbound virus particles and resuspend in the original volume. Store at 4
¶C.
A.6 Protocol for analysis of RV by real-time
RT-PCR
Materials list
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• RV samples - 140 µL/RNA extraction
• QIAamp Viral RNA Mini Kit (Qiagen, Germany)
• 99 % ethanol
• For real.time RT-PCR:
– AgPaht-ID One-Step RT-PCR Reagents (Thermo Fisher Scientific)
– Nuclease-free Water
– Forward primer (50 µM), nucleotide sequence (5’-3’): ACCATCTACA-
CATGACCCTC [87]
– Reverse primer(50 µM), nucleotide sequence (5’-3’): ACCATCTACA-
CATGACCCTC [87]
– TaqMan probe(50 µM), nucleotide sequence (5’-3’): ATGAGCACAATAGT-
TAAAAGCTAACACTGTCAA [87]
– Positive rotavirus RNA control
• PCR cycler: Rotor-Gene 6000 (Qiagen, Germany)
Protocol
1. Extract RNA from the virus samples with the QIAamp Viral RNA Mini Kit
according to the manufacturers protocol. Store RNA at -20¶C.
2. Mix reagents for real time RT-PCR, keep mix at 4 ¶C at all times. Each
sample is performed in duplicates to get an average Ct value for each sample.
RT-PCR Mastermix for one reaction of 15 µL (13 µL mastermix + 2 µL RNA
template):
4.624 µL Nuclease-free Water
7.5 µL 2x RT-PCR Bu er
0.12 µL Forward primer (50 µM)
0.12 µL Reverse primer (50 µM)
0.036 µL TaqMan probe (50 µM)
0.6 µL 25x RT-PCR Enzyme mix
13 µL in total 1 x Mastermix
3. Add 13 µL mastermix to each PCR tube and add 2 µL RNA template. Add
2 µL nuclease-freewater (use same water as the mastermix) to the negative
controls and 2 µL positive control (rotavirus RNA) to the positive controls.
Keep the mix at 4 ¶C at all times.
4. On a Rotorgene 6000 the real-time RT-PCR is performed accordingly:
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Reverse transcription 45 ¶C 10 min
RT inactivation and poly activation 95 ¶C 10 min
48 cycles 95 ¶C 15 seconds
60 ¶C 45 seconds
Plate read
5. Analyse results (Ct threshold = 0.01, Ct < 33 positive, Ct > 33 suspect
positive)
A.7 Protocol for hepatitis A virus (HAV)
inactivation
Material list
• HAV sample, genotype 1B, kept at -80 ¶ (cultured at the Environmental Vi-
rological Laboratory, Tor Vergata University, Rome, Italy)
• Formaldehyde, for molecular biology, 36.5-38% in H2O
• Slide-A-Lyser Dialysis Cassette 10k MWCO, 0.5-3 mL Capacity (Thermo
Fisher Scientific)
• 1 mL syringes
• 19-gauge 1.5 inch needles
• Phosphate bu ered saline (PBS)
Protocol
1. Thaw the HAV sample.
2. Dilute formaldehyde in HAV samples to a final concentration of 1:2000 formalde-
hyde to HAV sample. Take into account that the formaldehyde solution is
already diluted.
3. Incubate the formaldehyde with the HAV sample for 8 days at 4 ¶C.
4. Remove the formaldehyde from the HAV sample by dialysis using the Slide-
A-Lyser Dialysis Cassettes, 10k MWCO, at 4 ¶C. Load samples with a 1 mL
syringe and 19-gauge 1.5 inch needle. Change the dialysis bu er (PBS) after
2 h, 4 h and dialyse over night.
5. Store the inactivated HAV sample at 4 ¶C for further work.
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A.8 Protocol for hepatitis A virus biotinylation
with BPH linker and subsequent coupling
to magnetic beads
Materials list
• Inactivated HAV particles prepared according to protocol A.7
• BPH linker: EZ-Link Hydrazide-PEG4-Biotin (Thermo Fisher Scientific)
• Dimethylsulfoxid (DMSO)
• 0.2 M MES-bu er (pH 4.7-5.5) (Thermo Fisher Scientific)
• 0.1 M MES-bu er (pH 4.7-5.5) (Thermo Fisher Scientific)
• 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimid (EDC)
• Streptavidin-coated magnetic beads: Dynabeads M-280 Streptavidin (Thermo
Fisher Scientific)
• Slide-A-Lyser Dialysis Cassette 10k MWCO, 0.5-3 mL Capacity (Thermo
Fisher Scientific)
• 1 mL syringes
• 19-gauge 1.5 inch needles
• Magnetic separation rack
• Phosphate bu ered saline (PBS)
Protocol
Prepare a 250 mM linker stock solution by dissolving the BPH linker (mw: 505.26
g/mol) in DMSO. Keep the stock at -20¶C. The EDC must not be dissolved before
immediate usage, thus weigh o  appropriate amount to make a 100 mg/mL EDC in
0.1 MMES bu er solution.
1. Dilute virus samples 1:2 in 0.2 M MES-bu er to a final volume of 1 mL.
2. Dilute the BPH linker stock solution in a ration of 1:5 in MES bu er and add
25 µL to each virus suspension.
3. Dissolve the EDC to a concentration of 100 mg/mL EDC in MES bu er and
add 12.5 µL to each virus suspension.
4. Incubate for 2 h at room temperature with continuous mixing.
5. Stop reaction by dialysing samples against the BPH linker with Slide-A-Lyser
Dialysis Cassettes, 10k MWCO, at 4 ¶C. Load samples with a 1 mL syringe
and 19-gauge 1.5 inch needle. Change the dialysis bu er (PBS) after 2 h, 4 h
and dialyse over night.
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6. Wash 25 µL Dynabeads M-280 Streptavidin per mL biotinylated HAV samlpe
with 1 mL PBS bu er on a magnetic separator rack and discard supernatant.
Resuspend beads in 25 µL PBS bu er.
7. Add the dialysed biotinylated virus samples to the magnetic beads.
8. Incubate virus particles with the magnetic beads for 30 min at room temper-
ature with continuous mixing.
9. Separate the magnetic beads from the supernatant on a magnetic rack sepa-
rator. Keep the supernatant for PCR analysis to analyse the ratio of unbound
virus particles.
10. Wash the virus bound magnetic beads with PBS bu er three times to remove
any unbound virus particles and resuspend in the original volume. Store at 4
¶C.
A.9 Protocol for real-time PCR analysis of
hepatitis A virus samples
Materials list
• QIAamp Viral RNA Mini Kit (Qiagen, Germany)
• 99 % ethanol
• For reverse transcriptase:
– RNA template samples
– SuperScript III First-Strand Synthesis System (Invitrogen, Thermo Fisher
Scientific)
– Primer 4/4 (AGTCACACCTCTCCAGGAAAACTT)
– PCR tubes
– 1.5 mL Eppendorf tube
– Thermal cycler for conventional PCR
• For real-time PCR
– QIAGEN OneStep RT-PCR Kit (Qiagen)
– Rnase free water
– Sybr green, diluted 1:16 in sterile nuclease free water
– Primer 1/4 (TTTGTCTTTTAGTTGTTATTTGTCTGT)
– Primer 4/4 (AGTCACACCTCTCCAGGAAAACTT)
– Thermal cycler for real-time PCR
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Protocol
1. Extract RNA from the virus samples with the QIAamp Viral RNA Mini Kit
according to the manufacturers protocol. Store RNA at -20¶C.
2. Mix the reagents for reverse transcriptase. Add the following reagents directly
to each PCR tube, keep on ice:
1 µL Primer 4/4
1 µL 10 mM dNTPs
2 µL Total
Mix the remaining reagents for the reverse transcription in an Eppendorf tube,
keep it on ice. Mix for one reaction:
2 µL 10x RT Bu er
4 µL 25 mM MgCl2
2 µL 0.1 M DTT
1 µL RNaseOUT
1 µL SuperScript III RT
10 µL Total
3. Reverse transcription: Add 8 µL RNA template sample to each of the PCR
tubes. Incubate on a thermal cycler at 42 ¶C for 2 minutes. Cool on ice for
minimum 1 minute. Add 10 µL of the everse transcription PCR mix from the
Eppendorf tube to each PCR tubes. Incubate as follows:
95 ¶C 5 min
42 ¶C 1 h
95 ¶C 5 min
4. Add 1 µL RNase H to each tube and incubate at 37 ¶C for 20 minutes. Store
cDNA at -20 ¶C.
5. Mix reagents for real-time PCR. Perform duplicates of each sample. One
reaction consists of 23 µL master mix and 2 µL cDNA template. Master mix:
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12.5 µL Nuclease-free water
5 µL 5 x Qiagen OneStep RT-PCR bu er
1 µL dNTP mix, 10 mM
1.5 µL Primer 1/4, 10 µM
1.5 µL Primer 4/4, 10 µM
0.5 µL Sybr green, diluted 1:16 in nuclease-free water from stock (1:100)
1 µL Qiagen OneStep RT-PCR Enzyme mix
23 µL Total
Add 2 µL cDNA template to each tube. Make 2 negative controls with
nuclease-free water
6. Real-time PCR is done as follows:
95 ¶C 3 min
95 ¶C 30 s
45 ¶C 10 s
70 ¶C 60 s
7. Analyse results (Ct threshold = 0.01, Ct < 33 positive, Ct > 33 suspect
positive)
A.10 Protocol and materials for UV
immobilisation of aptamers on chips by
robotic spotting and subsequent
hybridising with rcDNA
Material list
• PEDOT:PSS screen printed PC chips, SD card chip, version 3
• Aptamers with a Poly(T)10-Poly(C)10 tag and spacer
• Autodrop Professional Positioning System, Microdrop Technologies GmbH,
Germany
• Autodrop pipette, AD-K-901, type 40, Microdrop Technologies GmbH, Ger-
many
• Spotting bu er (See specific experiment)
• Stratalinker 2400, Stratagene, CA, USA
• Wash bu er (See specific experiment)
• rcDNA
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HYBRIDISING WITH RCDNA 163• PerfectHyb Plus Hybridization Bu er
• Glas slides
• Confocal microscope (Zeiss, Germany)
Protocol
1. Spotting and UV cross-linking of aptamers onto chips:
a) Diluted aptamers to the final concentration in the spotting bu er. Ap-
proximately 200 µL of each aptamer solution is needed for spotting.
b) Mount an Autodrop pipette in the Autodrop Professional Positioning Sys-
tem and fill it with the aptamer solution. Setup the system for spotting
micro arrays according to the spotting layout in the specific experiment.
c) In the Autodrop Professional Positioning software load a spotting file
(.mvg) in the image control menu. Spotting distance from pipette to
substrate should be 1-1.5 mm. A horizontal spot distance of 0.15-0.2
mm should be used for spotting. Place a chip on the stage and align the
fiducials. Spot the micro array.
d) The spotted array on the chip should be dry before proceeding.
e) Cross-link aptamers on polymer substrates by UV exposure with a Stratalinker
2400, 254 nm. Time depends on the specific experiment.
f) First washing step: Wash chips with washing bu er according to the
specific experiment. Dry chips with compressed air.
2. Hybridisation with rcDNA
a) Dilute rcDNA to a final concentration of 500 nM in PerfectHyb Plus
Hybridization Bu er and place a drop on each chip in the area where the
aptamers were spotted. Cover with a glass slide.
b) Incubate for 1 hour at 37 ¶C, protect the fluorophores from bright light.
c) Second washing step: Wash chips in wash bu er according to the specific
experiment. Dry chips with compressed air. Keep chips in the dark.
d) Inspect the fluorescence by a confocal microscope(see figure A.4 or A.5
for examples).
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(a) 0.5 µM, 1 min, bright-field (b) 0.5 µM, 1 min, flurescence
(c) 0.5 µM, 5 min, bright-field (d) 0.5 µM, 5 min, flurescence
Figure A.4: Bright-field and fluorescent images of spotted aptamers after rcDNA
hybridisation, 0.5 µM, 1 or 5 min UV exposure
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(a) 0.05 µM, 1 min, bright-field (b) 0.05 µM, 1 min, flurescence
(c) 0.05 µM, 5 min, bright-field (d) 0.05 µM, 5 min, flurescence
Figure A.5: Bright-field and fluorescent images of spotted aptamers after rcDNA
hybridisation, 0.05 µM, 1 or 5 min UV exposure
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A.11 Protocol for ELASA based hybridisation
assay for examining the UV immobilisation
of aptamers on polymer substrates
Material list
• Aptamers, at least two di erent sequences (e.g. VP1T (see appendix B.2) and
SMV25 (see appendix B.3))
• rcDNA to aptamers with a 5’ end biotin tag (e.g. rcVP1T or rcSMV25)
• Aptamer dilution bu er: 0.15 M Sodium phosphate bu er with 0.004 % triton
X
• 96 well plates
• Stratalinker 2400, Stratagene, CA, USA
• HRP-Conjugate Streptavidin (Thermo Fisher Scientific)
• Hybridisation bu er: PerfectHyb Plus Hybridization Bu er
• Tris bu ered saline (TBS): 50 mM Tris Base, 140 mM NaCl, 36 mM HCl, pH
between 7.2-7.8
• Wash bu er: TBS with 0.05 % Tween 20, pH 8.0
• Blocking solution: TBS with 1 % bovine serum albumin (BSA)
• Conjugate dilution bu er: TBS with 1 % BSA, 0.05 % Tween 20, pH 8.0
• Stop solution: 2 M H2SO4
• TMB: substrate: 1-step Ultra TMB-ELISA (Thermo Fisher Scientific)
• Plate reader: Victor3 from Perkin Elmer
Equilibrate TMB substrate to room temperature before usage.
Protocol
1. Design a plate layout for the experiment, see figure A.6 for an example of plate
layout.
2. Dilute aptamers in Aptamer dilution bu er according to the concentrations
needed in the plate layout. Dispense 5 µL aptamer solution into each well
according to plate layout. Dispense 5 µL Aptamer dilution bu er in the Bu er
Control wells. Leave wells to dry in a oven heated to 60 ¶ C.
3. Illuminate well plates to UV light with the Stratalinker 2400 for the desired
amount of time.
4. Wash well plates 3 times with Wash bu er, 250 µL/well.
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SUBSTRATES 1675. Block wells with Blocking solution, 250 µL/well, for 30 min at room temper-
ature
6. Wash well plates 3 times with Wash bu er, 250 µL/well.
7. Dilute rcDNA in Hybridisation bu er according to the concentrations in the
plate layout. Add 30 µL/well, incubate for 60 min at 37 ¶ C.
8. Wash well plates 3 times with Wash bu er, 250 µL/well.
9. Dilute HRP-Conjugate Streptavidin in Conjugate dilution bu er (1:10000).
Add 50 µL/well, incubate for 60 min at room temperature.
10. Wash well plates 5 times with Wash bu er, 250 µL/well.
11. Add TMB substrate to all wells, 100 µL/well, incubate for 15 min at room
temperature.
12. Stop reaction by adding 100 µL/well of stop solution.
13. Measure absorbance at 450 nm, 0.1 s, with the plate reader.
14. Process and analyse results by calculating the average background signal (sig-
nal of the Bu er Control wells). Subtract the background signal from all wells.
Colour the wells according to the background signal value (no colour) and the
highest absorbance value (dark colour).
Figure A.6: Example of plate layout for UV ELISA
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A.11.1 OD data values of ELASA based hybridisation
assay for examining the UV immobilisation of
aptamers on polymer substrates
The data presented in this section is data acquired by the plate reader of the ELASA
experiments. The background of the controls have been subtracted the data values
of each plate. The background value is listed below each plate. Each plate was
coloured individually. The plate were coloured by the "New Formatting Roule",
2-Color scale, minimum: background value (white) and maximum: Highest Value
(dark orange) in Microsoft Excel 2016. The numbers in the tables are the optical
density (OD) measured at 450 nm, 0.1 s.
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1	µM 100	nM 10	nM 1	µM 100	nM 10	nM blank blank
1µM 1,962 1,725 0,728 -0,141 0,766 -0,161 0,129 -0,177
100	nM 1,947 1,422 0,369 -0,059 -0,187 -0,201 -0,188 0,422
10	nM 1,915 1,402 0,225 -0,168 -0,202 -0,201 0,298 -0,147
1	nM 0,940 0,661 0,091 1,347 -0,187 -0,189 0,375 -0,200
1µM -0,188 -0,188 -0,198 1,903 1,095 0,025 -0,184 -0,192
100	nM -0,110 -0,182 -0,198 1,930 1,090 0,025 0,319 -0,197
10	nM -0,151 1,378 -0,192 1,907 1,119 0,149 0,269 -0,138
1	nM -0,149 -0,172 -0,197 1,344 0,697 -0,036 -0,191 -0,193
Subtracted	average	background		-	blank 0,244
Plate	2 Dry No	UV
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM blank blank
1µM 1,783 0,793 1,228 0,034 0,009 0,006 0,028 0,019
100	nM 1,960 0,634 0,126 0,033 -0,007 -0,007 -0,009 0,000
10	nM 2,025 0,679 0,148 -0,008 -0,006 -0,005 -0,010 0,000
1	nM 1,359 0,616 0,110 -0,005 -0,005 0,009 -0,005 -0,006
1µM 0,029 0,000 -0,004 1,188 0,344 0,058 -0,004 -0,001
100	nM 0,022 0,020 -0,001 1,346 0,393 0,060 -0,006 -0,002
10	nM 0,002 0,012 0,003 0,867 0,314 0,031 -0,005 -0,005
1	nM -0,003 0,019 0,005 1,280 0,295 0,049 0,007 0,002
Subtracted	average	background		-	blank 0,052
cVP1
VP1T
cVP1
cSMV25
cSMV25
SMV25
VP1T SMV25
Plate	3 liquid UV
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM blank blank
1µM 0,127 -0,046 0,590 0,837 0,945 -0,069 -0,052 -0,072
100	nM -0,019 0,023 0,062 0,063 0,001 -0,077 -0,078 -0,080
10	nM -0,055 -0,072 0,602 -0,062 -0,048 -0,075 -0,064 -0,050
1	nM -0,045 -0,068 0,010 -0,047 -0,069 -0,077 -0,032 0,425
1µM -0,049 -0,081 0,285 0,399 0,713 -0,060 -0,062 -0,042
100	nM -0,065 -0,076 0,440 -0,031 0,762 0,254 0,200 0,150
10	nM -0,074 -0,067 -0,072 -0,042 -0,062 -0,053 -0,080 -0,002
1	nM -0,044 -0,076 -0,077 -0,023 -0,052 -0,083 -0,076 -0,082
Subtracted	average	background		-	blank 0,125
Plate	4 liquid No	UV
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM blank blank
1µM -0,018 0,208 -0,012 -0,023 -0,043 0,009 0,003 -0,043
100	nM -0,014 -0,048 -0,060 -0,034 -0,052 0,085 0,143 -0,062
10	nM -0,026 -0,056 -0,045 -0,050 -0,052 0,008 0,127 -0,066
1	nM -0,035 -0,064 -0,063 -0,054 -0,054 -0,037 0,217 -0,064
1µM -0,058 -0,036 -0,051 -0,052 -0,041 0,643 -0,039 -0,037
100	nM 0,002 -0,021 -0,036 -0,062 -0,061 0,491 -0,043 -0,067
10	nM 0,057 -0,045 -0,061 -0,049 -0,053 -0,056 -0,061 -0,067
1	nM -0,052 -0,056 -0,056 -0,063 0,337 0,328 0,014 0,050
Subtracted	average	background		-	blank 0,107
VP1T SMV25
cVP1
cSMV25
VP1T SMV25
cVP1
cSMV25
Figure A.7: Data: Comparison of UV immobilisation in wet or dry stage in
Nunclon plates. Two aptamers were tested: VP1T and SMV25. cVP1 and cSMV25
represents the biotinylated rcDNA strands of VP1T and SMV25, respectively
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Plate	#1	-	PEDOT:PSS,	Nunclon	plate,	UV	exposure,	no	plasma	treatment
10	nM 100	nM 1	µM 10	nM 100	nM 1	µM control control
cVP1T 1	µM 0,022 0,011 0,003 0,012 0,072 0,681 -0,005 0,019
Biotin 100	nM -0,001 -0,008 -0,003 0,001 0,379 1,011 0,002 0,003
10	nM -0,010 -0,007 -0,004 0,001 0,048 0,377 0,011 0,017
1	nM -0,007 -0,009 -0,021 -0,010 0,129 0,008 0,001 0,006
cSMV25 1	µM -0,006 0,048 0,220 -0,010 -0,012 -0,006 -0,004 0,007
Biotin 100	nM -0,009 0,014 0,387 -0,012 -0,007 -0,019 -0,005 0,011
10	nM -0,006 0,001 0,307 -0,006 -0,007 -0,010 -0,003 -0,019
1	nM -0,013 0,011 0,120 -0,016 -0,018 -0,024 -0,024 -0,016
Subtracted	average	background		-	blank 0,085
Plate	#2	-	PEDOT:PSS,	Nunclon	plate,	NO	UV	exposure,	no	plasma	treatment
10	nM 100	nM 1	µM 10	nM 100	nM 1	µM control control
cVP1T 1	µM 0,014 0,005 0,009 0,006 0,036 0,303 0,018 0,027
Biotin 100	nM -0,007 0,000 0,000 -0,004 0,077 0,354 -0,007 -0,004
10	nM -0,006 0,004 -0,005 -0,007 0,017 0,161 0,011 0,007
1	nM -0,011 -0,010 -0,006 0,010 0,021 0,019 -0,005 -0,003
cSMV25 1	µM -0,006 0,038 0,310 -0,007 -0,004 -0,005 0,004 0,020
Biotin 100	nM -0,008 0,004 0,161 -0,024 -0,007 -0,014 -0,007 0,004
10	nM -0,007 0,002 0,146 -0,014 -0,001 -0,013 -0,019 0,000
1	nM -0,017 -0,005 0,115 -0,021 -0,019 -0,022 -0,016 -0,030
Subtracted	average	background		-	blank 0,082
Plate	#3	-	Nunclon	plate,	UV	exposure,	no	plasma	treatment
10	nM 100	nM 1	µM 10	nM 100	nM 1	µM control control
cVP1T 1	µM 0,007 0,031 0,026 0,487 1,915 2,138 0,001 0,004
Biotin 100	nM 0,003 0,004 0,005 0,702 1,731 2,135 0,002 -0,001
10	nM -0,001 0,006 0,014 0,537 1,950 2,121 0,005 -0,002
1	nM -0,002 0,002 0,006 0,469 0,839 0,928 -0,002 -0,001
cSMV25 1	µM 0,303 1,480 2,126 0,001 0,001 0,001 0,000 0,003
Biotin 100	nM 0,276 1,465 2,103 -0,003 -0,003 -0,002 -0,002 0,000
10	nM 0,287 1,480 2,067 -0,004 -0,002 -0,003 -0,004 -0,003
1	nM 0,209 0,932 1,482 -0,002 -0,001 0,049 0,004 -0,003
Subtracted	average	background		-	blank 0,042
SMV25 VP1T Blank
SMV25 VP1T Blank
SMV25 VP1T Blank
Figure A.8: Data: ELASA experiments on Nunclon plate, PolySorp plate and
Nunclon plate with PEDOT:PSS, plates 1-3
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Plate	#4	-	Nunclon	plate,	NO	UV	exposure,	no	plasma	treatment
10	nM 100	nM 1	µM 10	nM 100	nM 1	µM control control
cVP1T 1	µM 0,005 0,011 0,008 0,178 0,785 1,932 0,006 0,005
Biotin 100	nM -0,003 -0,003 -0,002 0,155 0,823 2,008 -0,003 -0,002
10	nM -0,002 -0,002 0,000 0,188 1,035 2,055 -0,004 -0,001
1	nM -0,002 -0,002 -0,002 0,198 0,756 1,061 -0,003 -0,002
cSMV25 1	µM 0,082 0,421 1,415 0,000 -0,002 -0,001 -0,001 -0,001
Biotin 100	nM 0,082 0,358 1,339 -0,002 -0,002 0,001 -0,002 0,004
10	nM 0,072 0,466 1,648 -0,001 -0,003 0,000 -0,001 -0,002
1	nM 0,040 0,256 1,128 -0,002 -0,002 -0,002 -0,002 0,001
Subtracted	average	background		-	blank 0,041
Plate	#5	-	Polysorb	plate,UV	exposure,	no	plasma	treatment
10	nM 100	nM 1	µM 10	nM 100	nM 1	µM control control
cVP1T 1	µM 0,006 0,006 0,009 0,103 0,482 1,165 0,006 0,009
Biotin 100	nM -0,001 0,003 0,007 0,127 0,559 1,220 -0,002 -0,001
10	nM -0,002 -0,001 0,006 0,093 0,520 1,299 -0,003 -0,002
1	nM 0,000 0,005 0,006 0,063 0,156 0,267 -0,003 -0,002
cSMV25 1	µM 0,030 0,576 0,782 0,000 0,000 0,000 0,000 0,000
Biotin 100	nM 0,037 0,486 0,746 -0,002 0,010 -0,001 -0,001 -0,002
10	nM 0,033 0,586 0,822 0,001 0,003 0,002 0,002 -0,002
1	nM 0,043 0,301 0,427 0,002 0,004 -0,001 -0,001 -0,001
Subtracted	average	background		-	blank 0,039
Plate	#6	-	Polysorb	plate,NO	UV	exposure,	no	plasma	treatment
10	nM 100	nM 1	µM 10	nM 100	nM 1	µM control control
cVP1T 1	µM 0,01 0,01 0,01 0,01 0,02 0,20 0,00 0,01
Biotin 100	nM 0,01 0,01 0,00 0,01 0,01 0,21 0,00 0,00
10	nM 0,00 0,00 0,00 0,00 0,01 0,17 0,00 0,00
1	nM 0,00 0,00 0,00 0,00 0,02 0,11 0,00 0,00
cSMV25 1	µM 0,01 0,00 0,02 0,00 0,00 0,00 0,01 0,00
Biotin 100	nM 0,00 0,01 0,01 0,00 0,00 0,00 0,00 0,00
10	nM 0,00 0,00 0,02 0,00 0,00 0,00 0,01 0,00
1	nM 0,00 0,01 0,03 0,00 0,00 0,00 0,00 0,00
Subtracted	average	background		-	blank 0,04
SMV25 VP1T Blank
SMV25 VP1T Blank
SMV25 VP1T Blank
Figure A.9: Data: ELASA experiments on Nunclon plate, PolySorp plate and
Nunclon plate with PEDOT:PSS, plates 4-6
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Plate	#1	-	PEDOT:PSS,	Polysorb	plate,	CT-tag,	UV	exposure,	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,267 0,054 -0,006 0,000 -0,012 -0,005 -0,003 0,006
Biotin 100	nM 0,853 0,076 0,004 -0,006 0,001 -0,005 0,002 -0,007
10	nM 0,217 0,150 0,023 -0,001 -0,006 0,002 -0,008 0,008
1	nM 0,015 0,009 0,004 -0,001 0,003 0,000 0,005 -0,003
cSMV25 1	µM 0,000 -0,011 -0,001 0,268 0,014 0,008 0,000 -0,001
Biotin 100	nM -0,009 -0,011 -0,001 0,258 -0,012 0,010 0,001 -0,008
10	nM -0,007 -0,005 -0,002 0,208 -0,012 0,001 0,000 -0,001
1	nM -0,015 -0,003 -0,008 0,020 -0,021 0,007 0,008 -0,004
Subtracted	average	background		-	blank 0,072
Plate	#2	-	PEDOT:PSS,	Polysorb	plate,	CT-tag,	NO	UV	exposure,	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,200 0,003 -0,013 -0,011 -0,004 -0,006 0,016 0,014
Biotin 100	nM 0,368 0,027 0,004 0,008 0,008 0,000 0,000 -0,002
10	nM 0,062 0,036 0,004 -0,007 0,001 0,015 -0,008 0,001
1	nM -0,014 0,002 0,005 0,001 -0,016 -0,006 0,000 0,000
cSMV25 1	µM -0,023 -0,013 -0,001 0,156 0,012 -0,012 -0,003 0,002
Biotin 100	nM -0,021 -0,018 0,004 0,064 0,008 -0,002 0,005 0,008
10	nM -0,016 -0,029 -0,008 0,118 0,000 -0,003 -0,016 -0,004
1	nM -0,030 -0,034 -0,003 0,002 -0,007 -0,021 -0,016 -0,006
Subtracted	average	background		-	blank 0,087
Plate	#3	-	PEDOT:PSS,	Polysorb	plate,	NO	CT-tag,	UV	exposure,	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,495 0,022 0,022 0,018 0,018 0,008 0,013 0,007
Biotin 100	nM 0,355 0,027 0,000 0,008 -0,001 0,008 0,002 0,006
10	nM 0,238 0,022 0,005 0,015 0,014 0,012 0,004 0,000
1	nM 0,012 0,002 0,002 0,004 0,009 0,003 0,001 0,005
cSMV25 1	µM 0,011 0,005 0,003 0,476 0,019 0,002 -0,001 0,015
Biotin 100	nM -0,015 -0,004 -0,005 0,393 0,026 0,001 -0,005 -0,010
10	nM -0,009 -0,009 -0,005 0,487 -0,002 0,003 -0,007 -0,010
1	nM -0,010 0,000 0,004 0,116 0,024 -0,005 -0,009 -0,005
Subtracted	average	background		-	blank 0,074
Plate	#4	-	PEDOT:PSS,	Polysorb	plate,	NO	CT-tag,	NO	UV	exposure,	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,701 0,062 0,003 -0,002 -0,008 0,036 0,003 0,008
Biotin 100	nM 0,115 0,009 -0,005 -0,002 -0,008 -0,011 -0,012 -0,010
10	nM 0,026 0,015 -0,003 0,000 -0,007 -0,009 0,014 -0,005
1	nM -0,004 -0,008 -0,011 -0,003 -0,004 0,001 0,002 -0,001
cSMV25 1	µM 0,001 -0,007 -0,004 0,204 0,034 0,018 -0,001 -0,003
Biotin 100	nM -0,006 0,001 0,004 0,220 0,060 -0,004 0,000 -0,004
10	nM -0,013 -0,011 -0,006 0,152 0,009 0,004 -0,004 0,001
1	nM -0,012 -0,014 0,007 -0,001 -0,012 -0,020 0,017 0,000
Subtracted	average	background		-	blank 0,084
VP1T SMV25 Blank
VP1T SMV25 Blank
VP1T SMV25 Blank
VP1T SMV25 Blank
Figure A.10: Data: ELASA experiments on PolySorp plate and PolySorp plate
with PEDOT:PSS, TC-tag / no TC-tag plates 1-4
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Plate	#5	-	Polysorb	plate,	CT-tag,	UV	exposure,	NO	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 1,263 0,107 0,014 0,003 0,002 0,004 0,003 0,002
Biotin 100	nM 0,880 0,192 0,016 0,001 -0,001 -0,001 0,003 -0,001
10	nM 0,785 0,164 0,018 0,003 0,000 -0,001 0,000 0,000
1	nM 0,214 0,056 0,012 0,002 0,001 -0,001 -0,001 0,000
cSMV25 1	µM 0,013 0,006 0,008 0,566 0,355 0,022 0,000 0,000
Biotin 100	nM 0,005 0,017 0,000 0,654 0,281 0,013 -0,001 0,000
10	nM 0,015 0,005 0,016 0,642 0,339 0,010 -0,001 0,002
1	nM 0,037 0,003 0,004 0,300 0,100 0,020 0,000 0,000
Subtracted	average	background		-	blank 0,037
Plate	#6	-	Polysorb	plate,	CT-tag,	NO	UV	exposure,	NO	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,072 0,018 0,022 0,000 -0,001 -0,001 0,003 -0,002
Biotin 100	nM 0,025 0,011 0,007 -0,002 -0,003 -0,003 0,002 -0,002
10	nM 0,055 0,000 -0,003 -0,003 -0,003 -0,003 -0,004 -0,002
1	nM 0,013 -0,002 -0,004 -0,003 0,005 -0,003 -0,003 0,005
cSMV25 1	µM 0,006 -0,001 0,010 0,002 -0,002 -0,002 -0,002 -0,001
Biotin 100	nM 0,004 0,010 0,004 0,020 0,014 0,001 -0,002 -0,002
10	nM 0,002 0,005 0,014 0,015 0,004 0,002 -0,002 0,001
1	nM 0,005 0,008 0,004 0,010 0,027 0,027 0,005 0,005
Subtracted	average	background		-	blank 0,040
Plate	#7	-	Polysorb	plate,	NO	CT-tag,	UV	exposure,	NO	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,241 0,016 0,007 0,001 0,001 0,002 0,001 0,003
Biotin 100	nM 0,282 0,012 -0,001 -0,001 -0,002 -0,001 -0,001 -0,002
10	nM 0,172 0,013 0,000 0,000 -0,001 -0,001 -0,002 -0,002
1	nM 0,137 0,017 0,005 0,002 -0,001 -0,001 -0,002 -0,001
cSMV25 1	µM 0,004 0,002 0,000 0,602 0,034 0,001 0,000 0,001
Biotin 100	nM 0,002 0,004 0,001 0,570 0,028 0,003 -0,001 0,000
10	nM 0,004 0,002 0,001 0,539 0,034 0,002 -0,001 -0,001
1	nM 0,004 0,004 0,002 0,182 0,019 0,004 0,001 0,000
Subtracted	average	background		-	blank 0,037
Plate	#8	-	Polysorb	plate,	NO	CT-tag,	NO	UV	exposure,	NO	plasma	treatment
1	µM 100	nM 10	nM 1	µM 100	nM 10	nM control control
cVP1T 1	µM 0,054 0,009 0,007 0,007 0,002 0,023 0,019 0,004
Biotin 100	nM -0,005 -0,005 0,032 0,008 -0,007 0,002 -0,006 0,019
10	nM -0,001 -0,006 -0,005 -0,005 -0,001 -0,003 -0,007 0,024
1	nM 0,002 -0,003 -0,005 -0,007 0,004 -0,007 -0,006 -0,006
cSMV25 1	µM 0,021 0,075 -0,006 -0,003 -0,002 -0,007 -0,007 -0,006
Biotin 100	nM 0,016 -0,004 0,000 0,006 -0,001 -0,004 0,000 0,000
10	nM 0,004 -0,002 0,000 0,013 -0,005 0,004 -0,005 -0,006
1	nM -0,006 -0,004 -0,002 0,003 -0,003 -0,006 -0,005 -0,005
Subtracted	average	background		-	blank 0,044
VP1T SMV25 Blank
VP1T SMV25 Blank
VP1T SMV25 Blank
VP1T SMV25 Blank
Figure A.11: Data: ELASA experiments on PolySorp plate and PolySorp plate
with PEDOT:PSS, TC-tag / no TC-tag plates 5-8
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Chip	plate	9+10,	PEDOT:PSS,	2	layers,	PC	chips,	CT-tag,	time	exp
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 0,099 0,098 0,085 0,078 0,025 -0,001 0,010 0,061 0,049 0,060
plate	#9 cSMV25 1	µM 0,007 0,001 0,080 -0,013 -0,094 0,016 -0,020 -0,028 0,002 -0,026
No	UV	(0	min) cVP1T 100	nM -0,018 -0,016 -0,026 -0,011 -0,037 0,032 -0,028 -0,022 -0,024 -0,019
cSMV25 100	nM -0,015 -0,019 -0,023 -0,021 -0,042 -0,011 -0,032 -0,029 -0,031 -0,029
Chip	 cVP1T 1	µM 0,188 0,152 0,134 0,096 0,063 0,138 0,116 0,146 0,138 0,238
plate	#10 cSMV25 1	µM 0,037 -0,014 -0,001 0,006 -0,081 -0,023 -0,026 -0,015 -0,010 -0,013
UV	(1	min) cVP1T 100	nM 0,044 0,046 -0,002 -0,030 -0,016 -0,012 -0,017 0,017 0,006 0,026
cSMV25 100	nM 0,166 -0,034 -0,028 -0,031 -0,032 0,037 -0,025 -0,018 -0,022 -0,023
Subtracted	average	background		-	blank 0,128
Chip	plate	11+12,	PEDOT:PSS,	2	layers,	PC	chips,	CT-tag,	time	exp
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 0,265 0,257 0,128 0,077 0,064 0,030 0,090 0,116 0,074 0,185
plate	#11 cSMV25 1	µM -0,032 -0,036 -0,029 -0,031 -0,017 0,074 0,002 -0,022 -0,022 -0,015
UV	(5	min) cVP1T 100	nM 0,320 0,013 -0,035 -0,025 -0,042 -0,042 -0,051 -0,036 -0,045 -0,029
cSMV25 100	nM -0,047 -0,054 -0,055 -0,054 -0,065 -0,002 -0,011 -0,051 -0,056 -0,050
Chip	 cVP1T 1	µM 0,156 0,317 0,228 0,078 0,022 0,018 0,013 0,017 0,082 0,108
plate	#12 cSMV25 1	µM 0,014 -0,009 -0,003 -0,028 -0,036 0,168 0,198 0,001 -0,006 0,017
UV	(10	min) cVP1T 100	nM 0,061 0,036 -0,033 -0,051 -0,038 -0,008 -0,042 -0,040 -0,037 -0,026
cSMV25 100	nM -0,071 -0,018 0,008 -0,038 -0,039 0,022 0,044 -0,038 -0,046 -0,046
Subtracted	average	background		-	blank 0,148
Chip	plate	13+14,	PC	chips,	CT-tag,	time	exp
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 0,410 0,480 0,050 0,004 -0,006 -0,005 -0,007 -0,004 -0,006 0,001
plate	#13 cSMV25 1	µM 0,108 0,017 -0,001 -0,003 -0,006 0,131 0,054 -0,001 -0,004 0,001
No	UV	(0	min) cVP1T 100	nM 0,984 0,519 0,042 0,020 -0,005 0,022 -0,006 -0,003 -0,005 0,002
cSMV25 100	nM 0,135 0,000 -0,006 -0,006 -0,006 0,155 0,034 0,005 -0,003 0,009
Chip	 cVP1T 1	µM 1,146 0,756 0,098 0,014 -0,006 0,061 -0,003 -0,003 -0,004 0,001
plate	#14 cSMV25 1	µM 0,216 0,660 0,015 -0,007 -0,005 0,521 0,283 0,031 -0,001 -0,005
UV	(1	min) cVP1T 100	nM 1,234 0,878 0,096 0,002 -0,003 0,105 0,018 0,005 0,067 0,008
cSMV25 100	nM 0,181 -0,003 0,000 0,010 0,021 0,554 0,478 0,062 0,001 0,002
Subtracted	average	background		-	blank 0,049
Chip	plate	15+16,	PC	chips,	CT-tag,	time	exp
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 1,254 1,235 0,938 0,142 -0,009 0,096 -0,002 -0,008 -0,009 -0,006
plate	#15 cSMV25 1	µM 0,166 0,316 0,001 -0,004 -0,008 0,915 0,993 0,468 0,021 -0,008
UV	(5	min) cVP1T 100	nM 0,939 1,353 1,084 0,140 -0,008 0,421 0,000 -0,008 -0,006 -0,008
cSMV25 100	nM 0,030 0,003 0,011 -0,002 -0,008 0,771 0,922 0,490 0,088 -0,004
Chip	 cVP1T 1	µM 1,483 1,302 0,990 0,163 0,008 0,122 0,057 0,012 0,008 0,019
plate	#16 cSMV25 1	µM 0,138 0,162 0,079 0,004 0,001 0,838 0,769 0,238 0,091 0,008
UV	(10	min) cVP1T 100	nM 1,328 1,176 0,848 0,247 0,005 0,067 0,023 0,005 0,002 0,001
cSMV25 100	nM 0,011 0,017 0,044 0,008 0,000 0,825 0,836 0,436 0,081 0,014
Subtracted	average	background		-	blank 0,052
VP1T SMV25
VP1T SMV25
VP1T SMV25
VP1T SMV25
Figure A.12: Data: PC chips with/ without 2 layers PEDOT:PSS, UV exposure
time dependence. First repetition
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Chip	plate	1+2,	PEDOT:PSS,	1	layer,	PC	chips,	CT-tag
Blank Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer Buffer 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,095 0,287 0,173 0,117 0,183 0,110 0,080 0,075 0,100 0,412
plate	#1 cVP1T 100	nM -0,044 0,070 0,018 -0,025 -0,015 -0,061 -0,043 -0,050 -0,051 0,020
No	UV	 cSMV25 1	µM -0,052 -0,064 -0,066 -0,068 -0,047 -0,061 -0,014 -0,035 -0,061 -0,016
cSMV25 100	nM -0,073 -0,077 -0,077 -0,074 -0,055 -0,078 -0,032 -0,073 -0,076 -0,060
Chip	 cVP1T 1	µM 0,786 0,663 0,229 0,082 0,029 0,056 0,085 0,024 0,017 0,088
plate	#2 cVP1T 100	nM 0,328 0,513 0,125 -0,044 -0,033 -0,067 -0,069 -0,063 -0,062 -0,011
1	min	UV cSMV25 1	µM -0,065 -0,072 -0,066 -0,077 -0,073 -0,068 0,274 0,025 -0,054 -0,060
cSMV25 100	nM -0,078 -0,079 -0,078 -0,081 -0,064 -0,066 0,254 -0,003 -0,071 -0,074
Subtracted	average	background		-	blank 0,122
Chip	plate	3+4,	PEDOT:PSS	(1	layer	-	applied	with	paint	applicator),	Polycarbonate	chips,	CT-tag
Blank Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer Buffer 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,348 0,185 0,145 0,098 0,091 0,282 0,154 0,045 0,063 0,213
plate	#3 cVP1T 100	nM -0,009 0,068 0,006 -0,062 -0,015 0,019 -0,070 -0,086 -0,061 -0,002
5	min	UV cSMV25 1	µM -0,029 -0,076 -0,079 -0,082 -0,064 -0,104 0,995 0,677 -0,018 -0,088
cSMV25 100	nM -0,093 -0,104 -0,106 -0,108 -0,101 -0,112 0,915 0,303 -0,041 -0,107
Chip	 cVP1T 1	µM 0,443 0,187 0,252 0,190 0,108 0,222 0,084 0,005 0,059 0,235
plate	#4 cVP1T 100	nM 0,207 0,088 0,037 -0,022 -0,033 -0,057 -0,061 -0,077 -0,060 -0,008
10	min	UV cSMV25 1	µM -0,091 -0,102 -0,099 -0,107 -0,067 -0,085 0,407 0,035 -0,049 -0,029
cSMV25 100	nM -0,102 -0,119 -0,119 -0,118 -0,103 -0,104 0,089 0,005 -0,099 -0,098
Subtracted	average	background		-	blank 0,162
Chip	plate	5+6,	PEDOT:PSS	(2	layers	-	applied	with	paint	applicator),	Polycarbonate	chips,	CT-tag
Blank Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer Buffer 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,474 0,061 0,093 0,105 0,047 0,215 0,085 0,054 0,052 0,055
plate	#5 cVP1T 100	nM -0,043 -0,065 -0,069 -0,078 0,102 -0,051 -0,067 -0,079 -0,083 0,014
No	UV	 cSMV25 1	µM -0,108 -0,077 -0,102 -0,107 -0,103 -0,073 -0,090 -0,094 -0,098 -0,086
cSMV25 100	nM -0,109 -0,112 -0,116 -0,114 -0,114 -0,110 -0,111 -0,115 -0,117 -0,085
Chip	 cVP1T 1	µM 0,142 0,018 0,037 0,038 0,217 0,086 0,025 0,066 0,098 0,388
plate	#6 cVP1T 100	nM -0,045 -0,059 -0,062 -0,066 -0,003 -0,004 -0,072 -0,068 -0,070 0,043
1	min	UV cSMV25 1	µM -0,090 -0,089 -0,103 -0,103 -0,090 -0,070 -0,086 -0,093 -0,103 -0,078
cSMV25 100	nM -0,114 -0,118 -0,119 -0,123 -0,089 -0,103 -0,108 -0,112 -0,103 -0,109
Subtracted	average	background		-	blank 0,190
VP1T SMV25
VP1T SMV25
VP1T SMV25
Figure A.13: Data: PC chips with/ without 1 or 2 layers PEDOT:PSS, UV
exposure time dependence. Second repetition
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Chip	plate	7+8,	PEDOT:PSS	(2	layers	-	applied	with	paint	applicator),	Polycarbonate	chips,	CT-tag
Blank Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer Buffer 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,134 0,149 0,091 0,001 0,163 -0,036 -0,009 -0,059 -0,073 0,055
plate	#7 cVP1T 100	nM -0,019 0,056 0,012 -0,120 -0,055 -0,097 -0,105 -0,092 -0,105 -0,030
5	min	UV cSMV25 1	µM -0,110 -0,116 -0,112 -0,122 -0,109 -0,071 -0,066 -0,062 -0,108 -0,072
cSMV25 100	nM -0,127 -0,139 -0,140 -0,140 -0,133 -0,109 0,022 -0,080 -0,111 0,033
Chip	 cVP1T 1	µM 0,340 0,179 0,186 0,181 0,431 0,228 0,197 0,211 0,184 0,424
plate	#8 cVP1T 100	nM 0,044 -0,025 -0,005 -0,053 0,008 -0,019 -0,058 -0,071 -0,032 -0,006
10	min	UV cSMV25 1	µM -0,085 -0,125 -0,123 -0,125 -0,092 -0,072 -0,088 -0,099 -0,110 -0,108
cSMV25 100	nM -0,134 -0,135 -0,134 -0,134 -0,087 -0,112 -0,098 -0,104 -0,129 -0,128
Subtracted	average	background		-	blank 0,208
Chip	plate	9+10,	Polycarbonate	chips,	CT-tag
Blank Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer Buffer 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,474 0,318 -0,001 -0,028 0,107 -0,017 -0,035 -0,037 -0,037 -0,030
plate	#9 cVP1T 100	nM 0,484 0,316 0,061 -0,021 -0,042 -0,006 -0,035 -0,035 -0,035 -0,019
No	UV	 cSMV25 1	µM -0,035 -0,034 -0,034 -0,033 0,042 -0,032 -0,026 -0,032 -0,034 0,044
cSMV25 100	nM -0,033 -0,032 -0,032 -0,031 0,182 -0,032 -0,024 -0,034 -0,033 0,041
Chip	 cVP1T 1	µM 0,490 0,390 0,158 -0,022 -0,032 -0,035 -0,041 -0,041 -0,040 -0,026
plate	#10 cVP1T 100	nM 0,447 0,441 0,209 0,031 0,007 -0,042 -0,042 -0,042 -0,041 -0,027
1	min	UV cSMV25 1	µM -0,042 -0,042 -0,041 -0,041 -0,040 -0,028 0,248 0,046 -0,034 0,075
cSMV25 100	nM -0,020 -0,041 -0,041 -0,041 -0,019 -0,027 0,315 0,004 -0,035 -0,044
Subtracted	average	background		-	blank 0,079
Chip	plate	11+12,	Polycarbonate	chips,	CT-tag
Blank Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer Buffer 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,816 0,871 0,971 0,621 -0,013 -0,005 -0,015 -0,015 -0,022 -0,002
plate	#11 cVP1T 100	nM 0,925 0,807 0,865 0,650 0,000 -0,013 -0,010 -0,019 -0,021 -0,008
5	min	UV cSMV25 1	µM 0,033 -0,020 -0,022 -0,021 -0,019 -0,020 0,819 0,770 0,430 0,063
cSMV25 100	nM -0,010 -0,022 -0,021 -0,020 -0,015 -0,009 0,775 0,665 0,438 0,025
Chip	 cVP1T 1	µM 0,971 0,880 0,948 0,563 0,065 0,022 -0,009 -0,015 -0,016 -0,003
plate	#12 cVP1T 100	nM 1,082 0,958 0,911 0,844 0,006 -0,007 -0,013 -0,017 -0,018 -0,004
10	min	UV cSMV25 1	µM -0,015 -0,016 0,011 -0,018 -0,016 -0,020 0,886 0,750 0,410 -0,017
cSMV25 100	nM -0,019 -0,017 -0,017 -0,019 0,013 -0,018 0,648 0,654 0,184 -0,010
Subtracted	average	background		-	blank 0,059
VP1T SMV25
VP1T SMV25
VP1T SMV25
Figure A.14: Data: PC chips with/ without 1 or 2 layers PEDOT:PSS, UV
exposure time dependence. Second repetition
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Chip	plate	1+2,	PEDOT:PSS,	1	layer,	PC	chips
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip cVP1T 1	µM 0,343 0,461 0,256 0,124 0,153 0,317 0,097 0,063 0,198 0,155
plate #1 cSMV25 1	µM 0,057 -0,033 -0,044 -0,043 -0,055 0,526 0,290 0,039 0,001 -0,027
UV cVP1T 100	nM 0,427 0,135 0,021 0,004 0,019 -0,041 -0,047 -0,055 -0,036 -0,046
cSMV25 100	nM 0,082 -0,022 -0,034 -0,035 -0,037 0,712 0,179 -0,014 -0,070 -0,062
Chip cVP1T 1	µM 0,407 0,247 0,182 0,130 0,062 0,270 0,186 0,174 0,065 0,072
plate #2 cSMV25 1	µM 0,042 -0,054 -0,031 -0,042 -0,022 0,179 0,035 -0,009 -0,047 -0,036
No UV cVP1T 100	nM 0,246 0,011 -0,016 -0,047 -0,004 -0,013 -0,058 -0,062 -0,058 -0,058
cSMV25 100	nM -0,030 -0,061 -0,063 -0,061 -0,054 0,033 -0,013 -0,068 -0,080 -0,067
Subtracted	average	background		-	blank 0,168
Chip	plate	3+4,	PC	chips
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip cVP1T 1	µM 1,378 1,101 0,738 0,028 -0,006 0,040 -0,005 -0,002 -0,006 -0,006
plate #3 cSMV25 1	µM 0,627 0,022 -0,007 -0,011 0,001 0,854 0,717 0,802 0,072 -0,006
UV cVP1T 100	nM 1,554 1,152 0,710 0,032 -0,008 0,058 -0,002 -0,003 -0,001 -0,001
cSMV25 100	nM 0,369 -0,008 -0,007 -0,012 -0,009 1,336 0,615 0,738 0,064 -0,001
Chip cVP1T 1	µM 0,277 0,028 -0,001 -0,004 0,004 0,012 -0,004 -0,003 -0,003 0,001
plate #4 cSMV25 1	µM 0,137 -0,005 -0,009 -0,007 -0,006 0,306 -0,002 0,001 -0,001 -0,001
No UV cVP1T 100	nM 0,611 0,027 -0,002 -0,004 -0,001 0,124 0,004 0,007 0,009 0,009
cSMV25 100	nM 0,673 -0,003 -0,005 -0,003 -0,001 0,119 0,009 0,012 0,019 0,029
Subtracted	average	background		-	blank 0,055
SMV25
VP1T SMV25
VP1T
Figure A.15: Data: PC chips with/ without 1 layer PEDOT:PSS, UV / no UV
exposure, with TC-tag. First repetition
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Chip	plate	1+2,	PEDOT:PSS,	2	layers,	PC	chips,	CT-tag
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 0,247 0,243 0,143 0,077 0,061 0,089 0,072 0,097 0,056 0,058
plate	#1 cSMV25 1	µM 0,033 -0,012 -0,014 -0,017 -0,027 0,167 0,037 0,001 -0,003 -0,010
UV	(5	min) cVP1T 100	nM 0,186 0,113 0,038 -0,012 -0,034 -0,011 -0,042 -0,037 -0,027 -0,015
cSMV25 100	nM -0,027 -0,037 -0,034 -0,031 -0,033 0,078 0,081 -0,022 -0,028 -0,032
Chip	 cVP1T 1	µM 0,110 0,091 0,089 0,140 0,082 0,061 0,061 0,074 0,084 0,138
plate	#2 cSMV25 1	µM 0,042 -0,005 0,032 -0,035 -0,080 -0,037 0,056 0,005 -0,003 -0,012
No	UV cVP1T 100	nM -0,002 -0,021 -0,022 0,007 -0,003 0,035 -0,010 -0,008 0,011 -0,012
cSMV25 100	nM 0,052 -0,043 -0,034 -0,042 -0,053 0,124 -0,021 -0,022 -0,030 -0,027
Subtracted	average	background		-	blank 0,139
Chip	plate	3+4,	PC	chips,	CT-tag	
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 1,599 1,325 1,026 0,289 0,005 0,068 0,012 0,011 0,004 0,007
plate	#3 cSMV25 1	µM 0,044 0,020 0,015 0,007 0,005 0,876 0,973 0,592 0,094 0,010
UV	(5	min) cVP1T 100	nM 1,127 1,246 1,045 0,248 -0,001 0,018 0,005 0,003 -0,002 0,002
cSMV25 100	nM 0,023 0,006 0,002 0,001 -0,004 0,908 0,991 0,673 0,105 0,000
Chip	 cVP1T 1	µM 0,442 0,478 0,020 -0,002 -0,007 0,085 -0,004 -0,003 -0,004 -0,003
plate	#4 cSMV25 1	µM 0,033 -0,006 -0,004 -0,009 0,001 0,249 0,073 0,008 -0,005 0,003
No	UV cVP1T 100	nM 0,429 0,546 0,019 0,004 -0,005 0,019 -0,008 -0,008 -0,008 -0,006
cSMV25 100	nM 0,013 -0,003 -0,003 -0,007 -0,006 0,141 0,052 -0,006 -0,008 -0,002
Subtracted	average	background		-	blank 0,053
Chip	plate	5+6,	PEDOT:PSS,	2	layers,	PC	chips,	NO	CT-tag
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 0,185 0,098 0,112 0,085 0,223 0,050 0,100 0,115 0,121 0,181
plate	#5 cSMV25 1	µM -0,025 -0,015 -0,010 -0,019 -0,120 -0,014 -0,011 -0,013 -0,016 0,004
UV	(5	min) cVP1T 100	nM 0,206 -0,021 -0,003 0,001 -0,031 0,022 -0,001 0,005 0,003 -0,003
cSMV25 100	nM -0,045 -0,050 -0,053 -0,055 -0,063 0,050 -0,022 -0,034 -0,032 -0,033
Chip	 cVP1T 1	µM 0,208 0,121 0,138 0,117 0,107 0,010 0,085 0,092 0,053 0,012
plate	#6 cSMV25 1	µM -0,006 -0,018 -0,017 -0,006 -0,035 0,058 -0,033 -0,013 -0,049 -0,053
No	UV cVP1T 100	nM 0,048 -0,037 -0,041 -0,015 -0,043 0,155 -0,031 -0,040 -0,025 -0,034
cSMV25 100	nM -0,017 -0,047 -0,051 -0,056 -0,050 0,025 -0,046 -0,048 -0,047 -0,063
Subtracted	average	background		-	blank 0,157
Chip	plate	7+8,	PC	chips,	NO	CT-tag	
Blank Blank
5	µM 1	µM 100	nM 10	nm Buffer 5	µM 1	µM 100	nM 10	nm Buffer
Chip	 cVP1T 1	µM 0,618 0,775 0,474 0,148 -0,004 0,025 0,001 -0,005 0,000 0,005
plate	#7 cSMV25 1	µM 0,245 0,003 0,015 -0,004 -0,004 0,924 0,655 0,263 0,018 -0,002
UV	(5	min) cVP1T 100	nM 0,572 0,722 0,569 0,161 0,038 0,010 0,000 -0,006 0,009 0,000
cSMV25 100	nM 0,023 -0,004 -0,005 0,001 0,003 0,965 0,776 0,382 0,013 -0,007
Chip	 cVP1T 1	µM 0,127 0,502 0,165 0,081 0,001 0,023 -0,004 -0,003 -0,001 -0,006
plate	#8 cSMV25 1	µM 0,017 0,009 -0,005 -0,008 -0,004 0,012 0,048 -0,002 -0,001 -0,004
No	UV cVP1T 100	nM 0,092 0,375 0,257 0,067 -0,005 0,126 -0,006 -0,005 -0,005 -0,005
cSMV25 100	nM 0,012 -0,007 -0,008 -0,008 -0,002 0,142 0,047 0,040 -0,005 -0,007
Subtracted	average	background		-	blank 0,051
VP1T SMV25
VP1T SMV25
VP1T SMV25
VP1T SMV25
Figure A.16: Data: PC chips with/ without 2 layers PEDOT:PSS, UV / no UV
exposure, with/without TC-tag. Second repetition
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Chip	plate	1+2,	PEDOT:PSS,	1	layer,	PC	chips,	CT-tag
Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer 10	µM 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,802 0,713 0,398 0,226 0,199 0,100 0,115 0,015 0,064 0,210
plate	#1 cSMV25 1	µM -0,056 -0,038 -0,043 -0,055 -0,035 0,857 1,027 0,721 0,056 0,023
UV	(5	min) cVP1T 100	nM 1,040 0,796 0,453 0,082 -0,026 -0,048 -0,052 -0,044 -0,041 -0,016
cSMV25 100	nM -0,057 -0,056 -0,070 -0,068 -0,062 0,942 1,073 0,630 -0,011 -0,059
Chip	 cVP1T 1	µM 0,301 0,266 0,269 0,070 0,025 0,099 0,035 0,045 0,037 0,093
plate	#2 cSMV25 1	µM -0,061 -0,058 -0,057 -0,060 -0,050 0,028 0,221 0,121 -0,041 -0,039
No	UV cVP1T 100	nM -0,009 0,069 0,022 -0,032 -0,045 -0,091 -0,051 -0,051 -0,056 -0,071
cSMV25 100	nM -0,066 -0,074 -0,072 -0,074 -0,075 0,004 0,169 0,013 -0,070 -0,065
Subtracted	average	background		-	blank 0,129
Chip	plate	3+4,	PEDOT:PSS,	2	layers,	PC	chips,	CT-tag
Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer 10	µM 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,460 0,396 0,333 0,187 0,096 0,004 0,046 0,033 0,058 0,120
plate	#3 cSMV25 1	µM 0,042 -0,004 -0,021 -0,043 -0,080 0,161 0,398 0,066 -0,024 -0,008
UV	(5	min) cVP1T 100	nM 0,195 0,322 0,139 -0,006 -0,049 -0,005 -0,010 -0,024 -0,043 -0,007
cSMV25 100	nM -0,024 -0,049 -0,055 -0,062 -0,063 0,018 0,123 0,014 -0,046 -0,044
Chip	 cVP1T 1	µM 0,153 0,164 0,137 0,070 0,112 0,063 0,027 0,036 0,016 0,084
plate	#4 cSMV25 1	µM -0,013 -0,033 -0,036 -0,040 -0,033 -0,018 -0,029 -0,031 -0,042 -0,037
No	UV cVP1T 100	nM -0,001 0,041 0,024 -0,038 -0,055 -0,039 -0,047 -0,047 -0,054 -0,026
cSMV25 100	nM -0,062 -0,053 -0,050 -0,057 -0,057 -0,040 -0,042 -0,050 -0,032 0,044
Subtracted	average	background		-	blank 0,141
Chip	plate	5+6,	PC	chips,	CT-tag
Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer 10	µM 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 1,269 1,054 0,806 0,676 -0,107 -0,067 -0,036 -0,057 -0,105 -0,107
plate	#5 cSMV25 1	µM -0,033 -0,079 -0,063 -0,100 -0,082 0,576 0,547 0,675 0,432 -0,107
UV	(5	min) cVP1T 100	nM 1,039 1,029 0,859 0,685 -0,105 -0,074 -0,102 -0,105 -0,105 -0,105
cSMV25 100	nM -0,082 -0,095 -0,097 -0,105 -0,101 0,602 0,532 0,559 0,403 -0,107
Chip	 cVP1T 1	µM 0,204 0,291 -0,054 -0,102 -0,109 -0,090 -0,107 -0,108 -0,107 -0,103
plate	#6 cSMV25 1	µM -0,042 -0,108 -0,104 -0,106 -0,108 -0,006 -0,046 -0,099 -0,096 -0,098
No	UV cVP1T 100	nM 0,322 0,170 0,040 -0,098 -0,109 -0,097 -0,109 -0,106 -0,103 -0,090
cSMV25 100	nM -0,099 -0,107 -0,108 -0,110 -0,093 -0,089 -0,046 -0,099 -0,093 -0,071
Subtracted	average	background		-	blank 0,148
VP1T SMV25
VP1T SMV25
VP1T SMV25
Figure A.17: Data: PC chips with/ without 1 or 2 layers PEDOT:PSS, UV / no
UV exposure, with/without TC-tag. Third repetition (part 1)
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Chip	plate	7+8,	PEDOT:PSS,	1	layer,	PC	chips,	NO	CT-tag
Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer 10	µM 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,435 0,642 0,303 0,079 0,031 0,021 0,011 0,007 0,013 0,220
plate	#7 cSMV25 1	µM -0,019 -0,046 -0,055 -0,059 -0,055 0,013 0,107 0,032 -0,034 0,017
UV	(5	min) cVP1T 100	nM 0,091 0,155 0,055 -0,028 -0,035 0,033 -0,056 -0,058 -0,055 -0,037
cSMV25 100	nM -0,049 -0,059 -0,050 -0,053 -0,047 0,277 0,746 0,191 -0,010 -0,050
Chip	 cVP1T 1	µM 0,882 0,351 0,136 0,069 0,158 -0,029 0,039 0,059 0,055 0,032
plate	#8 cSMV25 1	µM -0,036 -0,041 -0,042 -0,039 -0,005 0,003 0,133 0,035 -0,029 -0,044
No	UV cVP1T 100	nM -0,025 0,150 0,046 -0,012 -0,050 -0,033 -0,030 -0,040 -0,044 -0,042
cSMV25 100	nM -0,052 -0,053 -0,050 -0,050 -0,058 -0,030 -0,013 -0,033 -0,037 -0,039
Subtracted	average	background		-	blank 0,111
Chip	plate	9+10,	PEDOT:PSS,	2	layers,	PC	chips,	NO	CT-tag
Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer 10	µM 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,341 0,274 0,192 0,107 0,051 0,132 0,108 -0,009 -0,031 0,082
plate	#9 cSMV25 1	µM -0,020 -0,052 -0,054 -0,062 -0,029 0,144 0,024 0,047 -0,063 0,026
UV	(5	min) cVP1T 100	nM 0,068 0,147 0,118 -0,039 -0,023 -0,085 -0,029 -0,030 -0,036 -0,044
cSMV25 100	nM -0,077 -0,082 -0,082 -0,076 -0,063 0,019 0,017 -0,032 -0,054 0,087
Chip	 cVP1T 1	µM 0,023 0,007 0,005 0,004 0,028 0,018 -0,009 -0,030 -0,041 0,130
plate	#10 cSMV25 1	µM -0,005 -0,061 -0,062 -0,070 -0,045 -0,053 -0,024 -0,054 -0,073 -0,027
No	UV cVP1T 100	nM 0,029 -0,022 -0,031 -0,076 -0,026 0,018 -0,051 -0,058 -0,068 -0,041
cSMV25 100	nM -0,079 -0,090 -0,093 -0,091 -0,026 -0,018 -0,075 -0,080 -0,085 -0,077
Subtracted	average	background		-	blank 0,167
Chip	plate	11+12,	PC	chips,	NO	CT-tag
Blank Blank
10	µM 5	µM 1	µM 100	nm Buffer 10	µM 5	µM 1	µM 100	nm Buffer
Chip	 cVP1T 1	µM 0,251 0,355 0,214 0,029 -0,016 0,007 -0,004 -0,009 -0,014 0,014
plate	#11 cSMV25 1	µM 0,015 -0,017 -0,018 -0,019 -0,019 0,451 0,518 0,306 0,065 0,005
UV	(5	min) cVP1T 100	nM 0,363 0,296 0,209 0,010 0,001 0,022 -0,018 -0,018 -0,013 -0,012
cSMV25 100	nM 0,020 -0,018 -0,010 -0,017 -0,018 0,551 0,582 0,446 -0,010 0,060
Chip	 cVP1T 1	µM 0,020 0,000 0,004 -0,016 -0,018 -0,010 -0,016 -0,018 -0,017 -0,014
plate	#12 cSMV25 1	µM -0,015 -0,018 -0,017 -0,016 -0,010 -0,005 -0,004 0,000 -0,011 0,022
No	UV cVP1T 100	nM 0,021 0,013 0,015 -0,015 -0,021 -0,008 -0,018 -0,015 -0,017 -0,002
cSMV25 100	nM -0,018 -0,019 -0,017 -0,015 -0,011 -0,006 -0,010 -0,005 -0,013 0,032
Subtracted	average	background		-	blank 0,058
VP1T SMV25
VP1T SMV25
VP1T SMV25
Figure A.18: Data: PC chips with/ without 1 or 2 layers PEDOT:PSS, UV / no
UV exposure, with/without TC-tag. Third repetition (part 2)
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A.12 Data analysis with MATLAB of EIS data
from VersaStat
Matlab script for data analysis:
1 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Julie Kirkegaard, julki, Lyngby 2015 %
3 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
5 clear all
close all
7 clc
9 set(0,'defaultlinelinewidth',1.9)
set(0,'DefaultAxesFontSize',18)
11
%%
13 data = load('test_for_chapter_biosensors-no2.txt');
15 % Removing the first 100 points:
data = data(100:4350,:);
17
txtE1 = 'E1, Positive';
19 txtE2 = 'E2, Negative';
txtE3 = 'E3, Positive';
21 txtE4 = 'E4, Negative';
23 chipnr = 1;
25 %%% SAMPLE: 1 mM Penicillin in 1:10 PBS
% Sample change - point of sample change in data point column:
27 PBS1 = 1400;
Sample1 = 2260;
29 Sample2 = 3130;
Sample3 = 3900;
31
% plot:
33 % Real_Z = 15
% Img_Z = 16
35 % |Z| = 17
RIZ = 17; % R -> real, I -> img, Z -> |Z|
37
% Data columns:
39 %
% 1: Segment #
41 % 2: Point #
% 3: E(V)
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43 % 4: I(A)
% 5: elapsed Time(s) - Changed to start at t = 0 at injection of ...
first concentration measurement
45 % 6: ADC Sync Input(V)
% 7: Current Range
47 % 8: Status
% 9: e Applied(V)
49 % 10: Frequency(Hz)
% 11: E Real
51 % 12: E Imag
% 13: I Real
53 % 14: I Imag
% 15: Z Real
55 % 16: Z Imag
%%% 17: |Z| - Calculated
57 %%% 18: Phase(Z) - Calculated
59 data(:,17) = sqrt(data(:,15).^2 + data(:,16).^2);
data(:,18) = atan(data(:,16)./data(:,15)).*(180/pi);
61
data = data(2300:3300,:);
63
time = (data(:,5)-data(1,5))./60;
65
%% Extracting data from each electrode
67
% finding index numbers for each electrode
69 E1 = find (data(:,17) < 204.1e3 & data(:,17) > 203.5e3);
E2 = find (data(:,17) < 193.8e3 & data(:,17) > 193.4e3);
71 E3 = find (data(:,17) < 202.6e3 & data(:,17) > 202e3);
E4 = find (data(:,17) < 184.5e3 & data(:,17) > 182.7e3);
73
figure(1)
75 plot(time(:,1), data(:,RIZ)./1e3,'-or')
hold on
77 plot(time(E1,1), data(E1,RIZ)./1e3,'-b')
plot(time(E2,1), data(E2,RIZ)./1e3,'-m')
79 plot(time(E3,1), data(E3,RIZ)./1e3,'-g')
plot(time(E4,1), data(E4,RIZ)./1e3,'- k')
81 hold off
title('Raw data with overlay of extracted electrode specific data')
83 xlabel('Time [min]')
ylabel('|Z| [kOhm]')
85 legend('Raw data',txtE1,txtE2,txtE3,txtE4)
87 %% Moving average filter
89 % Simple average of data columns 11-18
window_size = 12;
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91 filter_E11 = tsmovavg(data(E1,11:18),'s',window_size,1);
filter_E22 = tsmovavg(data(E2,11:18),'s',window_size,1);
93 filter_E33 = tsmovavg(data(E3,11:18),'s',window_size,1);
filter_E44 = tsmovavg(data(E4,11:18),'s',window_size,1);
95 % sorting data
filter_E1 = data(E1,:); filter_E1(:,11:18) = filter_E11;
97 filter_E2 = data(E2,:); filter_E2(:,11:18) = filter_E22;
filter_E3 = data(E3,:);filter_E3(:,11:18) = filter_E33;
99 filter_E4 = data(E4,:);filter_E4(:,11:18) = filter_E44;
101 figure(2)
plot(1:length(E1), data(E1,RIZ),'-b')
103 hold on
plot(1:length(E2), data(E2,RIZ),'-m')
105 plot(1:length(E3), data(E3,RIZ),'-g')
plot(1:length(E4), data(E4,RIZ),'-k')
107 plot(1:length(E1), filter_E1(:,RIZ),'-r')
plot(1:length(E2), filter_E2(:,RIZ),'-r')
109 plot(1:length(E3), filter_E3(:,RIZ),'-r')
plot(1:length(E4), filter_E4(:,RIZ),'-r')
111 hold off
title(['Chip ',num2str(chipnr), ' - Extracted data with running ...
average'])
113 legend(txtE1,txtE2,txtE3,txtE4, 'Running average')
xlabel('data point')
115 ylabel('|Z|')
117 %% Removing drift
119 % t_E1 = 1:length(E1);
121 sdata_E1 = filter_E1(12:end,RIZ);
t_E1 = 1:length(E1);
123 detrend_E1 = detrend(sdata_E1);
trend_E1 = sdata_E1 - detrend_E1;
125
127 sdata_E2 = filter_E2(12:end,RIZ);
t_E2 = 1:length(E2);
129 detrend_E2 = detrend(sdata_E2);
trend_E2 = sdata_E2 - detrend_E2;
131
sdata_E3 = filter_E3(12:end,RIZ);
133 t_E3 = 1:length(E3);
detrend_E3 = detrend(sdata_E3);
135 trend_E3 = sdata_E3 - detrend_E3;
137 sdata_E4 = filter_E4(12:end,RIZ);
t_E4 = 1:length(E4);
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139 detrend_E4 = detrend(sdata_E4);
trend_E4 = sdata_E4 - detrend_E4;
141
143 figure(222)
plot(1:length(E1), data(E1,RIZ),'-r')
145 hold on
plot(t_E1(12:end),sdata_E1,'-b');
147 plot(t_E1(12:end),trend_E1,':r')
149 plot(1:length(E2), data(E2,RIZ),'-r')
plot(t_E2(12:end),sdata_E2,'-m');
151 plot(t_E2(12:end),trend_E2,':r')
153 plot(1:length(E3), data(E3,RIZ),'-r')
plot(t_E3(12:end),sdata_E3,'-g');
155 plot(t_E3(12:end),trend_E3,':r')
157 plot(1:length(E4), data(E4,RIZ),'-r')
plot(t_E4(12:end),sdata_E4,'-k');
159 plot(t_E4(12:end),trend_E4,':r')
legend('Original Data','Filtered data','Trend')
161 xlabel('data point')
ylabel('|Z|')
163
165 figure(223)
plot(t_E1(12:end),detrend_E1,'b')
167 hold on
plot(t_E2(12:end),detrend_E2,'m')
169 plot(t_E3(12:end),detrend_E3,'g')
plot(t_E4(12:end),detrend_E4,'k')
171 title(['Chip ',num2str(chipnr), ' - Data with removed drift'])
legend(txtE1,txtE2,txtE3,txtE4)
173 xlabel('data point')
ylabel('|Z|')
175 %% Normalizing data in percent
177 x_E1 = detrend_E1(1:100,:);
x_E1_all = abs(min(detrend_E1(:,:)))+detrend_E1(:,:) ;
179 x_E1_null = abs(min(x_E1))+x_E1
m_E1 = mean(x_E1_null);
181 normP_E1 = 100 .* (x_E1_all-m_E1) ./ m_E1;
183 x_E2 = detrend_E2(1:100,:);
x_E2_all = detrend_E2(:,:);
185 m_E2 = mean(x_E2);
187 normP_E2 = 100 .* (x_E2_all-m_E2) ./ m_E2;
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189 x_E3 = detrend_E3(1:100,:);
x_E3_all = detrend_E3(:,:);
191 m_E3 = mean(x_E3);
normP_E3 = 100 .* (x_E3_all-m_E3) ./ m_E3;
193
x_E4 = detrend_E4(1:100,:);
195 x_E4_all = detrend_E4(:,:);
m_E4 = mean(x_E4);
197 normP_E4 = 100 .* (x_E4_all-m_E4) ./ m_E4;
199 figure(3)
plot( 1:length(normP_E1), normP_E1(:,1), '-b')
201 hold on
plot( 1:length(normP_E2), normP_E2(:,1), '-m')
203 plot( 1:length(normP_E3), normP_E3(:,1), '-g')
plot( 1:length(normP_E4), normP_E4(:,1), '-k')
205 hold off
legend(txtE1,txtE2,txtE3,txtE4)
207 title(['Chip ',num2str(chipnr), ' - EIS detection of 1 mM penicillin'])
xlabel('Number of data points')
209 ylabel('Relative change in percent [%]')
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Figure A.19: MATLAB figure output for EIS data analysis
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A.13 Plotting of model and data by MATLAB
Matlab script for plotting of model and data:
1 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Julie Kirkegaard, julki, Lyngby 2016 %
3 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
clear all
5 close all
clc
7
set(0,'defaultlinelinewidth',1.9)
9 set(0,'DefaultAxesFontSize',25)
%% Loading data and calculate the phase and modulus
11 data_E3 = load('sweep_e4_1-1000_pbs_2_matlab.txt');
13 %Modulus and phase of data
data_E3(:,7) = abs(data_E3(:,3) + 1i*data_E3(:,4));
15 data_E3(:,8) = angle(data_E3(:,3) + 1i*data_E3(:,4)).*(180/pi);
17 % column explanation of data:
% 1 Number
19 % 2 Frequency/Hz
% 3 impedance R/Ohm
21 % 4 impedance I/Ohm
% 5 Significance
23 % 6 Time/s
% 7 Modulus
25 % 8 Phase
27 %% Simulation
% elements from simulation
29 C1 = 1.16e-9;
R1 = 61e3;
31 R2 = 190e3;
W = 1.1e6;
33 CPE1 = 3.7e-6;
n1 = 0.93;
35
freq = data_E3(:,2);
37
%impedance of the elements
39 Z_C1 = 1./(1i*freq*C1);
Z_W = W * freq.^(-1/2) *(1-1i);
41 Z_CPE1 = 1./((1i*freq).^n1 *CPE1);
43 %impedance of parallel connections
Z_C1_R2 = 1 ./ (1./Z_C1 + 1/R2);
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45 Z_R1_W1 = 1 ./ (1/R1 + 1 ./ (Z_W) );
47 % total impedance
Z_total = Z_C1_R2 + Z_R1_W1 + Z_CPE1;
49
% components of total impedance
51 Z_real = real(Z_total);
Z_img = imag(Z_total);
53 Z_mod = sqrt(Z_real(:,1).^2 + Z_real(:,1).^2);
Z_phase = atan(Z_img(:,1)./Z_real(:,1)).*(180/pi);
55
%%
57 freq_range = [1:46]; % frequency index range plotted
59 figure(1)
h(1) = plot( data_E3(freq_range,3)/1000 , ...
-1*data_E3(freq_range,4)/1000,'-*b');
61 hold on
h(2) = plot( Z_real(freq_range,1)/1000 , ...
-1*Z_img(freq_range,1)/1000,'-*r');
63 set(gca,'DataAspectRatio',[1 1 1])
xlabel('Z_{Re} [kOhm]')
65 ylabel('- Z_{Im} [kOhm]')
legend('Data','Model')
67 ylim([0 520])
xlim([0 350])
69 hold off
71 figure(2)
semilogx( data_E3(freq_range,2) , data_E3(freq_range,7)/1000,'-*b')
73 hold on
semilogx( freq(freq_range,1) , Z_mod(freq_range,1)/1000,'-*r')
75 ylabel('|Z| [kOhm]')
xlabel('Frequency [Hz]')
77 legend('Data','Model')
xlim([0.5 100000])
79 hold off
81 figure(3)
semilogx( data_E3(freq_range,2) , data_E3(freq_range,8),'-*b')
83 hold on
semilogx( freq(freq_range,1) , Z_phase(freq_range,1),'-*r')
85 ylabel('Phase(Z) [Degree]')
xlabel('Frequency [Hz]')
87 legend('Data','Model')
xlim([0.5 100000])
89 hold off
B
Aptamer sequences
The aptamers listed here are the aptamers used in the experimental sections of the
thesis. The aptamer sequence is listed in bold and the modifications: TC-tag, spacer
and dye in normal font.
B.1 HNV-VP1
Sequence: TTTTTTTTTTCCCCCCCCCC /iSp12/GCCTCTTGTGAGCCTCCTAAC
GTCTGTAGTAGGGAGGATGGTCCGGGGCCCCGAGACGACGTTATCAGGCC
ATGCTTATTCTTGTCTCCC [7]
B.2 VP1T
Sequence: TTTTTTTTTTCCCCCCCCCC /iSp12/GTCTGTAGTAGGGAGGATGG
TCCGGGGCCCCGAGACGACGTTATCAGGC [7]
B.3 SMV-25
Sequence: TTTTTTTTTTCCCCCCCCCC /iSp12/CATCTGTGTGAAGACTATATGG
CGCTCACATATTTCTTTC [8]
B.4 A22-trunk aptamer
Sequence: TTTTTTTTTTCCCCCCCCCC /iSp12/CTGAGTCTCAAAACCGC
AATACACTGGTTG [45]
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B.5 Amp3
Sequence: ATTO550/TTTTTTTTTTCCCCCCCCCC/iSp12/GCGGGCGGTTGTAT
AGCGG [88]
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